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Abstract 
Objectives: Chlamydia trachomatis is the most prevalent sexually transmitted infection in 
the UK. Prevalence is highest among those aged under 25 years. Traditional efforts to 
screen and treat this largely asymptornatic infection have primarily focused on women, 
with no screening for men outwith sexual health clinics. However, screening and treating 
men, apart from reducing the total burden of disease, also serves as a primary prevention 
strategy for women. There is a lack of data on how best to involve men in screening, 
although recently 'innovative approaches' to target men have been advocated in the 
government's White Paper Thoosing Health'. The aims of this PhD study were to assess 
the feasibility of accessing non-medical settings within which to offer chlarnydia 
screening, to ascertain the knowledge of chlarnydia and young men's and women's views 
of towards non-medical screening, and to assess relative willingness to be screened for 
chlamydia by young men and women. 
Design: A mixed method study, using both quantitative and qualitative methods, with a 
survey conducted in each of three settings with all participants to assess knowledge of and 
attitudes towards screening for chlamydia in non-medical situations. All participants 
approached were offered opportunistic screening for chlamydia by urine sample. In-depth 
interviews were conducted with 24 participants (10 men and 14 women) to explore young 
people's views towards screening in non-medical settings. Participant observation 
techniques were also employed to collect data on young people's response to the offer of 
screening, 
Participants: Three hundred and sixty three young women and men aged between 16 and 
24 years participated in the survey; 24 in the depth interview. 
Setting: Three non-medical locations in Glasgow: 'Education' (a large further education 
college); 'Health and Fitness. ' (three local authority leisure centres); and, 'Workplace' (two 
contact centres). 
Results: Eighty-four percent of age eligible users approached participated in education 
health and fitness and workplace settings (n=126, n=133 and n--104, respectively). Of all 
sexually active people 113 (32%) were willing to be tested for chlamydia in non-medical 
settings. Uptake of testing was highest in the health and fitness setting (50% uptake for 
both women and men compared with 20% in education and 30% in workplace settingsy. In 
each setting young men were more willing than women to accept the offer of a chlamydia 
test. Overall, 40% of men approached provided a sample compared with 27% of all 
women. Disease prevalence was 4.4% (4.9% in men; 3.8% in women). Interview data 
suggests young men's willingness to be tested for chlaraydia in non-medical settings is due 
to convenience and raised awareness of the largely asymptomatic nature of chlamydia 
infection. Whilst 94% of men screened had never been tested for chlamydia before, one in 
three young women screened had previous screening experience. Women's lower uptake 
of screening was due to concerns about the public nature of the settings leading to stigma. 
Conclusions: Willingness to be screened in non-medical settings and views in support of 
non-medical screening were highest among men. Supports and barriers to willingness 
differed by gender, with men less concerned with the stigma of participating in screening 
in public settings than women and instead favouring the convenience of the offer. This 
approach reached young men who had never been screened before. Thus, increasing 
opportunities for the take-up of screening in non-medical settings could be an effective 
approach to reaching young men and have a significant impact on the incidence and 
prevalence of this easily treated STI, thereby reducing the future burden of unwanted 
reproductive health sequelae. 
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Preface 
For clarification purposes, it is useful to define some terms used throughout this thesis. 
First, the term 'chlamydia' refers to genital Chlamydia trachomatis. Second, in this thesis 
all settings that are non-medical are referred to as being non-medical settings. 
Community-based approaches or community screening studies are defined in this thesis as 
those which involve medical spaces, such as community family planning clinics and youth 
clinics that are often attached to schools. The author acknowledges that many clinical 
settings are referred to in the literature as 'community'; however the author wished to 
make a distinction between community and non-medical in this thesis. Third, the terms 
cyoung men' and 'young women' are often used and refer to men and women aged 16-25 
years. Where a distinction is to be made between persons under 20 years and those aged 
20-24, this will be clearly stated. 
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Definitions 
AIDS Acquired Immunodeficiency Syndrome 
CASI Computer-assisted self-completion interviews 
CDC Centres, for Disease Control and Prevention 
CI Confidence interval. A range of values for a variable of interest constructed 
so that this range has a specific probability of including the true value of the 
variable 
CM0 Chief Medical Officer 
EIA Enzyme Immunosorbant Assays 
FVU First-void urine (i. e. the first part of the stream) 
GUM Genitourinary Medicine Clinics 
HIV Human Immunodeficiency Virus 
1AQ Interviewer administered questionnaire 
LCR Ligase Chain Reaction, a specific kind of NAAT 
MSM Men who have sex with men 
NAAT Nucleic Acid Amplification Test- laboratory based test for the diagnosis of 
genital Chlaniydia trachoniatis 
Natsal National Survey of Sexual Attitudes and Lifestyles 
NGU Non-gonococcal urethritis 
OR Odds ratio. It is defined as the ratio of the odds of an event occurring in one 
group to the odds of it occurring in another group 
PCR Polymerase Chain Reaction, a specific kind of NAAT 
PID Pelvic Inflammatory Disease 
P&P Pen and Paper (refers to questionnaire completion method) 
RCT Randomised Control Trial 
SAQ Self-administered questionnaire 
SBHC School-based health centres 
STD Sexually Transmitted Disease. Refers only to infection causing symptoms 
or problems 
STI Sexually Transmitted Infection. Refers to infection with any germs that 
cause an STD, even if the infected person has no symptoms 
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Introduction 
"We have been appalled by the crisis in sexual health Ive have heard about 
atid witizessed during our Mquiiy. Me do itot use the word 'crisis' lightly but 
in this case it is appropriate. Ais is a ma r public health issue and the YO 
problems identified in this report must be addressed immediately. 
(House of Connizons Health Committee 2003). 
This was the conclusion of a House of Commons Health Committee report in 2003. 
Sexually transmitted infections (STIs) are hidden epidemics of considerable health and 
economic consequence in the UK. As such, they present a significant public health issue. 
Currently the most common STI in the LJK is Chlamydia trachornatis (chlamydia). This 
bacterial in fection is most common in young people under 25 years: there may be around 
1 in 10 young people under 25 with this infection (Chief Medical Officer's Expert 
Advisory Group 1998b). 
To date, much screening research and planning have largely centred on women (Hart et al. 
2002). There is currently a lack of data on how best to involve men in screening, although 
recently 'innovative approaches' to target men have been advocated in the government's 
White Paper Choosing Health (Department of Health 2001b) . As such, the current climate 
supports more 'innovative ways' with which to offer chlarnydia testing and screening to 
those at risk populations who have no symptoms of infection and who seldom access 
clinical services (specifically young men). 
The aims of this PhD study were to assess the feasibility of accessing non-medical settings 
within which to offer chlamydia screening, to ascertain the knowledge of chlamydia and 
young men's and women's views of towards non-medical screening, and to assess relative 
willingness to be screened for chlamydia by young men and women. 
Chapter I outlines the nature of the problem: first the chapter provides background 
epidemiology of chlamydia infection and describes the various control measures in place in 
various countries, including England and Scotland. The chapter then presents the key 
screening debates including how best to screen, where best to screen and to whom 
screening should be offered. Chapter 2 draws out in more detail the key issues that may 
impinge upon the effectiveness of screening approaches, with particular attention paid to 
the methods that improve the effectiveness of screening. The review of screening studies 
focuses on setting-specific issues because non-medical settings do not have the same 
infrastructure in place as clinical settings. Barriers'and supports to screening are explored. 
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The aims and objectives of this study are presented in Chapter 3, which also discusses the 
methodology and methods employed in this study. Particular issues of concern in the 
design of this study included the sensitive nature of the topic and the young age of the 
sample population (16-24 years) and these are discussed. The largely exploratory nature of 
this particular area of research meant that some of the planning was re-evaluated 
throughout the progress of data collection. This chapter also describes the approach to 
accessing non-medical settings within which to establish screening. 
In Chapters 4,5 and 6, the results of the study are presented. These chapters are presented 
according the overarching aims of the study: to assess feasibility, knowledge and, 
willingness. Chapter 4 describes the feasibility of gaining access to non-medical settings 
for the purpose of conducting a screening study. A large part of the data used in this 
chapter was drawn from fieldnote diaries, within which the author's experiences and 
observations during the study were noted, as well as the views of respondents that were 
conveyed within these settings. Interview data provides further information regarding how 
young men and women in the study settings responded to the offer of screening. Chapter 5 
describes the views of young men and women towards chlamydia screening as well as their 
knowledge of chlamydia. Both those who accepted screening and those who declined gave 
their views towards screening. Chapter 6 presents the results of the willingness of young 
men and women to accept the offer of screening, by providing a sample of urine. The 
proportion of those who accepted the offer is reported, by gender, age and setting. Factors 
reported by respondents as barriers or supports to accepting screening are discussed. 
The final summary and interpretation of results chapter (Chapter 7) draws together. the 
findings from the data chapters to address the aims of the study and the research questions. 
The chapter concludes by noting the limitations of the study, but also suggesting its 
contribution to the existing literature, and the implications to policy and further research. 
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Since the mid-1990s, the United Kingdom (LJK) has witnessed a rapid deterioration in 
sexual health; indeed, a recent Health Committee Report referred to a current 'crisis in 
sexual health' in the LJK (House of Commons Health Committee 2003). Sexually 
transmitted infections (STIs) are estimated to cost the NUS around E874 million per year in 
treatment and consequences. Of these genital Chlamydia trachomatis (chlamydia), the 
most common STI, costs around E100 million per year (Chief Medical Officer's Expert 
Advisory Group 1998b). Currently, around I in 10 sexually active young people under 25 
years in the UK are thought to be infected with chlamydia (Chief Medical Officer's Expert 
Advisory Group 1998b). Associated complications with chlamydia infection include 
pelvic inflammatory disease (PID), ectopic pregnancy and infertility. The physical and 
psychological impact on individual health, and the economic consequences of chlamydia 
signifies this infection as a major public health issue. 
The high prevalence of chlarnydia infection is not just a public health issue in the UK. 
According to the World Health Organisation (WHO) chIamydia infection is currently the 
most common bacterial STI in the industrialised world, with an estimated 92 million cases 
of chlamydia occurring worldwide each year, of which 5 million occur in Western Europe 
(WHO 2001). There have been notable rises in chlamydia in most western industrialised 
countries, including Sweden, USA, Canada, as well as in Australia and New Zealand since 
themid-1990s. At- the same time, reported rates of infection in all nations of the UK have 
mirrored this trend. The incidence of chlamydia infection has been increasing in England, 
Wales and Northern Ireland: from 30,794 in 1995 to 97,027 in 2004, a 215% increase 
(Health Protection Agency 2005). In Scotland, reported cases of this curable bacterial 
infection have continued to rise each year since the mid-1990s, with 15,865 cases reported 
to the Scottish Centre for Infection and Environmental Health (SCIEH) in 2004 from 
laboratories in Scotland, compared with 2679 in 1995 (Wallace et al. 2005). 
The response by government to the rising rate of chlamydia infections in the UK has been 
to examine the evidence for introducing a nationwide chlamydia screening programme. 
There has been a growing impetus towards introducing a national screening programme for 
chlamydia because active case finding and early treatment are strategies to prevent the 
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development of sequelae and to reduce transmission. A reduction in both of these will 
reduce costs to both the NHS and individual health. 
The possibility of introducing a national screening programme has been made more 
feasible since the introduction of highly sensitive tests that can be performed on non- 
invasively collected urine specimens (Catry et al. 1995). These tests are more acceptable 
to patients (Pimenta et al. 2003b) and therefore any proposed widespread screening may be 
more successful in reaching asymptornatic populations who do not present to health care 
settings for a genital examination. Currently, in England, chlamydia screening is being 
rolled-out across the country. The Department of Health aim to establish screening in all 
areas of England by 2007. 
As the devolved Government for Scotland, the Scottish Executive is responsible for health 
policy in Scotland. The screening programme for chlamydia that has been proposed by the 
Department of Health is specific to England. No chlamydia screening programme is 
planned in Scotland. As the thesis will describe, the English proposals to control 
chlamydia infection in the population places emphasis on opportunistically screening 
people predominantly when they access clinical settings (Department of Health 2001a; 
Department of Health 2001c); however, the largely asymptomatic nature of chlamydia 
infection means that many asymptomatic infections may not be identified thorough clinic- 
control efforts. It has been estimated that only around 10% of prevalent infections are 
diagnosed at genitourinary medicine (GUM) clinics (Chief Medical Officer's Expert 
Advisory Group 1998b). There is therefore a significant 'reservoir of infection' 
unidentified in the population (Fenton 2000). Taking screening and testing into non- 
medical settings within communities could be one approach to reach asymptomatic 
persons. The use of non-invasive tests offers new opportunities for screening outwith 
clinical settings. Evidence on the utility of non-medical approaches is emerging, from 
studies conducted in settings such as student bars (Hay et al. 2004), schools and 
universities (Cohen et al. 1999; Debattista et al. 2002b) and in field settings such as street 
comers and parks (Gunn et al. 1998; Rietmeijer et al. 1997). Despite this, further evidence 
on the feasibility of offering screening in non-medical settings is required. Such 
information would bolster the current evidence-base, upon which screening policy is 
based. 
This thesis therefore aims to assess the feasibility of an innovative approach to offering 
chlamydia screening to young men and women under 25 years: non-medical settings will 
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be chosen in which to establish screening. In this chapter, the first section outlines the 
epidemiology of chlamydia and discusses the implications of the development of sensitive 
tests, which can be performed on non-invasive samples such as urine samples. The second 
section of the chapter outlines the status of chlamydia screening around Europe, North 
American countries as well as some Australasian countries (Australia and New Zealand) to 
contextualise chlamydia control activities taking place in the broader context. Finally the 
chapter offers an exploration of the current debates (predominantly in England) regarding 
how best to screen, where to offer screening, and to whom screening efforts should be 
targeted. 
Clinical features of chlamydia 
Chlamydia trachomatis is an obligate intracellular human bacterial pathogen that infects 
the epithelia] cells' of the eye and genital tract, such as the urethra, cervix and fallopian 
tubes. Chlamydia has three important features: it is often asymptomatic; infection can 
persist for more than a year; and, if left untreated, it has been associated with 
complications, such as ectopic pregnancy, PID as well as infertility in women, and fertility 
complications in men. 
Chlarnydia is often symptomless in both women and men: around 50% of men and 70% of 
women may show no sign or symptoms of having infection (Chief Medical Officer's 
Expert Advisory Group 1998b). Symptoms associated with chlamydia infection are given 
in table 1. Chlamydia infections can therefore run both a symptomatic and an 
asymptomatic course. 
Table 1: Clinical features of chlamydia infection, in women and men 
Women 
Urethral discharge Vaginal discharge 
Dysuria (pain or discomfort on passing Intermenstrual bleeding (bleeding 
urine) between periods) 
Con unctivitis Post-coital bleeding (bleeding after 
intercourse) 
Dysuria 
Lower abdominal pain 
Painful intercourse 
Conjunctivitis 
2 Epithelial cells cover the surface of the body and line its cavities. 
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Untreated, chlamydia can remain undetected. In such cases, it has been suggested that 
there is an association between chlamydia infection and secondary complications in 
women, such as PID and its major sequelae, tubal infertility and ectopic pregnancy (Giertz 
et al. 1987; Hillis et al. 1997; Scholes et al. 1996). In females, chlamydia infects first the 
cervix, spreading to the endometrium. When left untreated the infection may ascend to the 
upper reproductive tract of women to the fallopian tubes where PID may manifest (Cates et 
al. 1994). In addition to infertility, chlamydia has also been associated with ectopic 
pregnancy and infant conjunctivitis - obtained during vaginal deliveries to a mother with 
chlamydia infection in the genital tract (Pellowe & Pratt 2006). In men, chlamydia mostly 
affects the urethra (the urine tube) or epididymis (the tube which carries sperm from the 
testicles) causing inflammation in the affected site of infection (Idahl et al. 2004). It has 
also been suggested that chlamydia can damage men's sperm (Eley et al. 2005). The 
association between chlamydia infection and future reproductive morbidity, for both sexes, 
highlight chlamydia infection as a serious health concern for individuals. 
Recently, however, it has been suggested that chlarnydia infection, in some cases, can clear 
up if left untreated (Morr6 et al. 2003). In addition, the link between chlamydia and 
subsequent associated sequelac, such as ectopic pregnancy and PID has been questioned 
(Honey & Templeton 2002). In a systematic review of screening articles Honey and 
Templeton (2002) found only two randomised control trials (RCTs) which proposed a link 
between chlarnydia infection and PBD (Giertz et al. 1987; Scholes et al. 1996). From the 
analysis of the two RCT studies, the authors concluded that there was as yet no 
unequivocal evidence for screening reducing the incidence of PID and its major sequelae, 
tubal infertility and ectopic pregnancy (Honey & Templeton 2002). The links between 
chlamydia and subsequent associated sequelae will be discussed in more detail in chapter 
2. The important point to bear in mind here is that the sparse evidence from RCTs 
(considered the most rigorous of methodology) of a link between chlamydia and PID, 
ectopic pregnancy and infertility has implications for future screening programmes, as well 
as cost-benefits that can be attributed to screening. Nevertheless, despite only two RCTs 
published in the literature other evidence does suggests it is biologically plausible that 
chlamydia can cause damage to reproductive organs in women (Cohen et al. 1999; Egger 
et al. 1998; Kamwendo et al. 2000). 
Epidemiology of infection 
Currently chlarnydia infection is the most common reported STI in Scotland, with 15,865 
cases diagnosed in 2004, having increased from 2679 in 1995 (Wallace et al. 2005). This 
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reported increase in chlamydia in Scotland is based on the collection of GUM clinic data. 
Data from GUM clinics started to be collected in Scotland in 1921/22 and continued until 
the early 1980s in an aggregated forrn showing Scotland only totals (ISD, 2005'). Until 
1990, chlamydia was reported in the category non-specific genital infections; since 1990 
chlamydia has been reported separately and since 1995 the collection of data became 
patient based (allowing the collection of information on gender and age). Since 1995, 
chlamydia reports in Scotland have mirrored trends reported in other nations of the United 
Kingdom: in England, Wales and Northern Ireland combined, there were 30,794 diagnoses 
made in 1995, increasing to 97,027 in 2004 -a 215% increase (Health Protection Agency 
2005). 
Epidemiological data suggests there is geographical, gender and age specific incidence of 
chlamydia infection. In Scotland in 2004, the majority, 21.9%, of reported cases of 
chlamydia were from Greater Glasgow Health Board, with 19% from Lothian, 11.3% from 
Grampian and 8% from Tayside (Wallace et al. 2005). There are also notable gender 
differences in incidence. The incidence of chlamydia is higher among women than men. 
In 2004,65.5% of reported cases in Scotland were among females. The highest incidence 
rates are reported among those under the age of 25, where rates have been increasing since 
1995 (see figure 1). The highest age prevalence among women and men in Scotland is 20- 
24 years (Wallace et al. 2005). 
Figure 1: GUM reports of genital chlamydia, by age, Scotland 1995 - 2004 
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The prevalence of chlamydia in the UK has not been comprehensively established 
(Underhill et al. 2003); however, epidemiological data from prevalence studies report 
prevalence between I% and 29%, depending on the population studied and diagnostic test 
used (Burstein et al. 1998a; Chief Medical Officer's Expert Advisory Group 1998b; Fenton 
et al. 2001c; Grun et al. 1997; MacMillan et al. 2005; Skjeldestad et al. 1997; Stokes 
1997). The highest age-prevalence reported in prevalence literature is in persons aged 
younger than 25 years old and it is estimated that around I in 10 young people have 
chlamydia in the UK (Chief Medical Officer's Expert Advisory Group 1998b). 
Prevalence data is based largely on studies of clinic-based populations, in particular GUM 
clinics and from primary care settings. In England, the Health Protection Agency compiles 
statistics based on quarterly reports from GUM clinics. In Scotland data is collected 
routinely from GUM clinics and laboratories. The reports from GUM and laboratories 
confirm only those who have been tested and identified with infection. Since many persons 
with chlamydia will show no sign(s) or symptom(s) of infection, reports of infection from 
GUM clinics may underestimate true prevalence. Furthermore, high proportions of 
chlamydia cases have also been found in primary care settings in the UK, indicating the 
distribution of chlamydia in the population as endemic and particularly associated with 
high-risk groups (Lowndes & Fenton 2004). However, only 10% of prevalent infections 
are diagnosed in GUM clinics (Chief Medical Officer's Expert Advisory Group 1998b). 
Clearly, methods for reaching asymptomatic persons who do not self-refer for testing are 
required. A screening programme for chlarnydia would need to be acceptable to target 
groups if it is to be successful in increasing testing activity and one recent important 
development that may aid the acceptability of screening has been the introduction of urine- 
based tests. 
Diagnosing chlarnydia: advances in diagnostic tests 
Enz"yme immunoassays (EIAs) and immunoflourescence techniques have been used for 
many years for the routine diagnosis of chlamydia infections (Stary 1999). Both of these 
techniques were perfon-ned on culture methods, which require cell scrapings from the site 
of infection - an invasive process for both women and men, and often painful for men. The 
development of nucleic acid amplification (NAA) assays, such as ligase chain reaction 
(LCR), polymerase chain reaction (PCR) and transcription-mediated amplification (TMA) 
is the most recent important advance in the field of diagnosis of sexually transmitted 
infections for two reasons: they can be performed on non-invasive samples, such as urine 
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samples, and they are more sensitive which means they will detect more cases of 
chlarnydia. 
Screening for asymptornatic chlamydia infections was first proposed in the mid-1980s 
(Handsfield et al. 1986). Amplification techniques were first developed and reported as 
being effective on non-invasively collected urine samples in 1988 (Caul et al. 1988). Caul 
and colleagues found that these new tests could detect the genetic material (DNA) of 
chlamydia bacteria. The diagnosis of chlamydia requires sensitive (identifying truly 
diseased persons) and specific (identifying truly non-diseased persons) tests that can be 
used on symptomatic and asymptomatic persons. NAA assays have been proven highly 
sensitive and specific: LCR and PCR have reported sensitivities of greater than 94% and 
specificity above 99% (Hadgu 1999; Stary 1999). In addition, both can be performed on 
non-invasive samples, such as first-void urine (FVU). In one of the first urine studies in 
symptomatic and asymptomatic women, the sensitivity of the LCR assay with FVU 
showed a detection rate for infected women almost 30% greater than that of endocervical 
swab culture (Lee et al. 1995). This was a surprise finding at the tiMC4. 
These newer diagnostic techniques improve the detection of chlamydia infection in various 
ways. Firstly, the greater sensitivity of these methods means that more infections are 
diagnosed in samples that are currently sent to laboratories. Secondly, urine tests, upon 
which LCR and PCR techniques can be performed, may increase testing in clinical settings 
during situations where there is no justification for genital examination and sampling. 
Thirdly, the use of urine samples to detect chlamydia pen-nits the expansion of screening 
beyond traditional clinic environments, which may reach at-risk groups not currently 
accessing healthcare settings in which opportunistic screening is being offered. 
Essentially, urine tests are assisting with widening the screening 'net'. 
The greater acceptability of these non-invasive tests has been reported in the literature 
(Hay et al. 1991; Logan et al. 2005; Pimenta et al. 2003b; Serlin et al. 2002). In Glasgow, 
when the LCR diagnostic test was introduced to the main testing laboratory in April 1997, 
the chlamydia testing activity increased four and a half times between 1996-1997 and 
1999-2000 and the detection rate rose from 4.8% to 7.8% (Scoular et al. 2001a). The 
greatest rise in activity was observed in general practice. Clearly, the new urine-based 
tests were more acceptable to both patients and professionals. 
4 http: //%vN"v. chlamydiae. com/restricted/do cs/I abtes ts/diag_noninvasive. asp flhome 
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The introduction of non-invasive samples has opened up opportunities for screening in 
settings not previously possible when swab-based sampling was common. Since the 
introduction of urine tests, studies have assessed the feasibility of offering screening in a 
range of non-medical settings. For example, postal methods and home testing are two 
methods that have been considered. Studies have also begun to assess the feasibility of 
urine-based screening in some non-medical settings (Cohen et al. 1998; David & Tang 
2003; Poulin et al. 2001; Rietmeijer et al. 1997). Self-sampling, using urine specimens, 
has been found to be as effective as practitioner sampling (Ostergaard et al. 1996). 
Studies involving the use of urine samples have shown that that scope for introducing 
testing extends beyond clinical settings and also outwith medical professionals', since 
respondents themselves are responsible for collecting their own urine sample. The use of 
urine samples for diagnosing chlamydia therefore has the potential to make the previously 
conceived impossible, possible: a wide range of settings could potentially be used in 
-which to establish chlamydia screening. Ten years ago, Professor Anne Johnson, principal 
investigator on the 1990 National Survey of Sexual Attitudes and Lifestyles (Natsal), 
commented that advances in diagnosis may make screening for chlamydia worthwhile 
(Johnson et al. 1996a). Alongside the increased use of urine tests there has been debate 
about introducing a national chlamydia screening programme (in England). Perhaps, as 
Professor Johnson suggested, the introduction of these non-invasive tests may have been a 
driving force behind the development of chlamydia screening policy. 
Status of chlarnydia screening in Europe and North 
America 
With the rapid rise in reported infections in all parts of the LJK, there has been a growing 
discourse regarding controlling chlamydia infection by introducing a screening 
programme. Various factors are associated with the proportion of chlamydia cases 
detected: screening practices, the sensitivity and specificity of tests, contact tracing and 
awareness among at-risk groups of the need for prompt testing. Clinicians do not 
necessarily determine screening practice; rather policy often drives this control measure. 
The response, therefore, of Health Departments in England and Scotland to this growing 
crisis in sexual health has an important effect on screening practices and so is worth 
discussing. 
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Before this, it is worth referencing the context of chlamydia control activities taking place 
at a European and North American level as this contributes to the evidence-base upon 
which policy in the LJK is shaped. Screening practices vary widely across the European 
countries'. STI clinic attendees and pregnant women are the population groups most 
frequently screened (Lowndes & Fenton 2004). There are also considerable variations in 
partner notification practices for STIs in western European countries (Lowndes & Fenton 
2004). Variations in screening and partner notification influence the degree to which 
asymptornatic patients and sexual contact are diagnosed, treated and recorded in 
surveillance statistics across the EU. 
Chlamydia control activities in Sweden have been cited as the most extensive in the world 
(Taylor-Robinson 1994). Opportunistic chlamydia screening of young women in a variety 
of healthcare settings was introduced in some Swedish counties in the early 1980s. Since 
May 1988, Swedish law has made it compulsory across the country to provide free testing, 
treatment and contact tracing to any patient with suspected chlamydia, and to report 
diagnosed infections (Herrmann & Egger 1995). Screening is targeted at sexually active 
women aged 15-29 years seeking contraception or abortion. Men are screened when found 
through contact tracing or if symptomatic and self-refer to a healthcare setting for testing. 
Guidelines for chlamydia screening were introduced in both Canada and USA in 1989 and 
1993, respectively. Both the 1989 Canadian Guidelines for Screening for Chlamydia 
Trachomatis Infection and the Centre for Disease Control (CDC) 1993 guidelines 
Recommendations for the prevention and management of Chlanlydia trachonlatis 
infections apply specifically to women. Men are screened through partner notification 
procedures and when they present to GUM (or STD) clinics. 
Australia introduced screening guidelines for women in 1997 as part of the National 
Management Guidelines for Sexually Transmissable Diseases and Genital Infections. Men 
are involved in screening through partner notification procedures. New Zealand has no 
screening for chlamydia in any population group. The Netherlands, Denmark, Finland, 
Switzerland and Austria all have no organised national chlamydia screening programmes 
(Lowndes & Fenton 2004). In a recent national population based study in the Netherlands 
nationwide screening for chlamydia was not indicated based on low prevalence of infection 
5 Data refers to 15 EU countries and Norway. From I May 2004,10 accession countries (Cyprus, the Czech 
Republic, Estonia, Hungary, Latvia, Lithuania, Malta, Poland, Slovakia and Slovenia) joined the union. 
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found in rural populations (van Bergen et al. 2005). However, in Austria, registered 
prostitutes are regularly screened and screening of pregnant women is also common. 
Chlarnydia screening in England and Scotland 
Until the mid-1990s there were no national policy or guidelines dealing with chlamydia 
screening in the UK. Testing was performed on symptomatic primary health care 
attendees, primarily in GUM settings. As previously mentioned, health is a devolved 
matter in the UK. Thus any discussion of health policy needs to take account of the 
differences which may exist between England and Scotland in the response to the rising 
rate of chlamydia infections. 
As regards England, in 1992 sexual health was one of five priority public health issues in 
Health of the Nation, the public health strategy for England (Department -of Health 1992). 
By 1999 Our Healthiei- Nation no longer prioritised sexual health; only four areas were 
now heralded as a priority for improving public health in England (Department of Health 
1999). Despite this, the Chief Medical Officer's (CMO) Expert Advisory Group on 
chlamydia was set up in 1996 to advise on issues pertaining to chlamydial infections and 
screening programmes. At this time the impetus was 'concern over the steep rise of 
chlamydia cases, particularly amongst the younger sexually active groups' (Kane et al. 
2001). This report is important in the English context as it laid the foundations for 
feasibility studies to be carried out into chlamydia screening around England. The Expert 
Advisory Group report highlighted the need to introduce measures to reduce the prevalence 
of infection and proposed a model for opportunistic screening to be assessed. The report 
concluded: 
'Opportunistic screening should also be offered to wonzen aged over 25 Ivith a new 
sexual partner or who have had two or more partners in the past 12 months although 
they are a lower priority than the younger age group which has higher prevalence 
rates' 
(Chief Medical Officer's Expert Advisory Group 1998a). 
In response to the CMO report, and with advice from the National Screening Committee, 
the Department of Health established a pilot study to examine the feasibility and 
acceptability of the CMO's screening model. The pilot study was established in two health 
authorities in England, Portsmouth and the Wirral, over one year (Pimenta et al. 2003a; 
Pimenta et al. 2003b). In September 1999, pilot work commenced in healthcare sites in 
Portsmouth and the Wirral (Underhill et al. 2003). The pilot study focused mainly on 16- 
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24 year old women and offered women screening by testing a urine sample using LCR. 
Men (aged 16-24 years) were screened by using the same methods at GUM and adolescent 
sexual health clinics. Screening settings in the pilot were general practice, family planning 
clinics, GUM clinics, young people clinics, antenatal clinics and others, including colleges 
and universities (Underhill et al. 2003). The pilot study screened 14,756 persons for 
chlarnydia. The overall prevalence was 9.6%, but varied by health care setting: the highest 
prevalence was detected in GUM clinics in Wirral and the lowest in gynaccology clinic 
attendees in Wirral. Urine screening was found to be highly acceptable to patients 
(Pimenta et al. 2003b). More detail on this study will be given in Chapter 2. Here the key 
point is that the CMO's model for screening, taking screening beyond GUM clinics, was 
assessed and found to be feasible and acceptable to patients. As such, the pilot study 
concurred with the CMO report findings by recommending opportunistic screening for all 
women aged 16-24 years attending any health care site and men attending sexual health 
care settings. 
The recommendations from the pilot study were endorsed in the first National Sti-ategyfor 
Sexual Health and HIV, published in 2001, in which screening for chlarnydia for specific 
groups (women under 25 years included) was recommended (Department of Health 
2001c). Chlarnydia screening in England has since gathered momentum, especially since 
the publication of the Health Select Committee report which described England as having a 
6crisis' in sexual health (House of Commons Health Committee 2003). However, at the 
time of writing, the money allocated for the implementation of the strategy was not ring- 
fenced; therefore, at this point in time it remains unclear how far the strategy will be 
implemented in each Primary Care Trust (PCT) in England, especially given the large 
amount of debt many PCTs have. 
No national chlamydia screening is planned in Scotland. Whilst there has been target 
based public health policy in Scotland since 1992 it was not until 1998 that sexual health 
was given specific reference in a Green Paper Working Togetherfor a Healthier Scotland 
(Department of Health 1998). The White Paper Tbivards a Healthier Scolland announced 
Government funding of fl5m for four national health demonstration projects to be 
established (Scottish Executive, 1999). One of the four projects is Healthy Respect, a 
three-year (phase one) project addressing sexual health and prevention of teenage 
pregnancies. 
Healthy Respect was established in 2000 and was located in the Lothian area (Central 
East) of Scotland. Phase I of Healthy Respect involved 19 projects, including postal 
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testing kits for chlamydia in a wide range of non-medical settings as well as chlamydia 
screening in Further Education (FE) colleges. Healthy Respect was evaluated externally, 
with a view to applying lessons learnt to fonn the basis of a model for the whole of 
Scotland (Tucker et al. 2005). Results from Phase I suggested that chlamydia screening in 
FE colleges was acceptable to young people and feasible (Kernaghan et al. 2005). The 
external evaluation, however, suggested the chlamydia testing component of the project 
had limited impact on uptake of testing in general practice in Lothian (Tucker et al. 2005). 
The evaluation report noted: 
'Overall, Healthy Respect in Lothian appeared to have little impact oil clinicians' 
practice although the few significant differences that were detected tended to 
suggest betterpractice in Lothian. 
(Tucker et al. 2005). 
The results of the Healthy Respect project will infonn subsequent work across Scotland 
regarding improving sexual health. In the meantime, chlarnydia screening in all healthcare 
settings in Scotland are informed by the Scottish Intercollegiate Guidelines Network 
(SIGN 2000). These guidelines were published in 2000 and recommended that testing for 
chlarnydia is performed on both women and men with symptoms or signs of chlarnydia. In 
addition, the guidelines recommended opportunistic screening of sexually active women 
under 25 years and women aged 25 years or older with two or more sexual partners in the 
last year or a change of sexual partner in the last year. As with other European and North 
American countries referred to above, opportunistic screening of men was not included in 
these recommendations as there were few data on men outwith GUM clinics. 
In 2002, a National Sexual Health Strategy was commissioned and a draft sexual health 
strategy for Scotland entitled Enhancing Sexual Wellbeing in Scotlan& A Sexual Health 
and Relationships Strategy was published September 2003. In the proposal, poor sexual 
health in Scotland was attributed to there having been 'neither leadership on sexual health 
issues nor recognition of sexual health as a priority at national level. ' (Scottish Executive 
2003a). The final strategy was published in February 2005. The strategy recommends 
population-based chlamydia screening for women under 25, with targeted screening for 
men who present to GUM clinics. 
Each country in Europe has experienced increase in incidence of reported chlamydia 
infections since the mid-1990s. From around this time, there are no systematic, register- 
based screening programmes for genital chlamydia in Europe, although this is the only 
intervention that has been shown to be effective in rapdomised controlled trials (Ostergaard 
Karen Lorimer, 2006 Chapter 1,25 
et al. 2000; Scholes et al. 1996). Whilst the English model for screening is opportunistic, 
the Scottish Executive has recommended a population-based approach. There is debate in 
the literature as to the best method to screen for chlamydia. This and other debates will 
now be considered. 
Screening debates 
Screening debates have largely centred upon three considerations: how best to screen; 
where to screen; and who to target screening efforts towards. Firstly, both population- 
based and opportunistic approaches to screening for chlamydia have been proposed. 
Secondly, clinic-control efforts have been the focus of most screening approaches but 
community-based approaches have been made possible by the introduction of urine-based 
samples. Thirdly, emerging evidence on the high asymptomatic infection in men and the 
results, from a recent population based survey of sexual attitudes and lifestyles, has 
questioned the failure to include men in screening approaches in England. Debates 
regarding whom best to screen have begun to raise questions over men's exclusion from 
screening beyond the level of partner notification. These three issues will now be dealt 
with in turn. 
Firstly, there is debate concerning how best to screen, which centres upon whether an 
opportunistic approach or population-based approach is the most effective method of 
controlling chlamydia infection in a population. Opportunistic screening offers a test to 
those who access health services even if attendances are unrelated to the disease being 
screened for. Population-based screening, or active screening, seeks out at-risk persons 
and offers screening. Postal screening methods are one example of population-based 
approaches. 
Considering opportunistic approaches first, the model for screening proposed in the CMO 
report was opportunistic screening of women under 25 years for chlamydia and men when 
they present to GUM clinics and as part of partner notification procedures (Chief Medical 
Officer's Expert Advisory Group 1998a). The two pilot studies established by the 
Department of Health followed this recommendation and the pilots were designed as 
opportunistic (Pimenta et al. 2000). In Scotland, SIGN Guideline 42 also recommends the 
opportunistic screening of women under 25 years who present to healthcare settings for 
any reason (Scottish Intercollegiate Guidelines Network 2000b). There is therefore a 
developing consensus in the LTK that opportunistic screening is the best method of 
screening for chlamydia. Perhaps the best example of an opportunistic approach has 
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occurred in Sweden: when opportunistic screening was introduced in the mid-1980s there 
was a reported reduction in chlarnydia infection between 1985 and 1995 (Hernnann & 
Egger 1995). 
Opportunistic approaches have been favoured on the grounds of cost-effectiveness (Gene 
et al. 1993; Gene & Mardh 1996; Paavonen 1997). Questions, however, have been raised 
in the literature regarding the effectiveness of opportunistic approaches to chlamydia 
screening. Low and Egger (2002), for example, suggest that much of the evidence, on 
which the decision to introduce opportunistic screening in England was based, stemmed 
from population-based evidence. The authors argue that it is as yet unclear how far such 
evidence can be extrapolated to opportunistic strategies (Low & Egger 2002). 
Further concerns have been raised regarding the extent to which opportunistic approaches 
have been implemented in primary healthcare settings, as recommended in policy and 
guidelines. As mentioned above, the allocated money for the strategy was not ring-fenced; 
therefore it remains unclear how much money will be directed to front line sexual health 
services and how much will be allocated to debt reduction in PCTs. In addition to 
financial restrictions, research has revealed other barriers to implementation for healthcare 
professionals. In a focus group study with members of primary healthcare teams in general 
practices around Southwest England, none of the practices were happy to discuss 
chlamydia in a consultation unrelated to sexual health (McNulty et al. 2004a). This study 
also found knowledge among healthcare professionals to be low, especially regarding the 
benefits of testing as well as when and how to take specimens (McNulty et al. 2004a). 
Other studies have found a low referral rate from primary healthcare settings to GUM 
(Mason et al. 1996; Ross et al. 1996). Some of this has been explained by low knowledge 
of specialist services by primary healthcare professionals in some areas (McNulty et al. 
2004a). Macleod and Smith (1999) have also suggested pragmatic issues, such as the 
limited time available to practitioners in general practice consultations, are likely to reduce 
the number of persons offered opportunistic screening for chlamydia in general practice 
(Macleod & Smith 1999). However, more recent research shows that general practice (in 
England) may be managing chlamydia infections more effectively. The authors of one 
study suggest: 
'a substantial and increasing number of sexually transmitted infections are 
diagnosed and treated in generalpractice and may reflect increasing engagement of 
generalpractitioners ivith sexual health' 
(Cassell et al. 2006). 
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More detail on the advantages and disadvantages of opportunistic screening will be drawn 
out in the next chapter (the review of empirical screening studies). Here, the key point is 
that questions have been raised over the effectiveness of opportunistic approaches, which 
stem from the underlying evidence upon which opportunistic approaches have been based 
as well as provider willingness to screen in healthcare settings. Community settings, such 
as general practice, may be improving management of chlamydia infections, however, the 
degree to which this is effectively reaching persons with asymptornatic infection remains 
unclear. Low et al (2002) suggest that 'a strategy combining opportunistic screening in 
health care settings, which tends to miss a large proportion of men at risk, and partner 
notification may not be sufficient to produce sustained reductions in chlarnydia 
prevalence '. A different approach advocated and undertaken by some has been 
population-based approaches. 
Population-based studies have become more feasible since the introduction of urine-based 
tests. Population-based approaches may have been slower to have been explored as the 
technology required to support PCR or LCR testing on urine samples was slow to be 
introduced throughout the country. As such, population approaches are still undergoing 
evaluation in the literature. Nevertheless, variations in cost-effectiveness, uptake and 
coverage of the target population have been found (see for example, Honey et al 2002). 
Specific detail on the different methods of taking screening to at-risk persons will be 
discussed in Chapter 2. 
Here, particular problems associated with this approach have begun to emerge, such as the 
coverage and uptake of screening in the target populations. The Chlamydia Screening 
Study (ClaSS) was designed as an active screening approach using general practice list and 
postal screening (Low et al. 2004). In all, 19,773 men and women aged between 19-39 
years were offered screening but the authors believed there had only been a 'modest' 
uptake (34%) achieved (Macleod et al. 2005b). The authors of this study reported that it 
was labour intensive to ensure repeat mailings were sent to those who failed to respond to 
the first mail (Macleod et al. 2005b). Despite this, the prevalence of infection found among 
men and women under 25 years was 5.1% and 6.2%, respectively (Macleod et al. 2005b). 
During evidence to the Health Select Committee, a population based strategy was proposed 
by the principal investigator of the Natsal 1990 study, on the basis that chlamydia is so 
widespread in society (House of Commons Health Committee 2003). Population 
approaches may, in this view, reach more people than clinic-control efforts. 
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A second issue considered in screening debates concerns where to screen. Traditional 
efforts to reduce infection rates have depended on testing for infection in clinic settings 
(such as GUM, general practice, family planning, and termination of pregnancy clinics), 
either when a person presents with symptoms or opportunistically during routine health 
care. This approach has its limitations: firstly, most people with infection do not 
experience symptoms and therefore have no physical cue to seek health care. Secondly, 
few young people, the most at-risk group for chlarnydia infection, use specialist sexual 
health services (Johnson et al. 1996b). Thirdly, poor knowledge of sexual health matters, 
especially among teenagers from lower socio-economic backgrounds, may affect ones 
ability to 'choose' health care (Devonshire et al. 1999; Scottish Executive 2003c). 
Barriers to young people accessing clinic-based settings for healthcare include poor 
accessibility due to geographical location, low referral to specialist sexual health services, 
low awareness and knowledge about chlamydia and low perception of risk. These issues 
will be expanded upon in the next chapter, but issues such as these underscore the 
argument for considering widening screening opportunities to settings outwith the 
traditional clinic boundary. 
Offering chlamydia screening in non-medical settings could be effective in reducing some 
of these barriers to accessing testing. This approach offers the opportunity to take testing 
to where young people can be found, which could reduce issues of access, especially in 
locations where specialist sexual health services are not conveniently located. Offering 
screening in non-medical settings also has the potential to raise awareness of chlamydia 
and the need for prompt testing to reduce the possibility of onward transmission and 
developing complications. If this approach became more widespread, then there is the 
possibility that screening could become 'normalised' by virtue of the increased visibility 
and accessibility. Young people accepting testing for chlamydia in non-medical settings 
may also avoid the associated stigma that is attached to accessing GUM clinics, although 
there is not yet enough evidence to suggest this would occur. 
Ultimately, the effectiveness in any control measure depends upon identifying 
asymptomatic infections promptly and reducing the onwards transmission and associated 
complications. As such, approaches to screening for chlamydia in non-medical settings, 
could have the effect of reducing costs to both the NHS (in treatment costs if the 
prevalence of infection declines) and to individuals (in terms of their physical and mental 
health). Screening in the wider community, especi. ally in non-medical settings, needs 
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evaluating if a significant impact on the problem is to be made since chlamydial infection 
is widely distributed among young, sexually active people who may have little contact with 
hcalth scrviccs (Stcphenson 1998). 
A third issue in the literature concerns to whom is screening best offered? In Scotland, 
testing is recommended in women and men presenting to healthcare settings with 
symptoms and in particular asymptomatic groups (see Table 2). It has also been proposed 
that women presenting to healthcare settings for reasons sexual health related or not, men 
who are partners of chlarnydia-positive persons should be offered screening for chlarnydia 
(SIGN 2000). Prevalence of infection varies considerably in the literature from 2.6% 
among women aged 18-35 years attending general practice for a smear test (Grun et al. 
1997), to 31.2% females attending GUM clinics (Burstein et al. 2001). However, 
prevalence is consistently highest among persons under 25 years (Adams et al. 2004a). 
Given the evidence regarding the prevalence, screening has been recommended for 
asymptornatic women who attend healthcare settings for any reason (SIGN 2000). Women 
younger than 25 years and sexually active, and those aged 25 years or older with two more 
partners in the last year or a change of sexual partner in the last year are recommended 
target populations for screening (SIGN 2000). No opportunistic screening was 
recommended for men due to a lack of data on men outwith GUM clinics (SIGN 2000). 
Table 2: Recommendations for testing symptomatic and asymptornatic groups for 
chlamydia (SIGN). 
Symptontatic Asymptoinatic 
Women Vaginal discharge Women undergoing TOP 
Post-coital/intermenstrual Attenders at GUM clinics 
Inflamed/fri able cervix (which may Persons with STIs presenting in 
bleed on contact) other clinics 
Urethritis Women prior to IUD insertion 
Pelvic inflammatory disease Egg donors 
Lower abdominal pain in the sexually Sexual partners of those with 
active chlamvdial infection 
Reactive arthritis in the sexually active 
Men Urethral discharge Semen donors 
Dysuria Attenders at GUM clinics 
Urethritis Persons with STIs presenting in 
Epididymo-orchitis in the sexually other clinics 
active Sexual partners of those with 
Reactive arthritis in the sexually chlamydial infection 
active. 
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Opportunistic screening approaches therefore tend to disproportionately target screening 
efforts towards female populations, since women used the healthcare settings in which 
opportunistic screening is offered more often than men, for example, termination of 
pregnancy clinics, family planning clinics and general practice. The opportunistic model 
of screening was justified in the CMO report as being evidence based and cost effective 
(Pimenta et al. 2000). However, there has been a growing discourse recently that advocates 
the involvement of men in chlamydia screening (Fenton 2000; Hart et al. 2002; Rogstad 
1996). This has stemmed from an increasing evidence-base, which suggests the prevalence 
of infection in men may be similar to that in women, and also that chlamydia may be 
mostly asymptornatic in men. 
Prevalence data from population-based studies in the UK, such as the Natsal 2000 and the 
ClaSS study, have shown significant reservoirs of asYrnptomatic untreated infection, which 
may be similar in men and women (Fenton et al. 2001a; The ClaSS Study Group 2001; 
Van Valkengoed et al. 1999). Recently, a systematic review of prevalence studies 
suggested the prevalence in men may be as high as that in females (Adams et al. 2004a). 
Furthermore, the second annual report from the National Chlamydia Screening 
Programme, for England, reports a higher prevalence of infection in men under 25 years 
than in women (11.9% compared with 10.9%, respectively) (NCSSG 2005). Until this 
data emerged, it had been assumed that the prevalence of infection was lower in men than 
in women, based on the view that men were symptomatic of infection more than women 
(Quinn et al. 1996). Similar prevalence of infection between men and women raises 
questions over the focus of opportunistic screening approaches being primarily upon 
women. Low (2004), for example, has drawn attention to a recent increase in chlamydia 
infections in Sweden, a country that has a reputation for having the most extensive 
chlamydia control activities in the world. Despite this, Sweden has witnessed a recent 
increase in reported chlamydia infections after a substantial downturn since the early- 
1990s (Gotz et al. 2002). These activities are largely opportunistic which, for Low, have 
failed as effective control measures to reducing the prevalence of chlamydia infection in 
the population as many men were not reached via this approach (Low & Egger 2002). In 
light of recently emerging findings, which suggest men are equally at risk of infection as 
women, there has been a growing acknowledgement that to effectively interrupt 
transmission, and tackle the growing rates of infection, men also need to be involved in 
screening, not just women. 
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Including men in screening is part of a primary prevention strategy for women - or 
reducing the risks of actually acquiring the infection; in other words, screening men 
benefits women (Hart et al. 2002). Reducing the risks of women acquiring the infection by 
reducing the prevalence of infection among men is a strong argument for screening men, 
especially in light of prevalence data that suggests there is a large reservoir of 
asymptornatic infection among young men in the population. The most important measure 
to prevent the spread of STIs in societies is primary prevention: these are measures to 
prevent an uninfected person becoming infected or attempts to eliminate or reduce the 
exposure of the infectious agent. Primary prevention strategies can be medically or 
behaviourally focused. As regards chlamydia, medical prevention strategies are limited, as 
no vaccine currently exists. The only effective prevention measures currently available are 
measures affecting personal behaviour. 
Secondary prevention measures attempt to prevent the infected asymptomatic person 
spreading the infection further and prevent complications. Partner tracing is an important 
part of secondary prevention measures. Including men in chlamydia screening 
programmes would identify asymptornatic infection and reduce complications in men, but 
it would also reduce the prevalence of infection in the population, from which women 
could acquire the infection. 
Including men in chlarnydia screening is important in disease control and prevention terms. 
In the absence of good epidemiological data on men, screening women will be ineffective 
in terms of eradication or control (Hart et al. 2002). As the Swedish experience suggests, 
the pool of prevalent male infections will not be effectively reduced via an opportunistic 
screening of women approach. Including men in screening constitutes a good control 
measure but it is also important in preventing any negative 'psychosocial consequences for 
women' (Duncan et al. 2001 a). 
The promotion of women's health and the associated attention placed upon the importance 
of gender within debates on health has facilitated the emerging argument for men's health. 
Women have led the way in promoting gender equality in health care debates; feminist 
debates often incorporated health into its exploration of women's disadvantage in society. 
However, recently the argument that gender differences be recognised in the field of sexual 
and reproductive health has been used to highlight the specific needs of men, which are not 
being addressed. In other words, men are now drawing links between gender and health in 
relation to the inequalities men face. Services for men who have sex with men (MSM) 
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have been provided for many decades; however, until recently there was little known about 
young heterosexual men's beliefs and behaviour in relation to screening, although evidence 
is beginning to emerge (Blake et al. 2003b; Fenton et al. 2001a). Young men areas likely 
as young women to acquire a sexually transmitted infection; therefore a key challenge of 
sexual health services is to involve young men in screening. 
Community and non-medical setting are being considered in feasibility and acceptability 
studies and could be one approach to including men in screening as well as women who 
may not use primary health care or specialist sexual health settings. Non-medical settings 
that have been considered include: student bars (Hay et al. 2004); mailed test kits and 
results rece ived on the Internet (Novak et al. 2003); population based mailed postal testing 
kits (Andersen et al. 1998; Macleod et al. 2005c); field settings (Gunn et al. 1998); mobile 
clinics (Kahn et al. 2003); and schools and universities (Cohen et al. 1999; Debattista et al. 
2002b). These studies found testing in all of these settings was feasible, largely due to the 
detection method with urine samples. More detail on these approaches will be given in the 
next chapter. The emerging findings from these first non-medical approaches which show 
feasibility and willingness at present underscore the importance of experimenting with 
alternative, innovative screening strategies directed at young men. 
Summary 
This chapter has focused on describing the epidemiology, policy developments and 
screening debates concerning genital chlamydia. It is apparent that the rising incidence of 
reported cases of chlamydia is not limited to Scotland, or the UK, but is occurring 
throughout Europe and North America. Whilst some countries have published guidelines 
and strategies for tackling the high incidence of chlamydia infection, no country has a 
systematic register-based screening programme for chlamydia. Increasing rates of 
infection in Sweden suggests this particular strategy of opportunistic screening has not 
controlled transmission - although men still only account for a quarter of those tested in 
Sweden (Low 2004). 
Theoretical models describing the main determinants of the incidence of sexually 
transmitted infections suggest that reducing the mean duration of infectiousness is likely to 
lead to substantially lower levels of disease (Yorke et al. 1978). Therefore, the theoretical 
underpinning of a screening programme is that it detects infections earlier. Screening for 
asymptornatic infection is key to reducing onward transmission and the risks of 
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complications. Opportunistic screening of women, with men included through partner 
notification processes, is the recommended approach to reducing population prevalence 
and complications associated with chlamydia infection (Chief Medical Officer's Expert 
Advisory Group 1998b; SIGN 2000). However, this chapter has illuminated questions 
regarding the effectiveness of this approach. The screening debates encompass questions 
regarding how best to screen, where to screen and to whom screening should be offered. 
Within these debates, issues such as the effectiveness of screening women, with men 
included through partner notification, has been questioned from a control point-of-view but 
also because of the potential for there to be negative implications to women (Duncan et al. 
2001a; Low & Egger 2002). Non-medical approaches to screening offer opportunities to 
widen the screening net and potentially reach at-risk asymptornatic persons who are 
currently being missed with clinic-control efforts. 
How best to screen, where to screen and to whom screening should be offered consist key 
debates in the screening literature. The following chapter offers a more detailed review of 
recent approaches to controlling transmission of chlamydia and outlines the barriers and 
supports to screening in various settings. The utility of screening in non-medical settings 
will also be further explored. 
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Chapter 2 
Existing Empirical Work: the evidence-base 
This chapter outlines the main findings from published research on chlamydia screening 
and testing of women and men. First, the chapter provides an overview of the chlamydia 
screening literature from the 1960s to the present day. Second, a more focused 
examination of recent research that has been carried out in clinical settings will be 
discussed. The third part of the chapter examines the literature concerning screening that 
has occurred in non-medical settings. 
In Chapter 1, the debate regarding how best to screen was outlined. The advantages and 
limitations of both opportunistic and population-based approaches were outlined. Key 
emphasis was placed upon how effective both approaches are in reaching persons with 
asymptomatic infection. In this chapter, the review of screening studies will draw out in 
more detail the key issues that may impinge upon the effectiveness of screening 
approaches, with particular attention paid to participation rates in the approaches cited in 
the literature as well as the number of infected individuals who are notified of their result, 
treatment and partner notification strategies. These are key concerns for any control 
measure, as the effectiveness of screening is limited unless persons identified as having 
chlamydia infection are treated and their partners notified. Lessons learned from the 
various approaches cited in the literature will infonn. the design of the research which 
underpins this thesis. 
Overview of the chlamyclia literature from the 1960s to 
present 
Early chlamydia research 
Early chlamydia research stemmed largely from research in the field of ophthalmology, as 
chlamydia is a cause of ocular trachoma. In 1903, interested in the experimental infection 
by Treponema pallidum (the pathogen responsible for syphilis) Neisser (whom Neisseria 
gonorrhoea is named after) undertook a journey to the island of Java together with t-wo 
other scientists - Ludwig Halberstaedter and Stanislaus von Prowazek. Against the will of 
Neisser, von Prowazek inoculated the eyes of orang-utans with trachoma material 
(obtained from eye scrapings from patients with trachoma) and found that the primates 
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developed conjunctival inclusions. Similar inclusions were found in the conjunctiva of 
infants, the cervix of their mothers and the urethral scrapings from male patients with non- 
gonococcal urethritis. But it was not until 1930 that Philip Thygeson and his colleagues 
were the first to prove the causal baby-mother-non-gonococcal urethritis (NGU) 
connection (Paavonen 2000). Subsequently, a series of papers were published in the 1964 
British Journal of Venereal Diseases (now known as Sexually Transmitted Infections), 
which detailed the isolation of the trachoma agent from the genital tract. Chlamydia was 
initially considered to be a virus as it cannot be cultured on routine artificial (nonliving) 
media used in the clinical microbiology lab - as this technique requires living cells so that 
it can replicate. However, unlike viruses, chlamydia is sensitive to antibiotics 
(tetracyclines and macrolides). That chlamydia is not a virus only became evident in 1965 
with the advent of tissue culture techniques and of electron microscopy. 
Interest in chlamydia infections around the late 1960s early-1970s began to move from the 
periphery of medicine to the mainstream. Rose and Schacter presented tentative 
conclusions in 1964 regarding the potential public health significance of these infections: 
they believed that some infections were sexually acquired as they had observed cases 
where no conjunctivitis was present (Paavonen 2000). A series of articles published in the 
British Journal of Venereal Diseases in 1972 reinforced the initial conclusions presented in 
1964. 
The scope of research on chlamydia subsequently broadened and extended to fields such as 
epidemiology, medical sociology, politics and anthropology. The aetiology of chlamydia, 
the sensitivity and specificity of tests, the prevalence of infection and who best to screen in 
clinic settings has dominated the literature since the publication of the first papers in 1964 
and 1972. Ensuing questions, such as where the disease was found, who was affected and 
how to control it, meant that subsequent research was rooted firmly within the 
epidemiological paradigm. 
The emergence of HIV/AIDS in the early-1980s gave a renewed impetus to sexual health 
research, in general. Since this time, there has been a 'mushrooming' of research on 
chlamydia published. To illuminate this point, a search of Medline, for example, from 
1966 to 2005, using the search term 'Chlamydia trachomatis' found 9,127 results: between 
1966 and 1976 there were 81 results; between 1976 and 1986 there were 1,892; between 
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1986 and 1996 there were 4,232; and, between. 1996 and 2006 (the first quarter) there were 
3,675 6. 
Despite the increased volume of published research, an early analysis of the literature 
highlighted debates concerning how best to screen, where best to screen and who best to 
screen (as discussed in Chapter 1). Gaps therefore remain in the evidence-base. The next 
section of the chapter offers a detailed discussion of the recent clinic-based screening 
literature. 
Screening studies 
Search strategy 
A search of the available literature was carried out using MEDLINE, EMBASE, Scopus 
and Cochrane Library databases. The search was performed on literature from 1980 
onwards'. Search terms included: chlamydia trachomatis; chlamydia trachomatis and 
screening; chlamydia and tests; chlamydia and men; chlamydia and re-infection; chlamydia 
and postal; chlamydia and mail; chlamydia and community; chlamydia and men; sexually 
transmitted infections and sexual health. In addition, studies located by these searches 
were then hand searched for additional references and selected key journals were 
rigorously searched (BMJ, Sexually Transmitted Infections, Sexually Transmitted 
Diseases, JAMA, Journal of Epidemiology and Community Health and International 
Journal of STD and AIDS). Given an aim of this thesis was to assess the feasibility of 
screening in non-medical settings, the literature was reviewed from the perspective-of 
setting-specific issues because non-medical settings do not have the same infrastructure in 
place as clinical settings, such as general practice, GUM and family planning. 
Clinical settings 
The key clinical sites where chlamydia screening have been offered include GUM, general 
practice, family planning and termination of pregnancy clinics, as well as in teenage health 
clinics (predominantly in America, although the Netherlands and the UK have such 
services). Such studies constitute the overwhelming body of the screening literature. 
6 This figure will increase by 31 December 2006. 
7 The literature has been searched in 2006 for any relevant afticles but this was not part of the original 
review. 
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Persons who may have chlamydia infection may present in many different medical settings 
(GUM, general practice, family planning, obstetrics & gynaecology and other hospital 
departments). The prevalence of infection found in clinical settings has a wide variation, 
from 2.6% among women aged 18-35 years attending general practice for a smear test 
(Grun et al. 1997), to 31.2% females attending GUM clinics (Burstein et al. 2001). In 
addition, the number of individuals tested in each setting varies, from 20 (Barlow et al. 
2001) to 42,944 (Scoular et al. 2001a). Prevalence estimates are also largely drawn from 
female populations, with few data available on the prevalence of infection in men. Women 
have thus constituted the primary testing or screening populations. Although, since the 
introduction of non-invasive tests men have been increasingly included in screening 
studies. 
Genitourinary medicine clinic seftings 
GUM clinics in the UK (or STD or what used to be known as venereal disease clinics) 
were established following the Royal Commission Report of 1916. These clinics were 
intended to provide open-access to facilities for confidential diagnosis and treatment of 
STIs. Today, GUM clinics throughout the LJK are primarily responsible for collecting 
national statistics on STIs: all GUM clinics in England and Wales have a statutory 
obligation to complete a statistical return (known as form KC60) of all attendances in the 
previous quarter, and send it to the Communicable Disease Surveillance Centre (CDSC; 
prior to 1996 returns were sent directly to the Department of Health). In Scotland, data on 
all completed 'patient-episodes' of treatment at these clinics are sent each quarter to 
Information Services Division (ISD) Scotland, where they are collated and analysed. 
National data collection from GUM clinics in Scotland began in 1921/22. In addition, 
throughout the UK, laboratory reports of STIs provide information on the diagnosis of 
STIs outwith GUM clinics. In Scotland, Health Protection Scotland (HPS), formerly 
known as the Scottish Centre for Infection and Envirom-nental Health (SCIEH) until 200 4, 
collates and publishes reports sent from GUM clinics, primary care, family planning clinics 
and hospital clinics. This provides an overall view of the prevalence of chlamydia 
infections reported in the population. 
The network of GUM clinics in the UK forrns the key clinical structure within the health 
service dedicated to diagnosis and treatment of sexually transmitted infections. Most 
patients seen at GUM clinics are recorded as 'self-referred' but the proportions who are 
reported as being referred from different sources vary between the sexes and by diagnosis 
(Noone et al. 1998). Studies conducted in GUM clinics provide infon-nation about the 
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prevalence of chlamydia infection, in women and men, the risk factors associated with 
infection, the number of co-infections and the referral rate from other health care services, 
such as general practice, family planning clinics and termination of pregnancy clinics. 
The number of positive diagnoses made in GUM clinics in the UK has been increasing 
since the 1990s, as reported in national data returns from GUM clinics. Explanations for 
this increase include the introduction of non-invasive tests methods. The introduction of 
ligase chain reaction (LCR) to the main chlamydia laboratory in Glasgow, for example, 
resulted in a four and a half times increase in testing activity between April 1996 and 
March 2000 (Scoular et al. 2001a). More tests were therefore performed in Glasgow, 
which led to an increase in the detection rate, from 4.8% in 1996-97 to 7.8% in 1999-2000 
(Scoular et al. 2001 a). The greater acceptability of urine tests to patients and professionals 
has been reported in the literature (Fenton et al. 2001a; Gunn et al. 1998; Pimenta et al. 
2003b). That urine tests are more acceptable to patients may have increased the numbers 
willing to be tested. Regardless of the test method, prevalence reports from GUM clinics 
have traditionally reported the highest prevalence of infection of all clinic-based settings. 
A high prevalence of infection is diagnosed in these settings, perhaps due to those 
exhibiting symptoms accessing this service more than those who are asymptomatic. The 
prevalence of infection found in GUM clinic settings ranges from 9.4% to 19.1% in men 
(Dixon et al. 2002; Evans et al. 1998; Higgins et al. 1998; Templeton et al. 2001); and 
3.0% to 31.2% in women (Burstein et al. 2001; Sudlow et al. 2001). 
It has been argued that GUM clinics attenders exhibit higher risk sexual behaviour than 
those in general population (Catchpole et al. 1997). Younger age, increased number of sex 
partners and low condom use have all been found to be associated with increased risk of 
chlamydia infection (Brown et al. 2004; Burstein et al. 2001; Hughes et al. 2000; 
LaMontagne et al. 2003; Radcliffe et al. 2001; Rosengard et al. 2004; Winter et al. 2000). 
Using data from the Portsmouth pilot Harindra et al found a large number of co-infections 
in GUM attendees (Harindra et al. 2002). Patients attending GUM in the Portsmouth pilot 
site and diagnosed with chlamydia were followed-up for 12 months: of 1075 patients 
diagnosed with chlarnydia, 285 attended the GUM clinic on at least one subsequent 
occasion, of whom 56 (19.6%) were diagnosed with chlarnydia (Lee et al. 2004). 
In addition to screening and testing patients who self-refer, GUM also assumes 
responsibility for many infected persons referred from other clinical services, such as 
general practice, family planning clinics, colposcopy and termination of pregnancy clinics. 
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Screening women in colposcopy yields a high prevalence of infection: in one study an 
8.3% prevalence was found with only 25% receiving treatment prior to the introduction of 
a treatment protocol (Blackwell et al. 2003). Norman and colleagues found only 10% of 
women who tested positive for chlamydia at antenatal, colposcopy and termination of 
pregnancy clinics actually attended GUM clinics, despite being referred for treatment 
(Norman et al. 2004). Other studies that have assessed the uptake of referral to GUM 
clinics have also found low rates of treatment (Groom et al. 2001; McNulty et al. 2004a; 
McNulty et al. 2004b; Wilkinson et al. 2000). Having a health adviser in community 
settings to offer infected persons treatment for their infection has been shown to improve 
the treatment rates of infected persons (Jones et al. 2002). Few studies have been 
conducted to assess why the referral rate from non-GUM settings is low; however one 
found poor factual knowledge about the organisation of GUM services, poor professional 
contact and perceived barriers for patients, such as stigma, reduced the referral rate 
(McClean et al. 1995). The efficacy of a screening strategy is limited if those diagnosed 
with infection are not subsequently treated. Prompt treatment for chlamydia infection is 
necessary to prevent the spread of infection and preventing the development of 
complications in individuals, as well as the increased costs to the NHS in treating these 
complications. 
An increase in screening practices in non-GUM clinical settings would increase the 
workload for GUM clinics; however, some observers have commented that 'currently 
GUM services in the UK arejailing to cope with the increasing workload associated with 
nianaging STIs and diagnosed HIV infections' (Djuretic et al. 2001). This pressure on 
GUM services (in England) was further highlighted in a House of Commons Health 
Committee Report on sexual health: 
'England is currently witnessing a rapid decline in its sexual health... Sexual health 
services appear ill-equipped to deal with the crisis that confronts theill. Median 
waiting thnes to services are currently around 10-12 days and soine services are 
turning hundreds ofpeople away each week' 
(House of Commons Health Committee 2003). 
This is despite the proposal in the National Strategy for Sexual Health and HIV, for 
England, for a 'broader role' for primary care in sexual health management (Department of 
Health 2001c). 
The apparent 'failure' of GUM clinics 'to cope' suggests that any measure to control 
population prevalence by increasing attendance at GUM may be limited unless there is an 
improvement in clinic capacity. In addition to GUM clinic capacity issues, tackling 
infections within GUM might also be limited by the low level of knowledge young 'at risk' 
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people have about chlamydia. Data is emerging regarding the poor levels of awareness 
and knowledge among young people about chlamydia. In one study with GUM clinic 
attendees 51% of men and 60% of women had heard of chlamydia, with the majority 
(82%) unaware of the potential consequences of infection (Devonshire et al. 1999). 
Similar findings were found in another study of GUM clinic attendees (Kellock et al. 
1999). Devonshire and colleagues concluded by suggesting that 'acquisition of knolvledge 
is important, both to reduce sexual risk taking behaviour and its consequences, and to 
allow for informed consent for chlainydia screening prograinines'. These studies were 
with GUM clinic attendees but there is sparse data on the knowledge of chlamydia among 
young persons in the wider community; therefore, it is unclear how far poor knowledge 
acts as a barrier to accessing specialist sexual health settings. Nevertheless, raising 
awareness about chlamydia has been recognised as an important aspect of any proposed 
screening programme (Devonshire et al. 1999). 
In addition to the problem of encouraging young people to attend GUM services, there is 
the additional barrier of physical access to such services, especially for persons in rural 
areas. As such, screening and testing being available outwith GUM clinics is important in 
Scotland as in some rural areas GUM clinics may be inaccessible - for example, there is no 
GUM service in West Lothian, a largely rural area of Central Scotland, therefore 
community-based family planning services are key sites for the introduction of chlarnydia 
screening in that area (Sudlow et al. 2001). In addition, the recommendations of the 
CMO's Expert Advisory Group, included 'Family planning clinics and general practice are 
key locations where testing for chlamydia could be undertaken with referral to GUM 
clinics recommended for partner notification and further management as necessary' (Chief 
Medical Officer's Expert Advisory Group 1998a). This review now considers screening 
and testing in other clinical settings. 
Family planning and general practice settings 
Prevalence studies with family planning clinic populations have all found peak prevalence 
among women under 25 years of age and a similarly high rate of infection in this age group 
- ranging from 2.2% to 24.1% (Burstein et al. 1998a; Burstein et al. 1998b; Han et al. 
1997). A 2.2% prevalence was found in a family planning clinic in which all women 
attending were offered opportunistic screening for chlamydia (Han et al. 1997). The 
highest prevalence was found in younger women (age 13-19,2.7%). Four clinics were 
involved in this study and prevalence varied by the clinic setting, which shows that 
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prevalence varied not just by age but also by location. In another study, consecutive 
adolescent females aged 12-19 years attending a family clinic were offered screening for 
chlarnydia infection; 24.1% of females received a positive diagnosis at their first visit, with 
the highest age prevalence found in 14 year olds (Burstein et al. 1998a). 
Many studies have included all women attending family planning, rather than those aged 
under 25 years; however, all have found the highest age prevalence in the younger age 
groups (Han et al. 1997; Howell et al. 1998; James et al. 1997; Marrazzo et al. 1997b; 
Miller et al. 2000; Sudlow et al. 2001). Other studies, targeting those aged under 25 have 
found similar high prevalence of infection. For example, in a study of women attending a 
large Scottish family planning clinic for emergency contraception, an overall prevalence of 
5.5% was found, with the highest age prevalence in women aged 24 or younger (7.6%) - 
prevalence was 5.3% in women aged 25 to 29 and 1.2% in women aged 30 or more (Kettle 
et al, 2002). A similar UK-based study found a similar prevalence of infection (8.1%) in 
women under 25 years (Macmillan et al. 2002). Similarly, Noone et al (2004) in a study of 
women attending family planning clinics in Glasgow, Edinburgh and Aberdeen found a 
prevalence of 8.2% in those under 25 years (Noone et al. 2004). The Department of 
Health pilot chlamydia screening project in Portsmouth and Wirral found prevalence of 
9.8% and 10.1%, respectively, in family planning clinics (Department of Health 2001a). 
If the Scottish Intercollegiate Guidelines Network (SIGN) guidelines were followed then 
all women under 25 attending family planning clinics would automatically be offered 
screening. Opportunistic screening of men was not recommended in the SIGN guidelines 
as there was limited evidence upon which to base recommendations (Scottish 
Intercollegiate Guidelines Network 2000a). Unsurprisingly, few screening efforts'in 
family planning have reported offering screening to young men under 25 years. As such, 
unlike in GUM settings, few young men will be offered the opportunity to be screened for 
chlamydia in family planning settings. As with GUM settings, family planning relies 
largely on self-referral. Few men use family planning clinics: in Glasgow, for example, 
only 107 men used family planning services at the Sandyford Initiative clinic (a sexual 
health service) in 2002/03 (The Sandyford Initiative 2004). 
Despite the low reported attendance at family planning clinics by men, a small number of 
studies that have offered men screening have shown it is feasible to include men in 
screening in these settings. In one study 905 women under 20 years and 53 men were 
screened by urine sample in a young people's family planning clinics in Merseyside, 
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England, with 5.7% prevalence found in men and 8.5% in women (Harvey et al. 2000). 
The authors acknowledge that whilst it was feasible to include the young men, there were 
poor rates of attendance for treatment; in addition, 12.5% of men failed to be informed of 
their positive result because of subjects' 'priorities changing over a short time' (Harvey et 
al. 2000). A recent study at a young women's health clinic in the USA introduced a male 
clinic within the same organisation and assessed the volume of attendance at the clinic 
(Raine et al. 2004). After one year I 10 new male patients had accessed the clinic. In 
addition, the authors reported that three quarters of young men learned of the clinic by 
word of mouth. Young women attending this clinic were asked to report in self-completed 
questionnaires their views on men being included in the clinic: 92% believed their care 
was similar after the male clinic opened. The authors conclude that more 'in reach' efforts 
(such as increasing clinic attendance) may be required in addition to outreach (extending 
services in the community) at family planning clinics to reach young men. 
However, those who do not access family planning services will not receive the offer of 
screening: many young women, especially adolescent women who do not attend for 
cervical screening or contraception, will not receive the offer of screening unless they 
attend a primary care setting. In addition, many men will not be reached via control efforts 
initiated in family planning. As such, other clinical settings, especially general practice, 
which is used by -80% of persons under 25 years old at least once per year (Boreham. et al. 
2003), may be important places in which to offer screening. 
The first chlarnydia screening study in general practice was in 1983 with women attending 
for a vaginal examination (Southgate et al. 1983). Since then few men have been targeted 
for screening in general practice settings. Where men have been included, the prevalence 
of infection found is lower than in women. In general the prevalence of chlamydia 
infection varies between 0.9% and 14.3% in UK general practices (Oakeshott et al. 2002a; 
Pierpoint et al. 2000). Prevalence found depends on the population tested; nevertheless, 
the highest age prevalence found in general practice has been among those aged under 25 
years. Among women, the prevalence found ranges from 2.0% among women aged 17-35 
years attending general practice for a smear test (Thomson & Wallace 1994), to 14.3% 
among early-pregnant teenagers attending general practice for a routine appointment 
(Oakeshott et al. 2002b). The Department of Health pilot studies in Portsmouth and Wirral 
found 8.5% and 8.7% prevalence among women attending general practice, respectively 
(Pimenta et al. 2003a). Among men, the prevalence of infection found ranges from 0.9% 
among men aged 18-35 years attending their general practice afler being invited for 
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screening (Pierpoint et al. 2000), to 6.2% among men aged 25-29 years whom were offered 
opportunistic screening when they attended their general practice (Kretzschmar et al. 
2001). As with other healthcare settings already discussed, the prevalence of infection in 
general practice varies by age and gender. 
The literature suggests problems exist regarding establishing screening within general 
practice. Essentially, these setting-related issues result in many people not receiving 
screening or else many GP attendees over 25 years old (the group less at risk of having 
chlarnydia infection) receiving the most screening. Some women in general practice are 
offered screening during their 'smear' tests; however this targets older women and 
excludes young teenagers, therefore, many younger women may not be offered screening 
in this location. Young men may also be overlooked within general practice. In one study 
it was found that 54.5% of practice nurses in primary care had never tested men (Robertson 
& Williams 2005). Of 115 persons under 25 years tested via an opportunistic approach in 
another general practice-based study, only 6 were men (Harris 2005). At the end of the 
first year of the roll out of chlamydia screening in England, only 10% of tests conducted 
came from general practice (LaMontagne et al. 2004). In 2004, the Sandyford Initiative in 
Glasgow received 1,123 referrals (8% of all referrals)' from general practice, which 
suggests the low screening rate in general practice in England is not context-specific. 
Whilst many young people making use of general practice might not be offered screening, 
many who do not use such settings are also not reached through this opportunistic 
approach. Thus, many young men and women are not reached via general practice-based 
screening. As such, and as with GUM and family planning settings, opportunistic 
screening and testing in many clinic-based settings are limited in their reach. Essentially, it 
would appear that the 'screening net' is being cast short. 
In relation to some of these problems raised above, qualitative work has been carried out to 
explore the reasons for the variation in testing between practices and what barriers exist for 
healthcare staff that impinges on the testing rates within practices. Such work has 
suggested low knowledge among many general practice staff, as well as concerns about 
testing men have been found to be barriers to effective screening in general practice (Gott 
et al. 2004; Kinn et al. 2000; McNulty et al. 2004a). Focus group research with members 
of a primary care team in Southwest England identified barriers to a ftiller implementation 
of screening guidelines, which included lack of knowledge of the benefits of testing, when 
and how to take specimens, lack of time, worries about discussing sexual health, and lack 
' http: //NvNvNv. isdscotland. org/isd/files/sexli-gum-table6. xls 
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of guidance (McNulty et al. 2004a). Concerns about knowledge of sexual health matters 
has been reported elsewhere in the literature (Humphrey & Nazareth 2001). A 
questionnaire survey of 233 practice nurses identified similar barriers, including lack of 
time, lack of training and concerns about not being able to cope with the issues raised by 
the patient (Stokes & Mears 2000). Training for doctors and nurses in managing sexual 
health at both undergraduate and postgraduate levels has also been deemed inadequate 
(Adler 1998). Many commentators, therefore, argue that general practitioners and practice 
nurses need more education regarding these issues so that screening in these settings are 
effective in reaching these clinic attendees and controlling infections which are diagnosed 
(Gott et al. 2004; Kinn et al. 2000; McNulty et al. 2004a). 
Other clinical settings 
Youth, or teen, clinics are often cited in the literature as being community settings. For 
example, in a recent literature review, testing initiatives carried out at school-based health 
centres (SBHCs) were described as community settings (Ford et al. 2004b). However, as 
stated in the preface to the thesis, youth clinics as well as clinics attached to schools and 
universities are, in this thesis, considered clinical settings. Most of the literature on 
screening in school-based or youth clinic settings stems from the USA. In the UK, some 
studies have been conducted in youth clinics (Armitage et al. 2004; Clements 1999; James 
et al. 1999). All of these studies have focused on assessing the feasibility of screening in 
these settings as well as ascertaining the prevalence of infection among this population. As 
with many family planning and general practice-based studies, young women consist the 
majority of youth clinic study populations and remain the focus of screening progranunes 
in these settings. 
Studies conducted in adolescent clinics in America have found rates of chlamydia infection 
ranging from 0.5% to 26.0% (Beck-Sague et al. 1998; Debattista et al. 2002b; Marrazzo et 
al. 1997a); participants' ages range from 13 to 20 years. Prevalence is highest in those 
accessing youth services who have symptoms: in one study the prevalence among 
symptomatic young men and women (screened in school clinics and adolescent clinics) 
was 26.0% and 10.7%, respectively; in asymptomatic youths the prevalence was 5.3% and 
7.6%, respectively (Marrazzo et al. 1997a). In another study, screening was offered to 
young women who attended adolescent clinics; a 20.7% prevalence of infection was found 
among those aged 13-20 years (Beck-Sague et al. 1998). This high prevalence is perhaps 
not entirely unexpected among a population who self-refer to a clinical setting for 
healthcare. Among young women attending youth clinics for the purpose of a smear test, 
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or general health care who are asymptomatic, one study found an 11% prevalence among 
women aged 13-19 years (James et al. 1999). Thus, unlike in studies conducted within 
general practice settings, there appears to be a consistently high prevalence of infection 
being diagnosed in youth clinic attendees. This is occurring despite the recommendations 
the Centres for Disease Control and Prevention (CDC) made in 1993 to screen all sexually 
active female adolescents (those under 20 years) for chlamydia whenever they undergo a 
pelvic examination as well as yearly screening for those adolescent females considered at 
risk. 
Screening was offered to teenage girls aged 13-20 years who attended a Birmingham-based 
(UK) teenage health clinic for contraception, a cervical smear or who were being referred 
for tennination of pregnancy. The overall prevalence of infection was 11% (94/857), with 
the highest percentage of positive cases among those attending for a cervical smear (34%) 
followed by those referred for termination of pregnancy (23%). This prevalence may be an 
underestimate of infection due to the use of EIA tests that are not as sensitive as the newer 
DNA based tests. No other studies in youth clinics in the UK have been reported in the 
literature. An outreach health adviser was present in one community teenage health clinic 
to facilitate treatment of chlamydia infected young women and conduct partner notification 
(Jones et al. 2002). All 62 women who tested positive (12.9% of those who were 
screened) received their result and were treated. The authors believed this approach to 
managing infections 'helps to address the need for alternative management strategies' 
(Jones et al. 2002). 
Studies conducted in youth clinics that have included young men find the prevalence of 
infection increased with age. The target populations at school-based and youth clinics are 
mostly under 20 years. The prevalence of infection in young men has been found to 
increase with age, so that the highest prevalence in men is found in those aged 20-24 years 
(Low et al. 1997). As such, screening and testing in these youth settings may identify 
more infections among young women than men. A finding from one study, that attempted 
to include young men under 20 years in screening in a family planning clinic for young 
people, was that it was 'difficult to hold their attention Iong enough to complete the 
process of treamient atid contact tracitig' (Harvey et al. 2000). Barriers to screening in 
youth clinics therefore appear to be more than access, as engaging young men in screening 
and maintaining their contact throughout the process of treatment and partner notification 
would appear to also be problematic. 
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Screening in schools may yield more infections among women and some commentators 
have suggested that many of these young women may be engaging in sexual activity with 
men in sexual networks outwith the school (in other words, older men). In comparison, 
young men in school-based settings are more likely to be part of school-based sexual 
networks (Cohen et al. 1999). It would seem then that screening is more cost-effective in 
these youth settings if screening is targeted at young women. However, this would raise 
issues regarding responsibility for sexual health and perhaps place the burden of 
responsibility on young women. 
Sequelae argument: why only screen women? 
Cost-effective analyses have been conducted to assess the best approach to screening for 
chlamydia (Adams et al. 2004b; Honey et al. 2002). A review of cost effectiveness studies 
by Honey et al (2002) found that, depending on the model assumptions, screening females 
for chlamydia infection could be cost effective under various baseline prevalence 
estimates, especially when age is used to select women and DNA testing methods are used. 
Cost effectiveness analyses tend to favour screening women with partner notification (the 
process of contacting partners of infected persons) attached primarily to curb re-infection, 
thus preventing possible sequelae in women. Cost savings are made by avoiding 
complications, such as PID, ectopic pregnancy and infertility. However, the case for there 
being a definitive link between chlarnydial infection of the lower genital tract and 
subsequent ascension resulting in endemetritis, salpingitis, tubo-ovarian abscess or general 
inflammation of the pelvic organs has yet to be convincingly made. 
A systematic review of the literature by Honey and Templeton (2002) attempted to assess 
the link between chlamydia infection and sequelae such as PID. Before discussing this 
important paper, a brief outline of PED and other associated sequelae is useful. PID is 
caused by the ascension of chlamydia infection from the lower genital tract. As infection 
ascends, the inflammation in the cervix causes cervicitis, which is thought to infect the 
endometrium, causing endometritis. Following from cervicitis and endometritis, PED is 
thought to occur. The correlation between PID and chlamydia antibodies links the two in 
the literature (Washington et al. 1991; Westrom et al. 1991). It is difficult to diagnose PID 
and it often requires a laparoscopy. Moreover, many women can suffer from a mild 
asymptornatic form of PID but go on to develop serious consequences. With the impetus 
towards introducing screening for chlamydia, Honey and Templeton (2002) assessed the 
evidence for the role of chlamydia infection in PID. 
Karen Lorimer, 2006 Chapter 2,47 
Two randomised control trials (RCT) were identified in the review of papers from 1980 to 
2000 (Honey & Templeton 2002). The first, by Scholes et al (1996), targeted women 
enrolled on a health maintenance organisation (HMO) in western Washington, USA. The 
aim of the intervention was to screen women according to risk factors (age, number of 
recent sexual partners) whilst leaving the other group to receive usual care. Of the women 
in the screened group who were tested for chlamydia (645/1009), 7% (44) tested positive. 
No figures were available for the usual care group for comparison. The respondents were 
followed-up 12 months later with a questionnaire within which they were asked to report 
an episode of PID. After comparing the questionnaires with medical records there were 9 
cases of PID among women from the screened group whereas 33 were reported from those 
who received usual care. The screened group, therefore, had a 56% lower incidence of 
PED than those in the usual care group. Scholes et al concluded that screening at risk 
women for chlamydia reduces the incidence of PID. 
In the second RCT, women accessing a health care facility for termination of pregnancy 
were invited to participate in screening (Giertz et al. 1987). Women were randomly 
selected to be screened for chlamydia or be tested if they developed symptoms post- 
operatively. Of the screened group 14.2% (41/288) tested positive for chlamydia. The 
case was made for a link between lower genital tract infection and subsequent risk from 
upper genital tract inflammation. 
However, both studies failed to fully detail the randomisation procedures use to allocate 
women to their respective groups. Furthermore, Scholes et al did not have consistency in 
the follow-up procedures for both groups: whilst non-responders in the control group 
received calls and letters encouraging them to participate, those in the usual care group did 
not. This study also relied upon the women self reporting incidence of PID. This is 
problematic as it relies upon not just a similar standard of knowledge between all 
participants but also a particular level of knowledge about a disease that is usually 
confirmed with laparoscopy. 
Since 2000, no further trials on the topic have been conducted. Thus, there currently exists 
no significant evidence to suggest that after being infected with chlamydia a woman is at 
risk from upper genital tract inflammation. Despite this, there is an assumption in current 
literature that screening for chlamydia is cost-saving as it prevents PID. Evidence from 
non-RCT studies has also suggested an association between chlamydia infection and 
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subsequent upper genital tract infection. In a cross-sectional study by Wiesenfeld and 
colleagues women attending a health clinic and subsequently diagnosed with either 
chlarnydia, gonorrhoea or bacterial vaginosis were enrolled to assess whether lower genital 
tract infection is associated with subclinical PID (Wiesenfeld et al. 2002). The median age 
of the cohort was 22 years and most participants reported lower genital tract symptoms. 
Subclinical PID was found to be present in 13% of the women. The authors found that 
chlamydia infections were associated with higher rates of subclinical PID, since 27% of 
women infected with chlamydia were also diagnosed with subelinical PID compared with 
I I% of those without chlamydia infection. However, the women at greater risk already 
had an infection of the lower genital tract upon enrolment and, as such, it may not prove 
useful to extrapolate results to asymptornatic women in the general. population. 
In another study, Whittington et al suggest a link between second or subsequent chlamydial 
infections and sequelae (Whittington et al. 2001). Their prospective cohort study aimed to 
identify factors associated with repeat infections of chlamydia. Young women were 
enrolled from adolescent medicine clinics in various urban sites of the USA; they were 
screened for chlamydia and followed-up at I month and 4 months after completion of 
treatment. Of 1,194 young women enrolled, 792 completed the first follow-up. LCR tests 
on first void urine (i. e. the first part of the stream) were performed at the first follow-up 
which showed 50 of 792 (6.3%) had chlamydial infection. A total of 505 women (68.1%) 
returned for a second visit. Rates of chlamydia among this group using LCR urine tests 
was 36 (7.1%) of the 505 women. Overall, 13.4% of women had repeat infections of 
uncomplicated chlamydia - or I in 7 women remained infected or became re-infected. The 
low numbers of eligible women returning for each visit is problematic with this study and 
questions the validity of the rates of persistent/re-infection. Definitive determinants of 
recurrent infection were not conclusively identified with this study. This allows for 
questions to be raised over the suggested link between chlamydia and sequelae such as PID 
as the implication of the pathogen remain unclear. Indeed, one recent commentator 
suggests that despite massive reductions in PID and ectopic pregnancy cases corresponding 
with decreases in the prevalence of chlamydia infection concomitant with a national 
chlamydia screening programme in Sweden, it is too early to definitively conclude that 
screening activities were the cause (Mardh 2002). More research is required to assess the 
possibility of a link between recurrent infections and sequelae such as PID. This therefore, 
has implications for cost-analyses of the benefits of screening, especially the targeting of 
women. 
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Barriers to the effectiveness of clinic-based approaches 
The preceding sections have outlined the prevalence of chlamydia infection found in 
various clinical settings. The prevalence varies by setting and also by the age and gender 
of those screened. The data consistently suggests that young people aged under 25 years 
are at greatest risk of having chlamydia. However, data suggests that not all clinic settings 
are effectively reaching young asymptornatic at-risk persons. For example, in general 
practice there are barriers such as screening practices and the knowledge and confidence of 
healthcare professionals to screen young persons for chlamydia when they access general 
practice for non-sexual healthcare related matters. It has also been suggested that only 
around 10% of prevalent infections are diagnosed in GUM settings in the UK (Chief 
Medical Officer's Expert Advisory Group 1998b; Simms et al. 1997). In a supporting 
paper accompanying the publication of the draft Scottish sexual health strategy, other 
barriers to the effectiveness of opportunistic screening in clinical settings are discussed 
(Scottish Executive 2003b). 
The Scott Porter review in 2002 identified accessibility as an important issue for sexual 
and reproductive health services (Butler & Solomon 2002). Other research also suggests 
that location is an important factor associated with service uptake (Allaby 1995; Clements 
et al. 1999). Although there may be a wide range of services (and in different settings) 
available, they may not always be accessible to those who need the service. For example, 
opening times, geographical locations and premises could impact negatively on service 
uptake (Scottish Executive 2003b). Research has also suggested that staff attitudes, 
knowledge of young persons' rights and user perception of how confidentiality is dealt 
with are important factors associated with young people accessing services (Burack 2000). 
This supports the findings of the review of sexual health services in Scotland (Butler & 
Solomon 2002). Young people being offered a choice of gender of staff may be factors 
encouraging increasing attendances (Armitage et al. 2004). Stigma associated with GUM 
clinic attendance has also been reported in the literature as an important barrier to 
accessing screening (Cunningham et al. 2002; Fortenberry et al. 2002; Scoular et al. 
2001b). A further barrier to accessing sexual and reproductive services among young 
people may also be related to levels of knowledge about STIs. The chapter previously 
discussed the poor levels of knowledge of chlamydia among GUM and also family 
planning clinic attendees (Devonshire et al. 1999; Kellock et al. 1999; Piercy et al. 2000). 
Survey work with school children, aged 13-16 years, has also revealed a poor awareness of 
chlamydia and, among those who had heard of it, a 'superficial knowledge' (Garside et al. 
2001). Garside et al (2001) found that few respondents were aware of the existence of 
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special services for STIs. These barriers to accessing clinical settings could be significant 
enough to limit the effectiveness of clinic-control efforts. As such, 'innovative approaches' 
to target both men and women have been advocated in the government's White Paper 
Choosing Health, so that screening reaches those whom clinic-control efforts currently 
C miss'(Department of Health 2001b). 
Screening in 'innovative' non-medical settings could be an additional strategy for the 
control of chlamydial infection among difficult-to-reach populations. However, offering 
screening in non-medical settings is a recent approach to STI control since it has primarily 
been since the introduction of urine-based tests that this approach has become more 
feasible. There may be specific setting-related issues in non-medical settings that require 
further exploration before they can be recommended as a useful approach to controlling 
chlarnydia prevalence. The next section of the chapter now considers key issues pertaining 
to screening in non-medical settings (including postal approaches) that might affect the 
design and, ultimately, the feasibility of this approach. 
Non-medical settings 
The introduction of tests that can be performed on urine samples has been a pivotal 
development in the field of chlarnydia research as it allows for the possibility of taking 
testing beyond traditional clinic-based settings, providing an important opportunity to 
develop screening strategies targeting those at risk who seldom, or never, access prima ry 
care or GUM settings. The introduction of these newer DNA-based tests in the mid-1990s 
means that testing in non-medical settings has become possible in the last decade. A 
variety of non-clinical settings are cited in the literature, in which chlamydia screening has 
been offered. Some of these settings have included: military barracks, detention centres, 
bars; and field settings such as parks and street comers. 
Setting-specific issues as well as participation rates, the success of notifying infected 
persons their results and them receiving treatment have been reported as key issues in the 
literature concerning screening in non-medical settings. These issues are less commonly 
cited in studies within clinic-based settings, as there is a different infrastructure in place, 
such as contact information for patients. This part of the chapter considers these issues in 
relation to work undertaken in non-medical settings. Some research suggests that, 
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certainly with effort, infected persons can be successfully treated and partner notification 
undertaken in non-medical settings. 
Since many non-medical screening studies have used convenience sampling, with little 
baseline information collected on the potential screening population, it is often difficult for 
participation rates to be reported. Despite this, participation rates in non-medical screening 
studies have been reported in two ways: firstly, some have reported the proportion of those 
approached who were tested; and secondly, other studies report the time taken to recruit 
participants. When researchers have estimated the proportion of those approached who 
provided a sample for testing, participation ranges from 14% (Gunn et al. 1998) (peer 
outreach workers approaching adolescents in non-facility settings, such as parks, athletic 
fields and street comers) to 100%, (McKay et al. 2003) (new recruits to a military 
barracks). Similar studies report participation to be high: 87% accepted the offer of 
screening at a further education college (Low et al. 2003) and 60% of men provided 
samples when approached at a university sports arena (Powell et al. 2005). 
In other studies, the time taken to recruit samples was given. In one study by Jones et al 
(2000) 31 events were held at various non-medical settings in Missouri, USA, such as 
homeless shelters, soup kitchens and bars, during which presentations were made or tables 
were set-up and passers-by were recruited (resulting in an average 3.2 hours per screening 
session). In all, 277 men and women participated (40.8% were male) by providing a urine 
sample. Outreach workers in a study conducted in Quebec City, Canada were able to test 
626 men and women in 6 months (Poulin et al. 2001); in another 31 samples were 
collected over a 6-week period as the result of a mass media campaign to encourage care- 
seeking behaviour (Oh et al. 2002). A study similar to that of Poulin and colleagues took 
20 months to test 486 young men from facility and field settings in Denver, Colorado 
(Rietmeijer et al. 1997). The highest participation rates appear to occur when there are 
staff present to encourage testing uptake and provide further information. In addition, 
military settings achieve a high participation. This, in part, may be due to the testing being 
offered as part of the entrance medical examination, during which a sample of urine is 
provided (Gaydos et al. 1998; Lechner et al. 2002; McKay et al. 2003; Shafer et al. 1993). 
Some studies using non-medical settings have also gathered background data on 
respondents in the field settings. In one study, peer educators were trained to approach 
young men and women in informal field sites where youths "hang out", such as parks, 
street comers and car parks, but also in facilities (such as community/recreation centres), 
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as part of the Denver Public Health Youth in Action programme (Rietmeijer et al. 1997). 
Surveys were conducted at the same time and 77% of questionnaires were completed 
during 496 'screening encounters". Data such as demographic variables, risk factors and 
condom use were collected from 376 young men. The authors found that the young men 
who agreed to provide a urine sample for testing in the field settings, compared with those 
who gave a sample in facility settings in the study, reported significantly more risk factors 
for infection, which included: had vaginal sex in the past 30 days, currently dating and 
number of sexual partners in the past 6 months. The prevalence of infection from field 
participants was significantly higher than that of facility recruited participants (11.9% 
compared with 4.4%, respectively). 
In a similar study, also conducted in the USA, a brief questionnaire was completed by all 
participants in settings such as shelters, residence facilities, soup kitchens and bars (Jones 
et al. 2000). The brief survey elicited demographic data, symptom status, sexual history 
and written consent. A total of 277 persons were screened at 31 events at 20 different 
community-based sites. The mean number of reported sexual partners in the last three 
months was 2, and 69.5% of respondents reported they did not use a condom at last 
intercourse. Younger age was associated with infection status, with 13.6% of people age 
24 or younger infected compared to a 6.1% prevalence overall. However, gender, race, 
symptom status, and condom use at last intercourse or number of sexual partners in the 
past three months did not correlate with likelihood of infection. 
Few other studies have gathered such information on risk factors; therefore, it is difficult to 
detennine to what extent the 'worried well' are participating in non-medical screening. 
That a high prevalence of infection is found in asymptomatic hard-to-reach groups of 
youths suggests that it is not the 'worried well' that are participating. 
The prevalence of chlamydia infection found in non-medical settings, among those tested, 
varies by gender. Among women the prevalence ranges from 3.6% to 28.3% (Jones et al. 
2000; Klausner et al. 2001; Oh et al. 1998; Poulin et al. 2001; Stock et al. 2001); among 
men 1% to 9.8% (Gunn et al. 1998; Jones et al. 2000; Low et al. 2003; McKay et al. 2003; 
Oh et al. 1998; Poulin et al. 2001; Powell et al. 2005; Rietmeijer et al. 1997; Stock et al. 
2001). In addition, multi-site testing studies have shown that the prevalence of infection 
varies by setting (Jones et al. 2000; Marrazzo et al. 1997a; Rietmeijer et al. 1997; Shafer et 
al. 1993). In addition to gender and setting, age is also a factor affecting the prevalence of 
9A phrase used by the authors to refer to the time spent approaching youths in field settings. 
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infection detected in testing. Studies testing asymptornatic people in non-medical settings 
consistently find higher prevalence in the younger age groups, specifically those aged 
under 20 years. 
Notifying persons diagnosed as positive for chiamydia infection poses particular concerns 
for a non-medical control approach. If young people are approached in settings where there 
is no access to their contact information then participants would either need to call a 
number to obtain their result or such inforination would need to be obtained from the 
individuals within the setting so that participants could be contacted with their result. 
Thus, many studies have relied on either requesting participants call for their test results or 
obtaining contact information at the time the sample is obtained. Of these two approaches, 
notification appears to be most successful when contact infori-nation is provided at the time 
of screening. In one study, with men who have sex with men (MSM), only 19% of 
participants who provided a sample, and 22% of those testing positive, contacted the clinic 
within 6 weeks of the initial contact at the entertainment venues (Debattista et al. 2002a). 
Other studies, which have collected contact information at the time of testing, report much 
higher notification of results: in one study those who tested positive were contacted by 
clinic staff via the contact information given at the time of screening and 100% of people 
testing positive were contacted (Jones et al. 2002). In similar field based studies 95% of 
street workers were notified (Poulin et al. 2001) and 97% of young men testing positive 
were contacted (Rictmeijer et al. 1997) by study staff. In another more recent study, young 
men were contacted with their results via mobile telephone or by e-mail and all received 
their results, with 70% choosing to be contacted via mobile telephone (Powell et al. 2005). 
Thus, obtaining contact inforination at the time the sample is provided is an important part 
of any non-medical screening strategy. However, the utility of any chlamydia screening 
prograrnme lies not solely in identifying infected persons and notifying results, it is crucial 
to the control of infection that infected persons are also treated. 
Most non-medical screening approaches have reported high treatment rates: 97% of 
persons were treated in an average of 8 days with directly observed therapy in Denver 
(Rietmeijer et al. 1997), 91.7% were successfully treated in another (Jones et al. 2000), and 
100% of infected persons were successfully treated in another study (Gunn et al. 1998). 
These studies involved opportunistically approaching youths in parks, street comers and 
other outdoor settings and offered treatment in the field. In one such study, respondents 
who tested positive for a STI at a mobile clinic were requested to attend a clinic for 
treatment and 90% were treated (Kahn et al. 2003).. Although such studies report a high 
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percentage of respondents receiving treatment after participating in a community approach 
to screening, there is variation in the time taken between notification of results and 
treatment noted in the literature. Three studies in the literature report the testing-to- 
treatment interval (Rictmeijer et al. 1997). Of these, the shortest times were associated 
with treatment being provided in the field (Rietmeijer et al. 1997), when test results were 
faxed to respondents' doctors (Jones et al. 2000), and the length of stay at a juvenile 
detention centre (Oh et al. 1998). Clearly, these emerging data suggest that ensuring 
respondents receive treatment is an important consideration in the design of a screening 
approach. Treatment of potentially infected partners is also a key consideration in the 
literature and raises methodological questions for non-medical approaches to chlamydia 
screening. 
Partner notification is the process of contacting partners of infected persons and advising 
them they may have been exposed to an infection and to urgently seek medical attention. 
Partner notification was recognised as important in STI prevention in 1942 in the LJK, 
under Defence Regulation 33B (Cowan et al. 1996). This health regulation was repealed in 
1947. In 1968 the first official document to outline the partner contact process, the 
National Health Service [Venereal Disease] Regulations, was published, which was 
superseded in 1974. These regulations are still in place today. In the UK, Health Advisers 
who are attached to GUM clinics undertake the majority of partner notification. The 
theory behind partner contact is that pre-and-asymptomatic infections can be identified and 
treated, thereby preventing the unknowing onwards transmission of infection, and therefore 
interrupting the chain of transmission. When patients at GUM settings are diagnosed with 
an infection, they are counselled on the availability of partner notification during their 
treatment. 
Few non-medical screening studies report the number of contacts traced or describe the 
strategy in place to contact partners of infected individuals. However, in those where 
information has been reported, a high number of infected persons are counselled on partner 
notification, with many partners successfully contacted and treated. In one study, despite 
young men being recruited from parks, alleys and street comers, 75% of the partners of 
infected mate youths were contacted and treated (Gunn et al. 1998). 'In a population study 
with postal testing, the partners of women with positive chlamydia tests diagnosed in GP 
clinic settings were contacted by two methods to assess the most effective method 
(Andersen et al. 1998). Women in the intervention group were supplied with a home urine 
test kit to give to their partners (to be analysed subsequently with the PCR method); in the 
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control group women were asked to provide their partners with an envelope, in which a 
request to seek treatment at a clinic was made. In the intervention group, 68% of partners 
were contacted, compared with 28% in the control group. Furthermore, there was a trend 
for the partners of women in the intervention group to be tested earlier than those in the 
control group (mean delay time 12.7 days compared with 17.7 days, respectively). 
Simms et al suggest that diagnosis is not a valid outcome measure to evaluate sexual health 
intervention: if patients identified with infection are not treated then they are lost to 
follow-up, which in turn results in poor rates of partner notification, increased likelihood of 
further transmission, reduction in the impact of testing on incidence, and increased risk of 
complications, especially in women (Simrns et al. 2001). Treatment and contact tracing is 
a fundamental part of a screening strategy if it is to be effective in controlling, and 
ultimately reducing, incidence, and possibly the associated sequelae. 
Home testing 
Whilst opportunistic approaches to screening primarily target subpopulations, such as 
clinic attendees and those found using non-medical facilities, population-based approaches 
have been evaluated as an alternative strategy of controlling transmission of infection. 
However, few population based systematic screening programmes have been carried out 
and attempts to validate selective screening criteria have shown poor performance 
(Macleod et al. 2005b). 
Postal testing is the most commonly cited population level approach in the literature. 
Postal testing has been used as one approach to target populations who do not access 
specific sites, even non-medical settings. Postal approaches have been made possible due 
to the introduction of urine-based testing. A number of large-scale studies have utilised a 
postal approach to screening, such as the large feasibility surveys in the Netherlands, as 
well as other cross sectional surveys, such as the UK ClaSS study in Bristol (Macleod et al. 
2005c; van Bergen et al. 2005). Postal testing has been used to assess prevalence, the 
willingness to accept the offer of screening via this method, the effectiveness in screening 
partners of chlamydia infected persons as well as a method of re-screening (Kjaer et al. 
2000). The prevalence of infection found in these studies among young men ranges from 
1.2% in male undergraduates (Rogstad et al. 2001), to 7.8% from screening that was 
initiated through advertisements in the media (Andersen et al. 2001); in females, the 
prevalence of infection found using mailed specimens ranges from 2.5% in a cross 
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sectional study in the Netherlands (van Bergen et al. 2005) to 14.0% in a pharmacy 
initiated postal testing approach (van Bergen et al. 2004). The highest age prevalence was 
in men and women aged under 25 years. 
Many postal prevalence studies have relied on recruitment strategies linked to, or based in, 
clinical settings, for example initiated through GP lists (Low et al. 2004). This has affected 
the population reached, as firstly these studies have shown varying percentages of 'ghost' 
addresses, and secondly some 'at risk' persons may not be registered with a GP, such as 
homeless youth, student populations and those from lower socio-economic backgrounds. 
The ClaSS study in Bristol achieved a 22.2% uptake among the 16-24 age group after the 
first postal invitation; however uptake was lower in men in this age group than women, 
with 18.9% of men compared with 25.3% of women responding to screening by mailing a 
sample (Macleod et al. 2005a). Other postal studies have been initiated from pharmacies. 
In one study, 'hard-to-reach' young women who attended their health-centre pharmacy to 
collect contraceptive prescriptions were opportunistically offered screening by taking a 
postal kit home with them (van Bergen et al. 2004). In this study, 73% of the women 
(aged 15-29 years), when offered, did not provide a sample for chlamydia testing. Postal 
testing relies on motivation for care, knowledge of the importance of screening and self- 
efficacy. Perhaps, in part, this might explain the low uptake in this setting. Uptake in 
population-bascd approached which use postal specimens has been said to achieve Vinlited 
coverage.. and [risks] inissing those potentially at inost risk' (Lewis 2005). 
The second British National Survey of Sexual Attitudes and Lifestyles (Natsal), which was 
conducted between May 1999 and February 2001, incorporated urinary chlamydia testing 
with a stratified cluster of 5026 respondents ages between 18 and 44 years (Fenton et al. 
2001c). Chlamydia was found in 2.2% of men and 1.5% of women. From inter-view data 
with 36 respondents to assess the acceptability of the screening, understanding the test, 
trust and rapport with the interviewer and whether someone else was present at the time 
were all found to be associated with willingness to provide a sample for testing (Fenton et 
al. 2001a). Moreover, the behavioural data collected as part of the Natsal indicated that 
those who provided samples were found to be at somewhat greater risk of infection on 
average than those who declined to provide a sample (McCadden et al. 2005). 
Whilst the uptake of urine-based chlarnydia screening was high as part of the second 
Natsal, in another study the uptake was low. Between 2002-2004 the Men's Health Forum 
initiated a study to assess the feasibility of offering men screening for chlamydia by 
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collecting a 'kit' from colleges and workplaces (The Men's Health Forum 2005). Men at 
the participating settings in England could collect a kit from a toilet or other 'male-only' 
area, take it home and supply a sample of urine for postage to a laboratory. Posters and 
leaflets were distributed in the settings one week prior to the availability of the testing kits, 
to draw attention to the study. The participation rates were estimated based on those 
eligible for testing, and number of kits taken from the venue. In the college setting 100 
kits were removed and 41 samples (41%) were returned to the laboratory; in the workplace 
settings 2,359 kits were taken and 285 (12.1%) returned to the laboratory. The prevalence 
of infection was only reported for the workplace settings (1%), with a 3.4% prevalence 
found in men under 30 years. In contrast to the Healthy Respect project (described in 
Chapter VO), 77% of kits were used by men. As such, and in contrast to Natsal 2000, that 
no person was present to motivate young men to seek testing may have been a factor 
affecting the low uptake of screening in this study. Recent research suggests that single 
recruiter approaching individuals is less effective at recruiting young people into screening 
(Ivaz et al. 2006). 
As with all research, bias can influence the results of postal surveys. If core 'at risk' 
groups are under or over-represented then this will impact on results. Postal testing is 
often initiated from GP lists, so those who are not on lists or who do not access a phan-nacy 
are not included (Bates & Rogstad 2000). This potentially adds bias to such studies as they 
may be under or over-representing at risk 'core' groups, which will affect results and make 
it difficult to extrapolate to the general population. 
Other non-medical settings 
With regards to other non-medical settings, screening has been offered to new male and 
female military recruits, with a high prevalence of infection found - ranging from 2.7% to 
15% (Brodine et al. 1998; Fioravante et al. 2005; Gaydos et al. 1998; Lechner et al. 2002; 
McKay et al. 2003; Shafer et al. 1993; Stary et al. 1996). Screening of female recruits has 
revealed a high prevalence of infection, ranging from 2.7% to 15.0% (Brodine et al. 1998; 
Lechner et al. 2002); in men 3.4% to 11.0% (Brodine et al. 1998; Lechner et al. 2002). A 
high percentage of these recruits were asymptomatic, for example, in one recent study with 
798 male military recruits who were screened as part of their routine medical examination, 
9.8% were infected with chlamydia and 88% were asymptomatic (McKay et al. 2003). Re- 
10 Healthy Respect is a Scottish Executive ftinded Demonstration project, within which chlamydia screening 
has been piloted at further education colleges in Lothian, Scotland. Postal testing kits have also been 
made available in High Street stores, such as Boot and Fopp, which persons can take home, provide a 
urine sample and post themselves to a laboratory for testing. 
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infections have also been assessed, with a high rate of re-infections found in one 
population of military recruits: of 11,771 initially diagnosed with chlamydia, 879 became 
re-infected within the four year study period (or until they ceased service) (Barnett & 
Brundage 2001). 
Screening has also been offered to juveniles in young offenders institutions in the UK and 
USA (David & Tang 2003; Mrus et al. 2001; Oh et al. 1998; Pack et al. 2000). A high rate 
of infection has been found in these settings of between 8.8% and 28.3% (Oh et al. 1998). 
Chlarnydia prevalence among male detained youth under 20 years of age has ranged from 
8.8% to 12.4%, which is as high as the prevalence found in GUM settings (David & Tang 
2003; Oh et al. 1998). The high rates of infection found in both female and male detained 
youth suggest an urgent need to detect and successfully treat these infections before the 
youths are released and possibly spread the infection. The high risk sexual behaviour 
reported by many respondents suggests that further transmission is a significant possibility 
(David & Tang 2003). Indeed, David and Tang (2003) suggest detained youth populations 
bear similarities with young male GUM populations, with regards to prevalence of 
infection detected, high risk reported sexual behaviour and previous history of STIs. 
There are, however, setting specific issues with screening for chlamydia in young 
offenders institutions: transfers and court cases often become problematic for successful 
treatment, partner notification and follow-up. In addition, confidentiality is not always 
possible during partner notification sessions due to the presence of a guard (David & Tang 
2003). Nevertheless, a high rate of asymptomatic infection has been found among 
incarcerated youth: Pack et al (2000) found 84% of persons testing positive for chlamydia 
were asymptomatic. A self administered survey was conducted with 87 male youths in one 
study to assess the level of knowledge of chlamydia and the factors associated with a 
reported willingness to be screened for chlamydia (Blake et al. 2003a) . Forty-one per cent 
thought it was possible to die from chlamydia but 90% were willing to be tested for 
chlamydia using a urine test. The authors concluded that dispelling the myths and 
providing young people with more information about chlamydia may be necessary to 
motivate male youth to seek testing. (Blake et al. 2003a) In a similar study, the authors 
also suggested that education and community services are necessary to break the cycle of 
infection for this high-risk population (Kelly et al. ). 
Chlamydia screening has also been offered to student populations; the prevalence found 
among young males tested in college or university se. ttings varies from 2.2% to 8.4% (Lee 
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et al. 2005; Stock et al. 2001); in women the prevalence ranges from 2.2% to 10.6% (ka et 
al. 2005; Lee et al. 2005). The method of approaching students and inviting them to 
participate in screening differs. Some studies have contacted students by mail and offered 
them screening by attending a lab or clinic facility to provide a sample of urine for testing 
(Stock et al. 2001). Others have offered health promotion sessions in further education 
colleges followed by screening (Low et al. 2003). In the study by Low et al (2003) only 
those who attended the sessions were offered screening; therefore those who lacked the 
motivation or understanding to attend the health promotion event were not reached; 
however, the 9.2% prevalence found by Low and colleagues may suggest that those who 
considered themselves to be at risk of infection did in fact attend the events. With no 
information collected on non-attenders, this remains conjecture. Postal initiated testing 
with male undergraduates yielded a 29.1% uptake in another study (Rogstad et al. 2001). 
In contrast, a large community programme, which involved 158 sites, including further 
education colleges and universities (n=16), in which young men and women were 
approached in each setting and offered opportunistic screening, reported a high uptake of 
screening in the educational settings (Bauer et al. 2004). Bauer et al also reported a high 
treatment rate of 93.8%, with an atypically higher prevalence of infection found in young 
men (4.8% compared with 3.6% for women). 
Summary 
'Innovative' approaches to offering screening have been suggested (Department of Health 
2001b). The review of chlamydia screening discussed the potential for clinic-control 
efforts to be ineffective in reducing and/or eradicating chlamydia. Various barriers to the 
effectiveness of opportunistic approaches and population-based approaches were discussed 
including accessibility, knowledge and the extent to which various approaches effectively 
reach at-risk persons. Offering screening to key at-risk groups, such as those under 25 
years in clinical settings, will obtain a large coverage. GUM and family planning clinics as 
well as general practice have detected a high prevalence of infection among persons under 
25 years. Despite this, there will inevitably be those who are 'missed', whether this is due 
to their lack of care-seeking behaviour, poor access to services by virtue of geography or 
not receiving the offer of screening when attending health care settings. Given the weight 
of focus of screening upon women, many of these persons could be young men. 
The CMO's Expert Advisory Group acknowledged that the lack of evidence on the 
effectiveness of screening in heterosexual men, male attitudes about reproductive health, 
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and the difficulty in accessing young men influenced their recommendations on screening 
(Fenton 2000). Young men especially are widely believed to be an intractably difficult 
group to reach and engage. However, the results of research using non-medical settings 
and outreach strategies have shown that young men are contactable and it is feasible to 
offer them screening via alternative routes. Some of this work has required flexible 
approaches to engaging with young men and women, who may never have heard of 
chlamydia, or at least have a poor knowledge about the need for prompt testing and 
treatment to reduce the possibility of developing complications and spreading 
asymptomatic infection. Nevertheless, emerging findings are promising and suggest that 
there is willingness among these 'hard-to-reach' groups and that more 'innovative' 
methods are feasible. 
There is still, however, a lack of data on young men and women's views towards screening 
being offered in non-medical settings, especially young men's. Qualitative work has 
largely been conducted with female GUM clinic attenders. These study populations may 
have different views and needs than their female peers who may not access GUM clinics. 
Neither might the views of women be extrapolated to those of young men. Whilst 
continuing to assess the best method, approach and setting in which to offer screening is 
important to strengthen the evidence-base, there is also a strong case to obtain young men 
and women's views regarding the actual experience of being offered screening in non- 
medical settings. 
This study aims to establish screening in various non-medical settings. The views of 
young men and women were also obtained to contextualise the uptake of screening and 
assess the barriers and supports to screening in the study settings. Understanding young 
people's care-seeking behaviour, willingness to participate in chlamydia screening, as well 
as their views towards screening could be crucial to the design and ultimately success of 
screening approaches. The next chapter outlines the methodology and methods chosen for 
this study as well as a description of establishing screening in the pilot setting and the 
approach made to the non-medical settings for the purpose of establishing the main study 
settings. 
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This study was designed as a mixed-methods study, using both quantitative and qualitative 
methods. The chapter gives an account of the choice of methods within a discussion of 
their appropriateness for use in sensitive research. The chapter then goes on to outline the 
reasons for choosing the fieldwork settings and method of data collection. The ethical 
considerations this study raised are discussed, including the importance of informed 
consent. In addition, throughout this chapter a consideration of the implications of the 
sensitive nature of this research is discussed in relation to all aspects of design, 
implementation and analysis. 
Aims and research questions 
Although screening for chlamydia is currently offered in a variety of healthcare settings, a 
large number of young at-risk persons may not receive testing or screening. The previous 
chapters outlined barriers to clinic-based approaches, including problems with access. 
How best to establish screening in non-medical settings remains unclear as the data 
available in the literature is limited. However, the current climate supports more 
I innovative approaches to offering screening to those persons at risk but currently not 
receiving the offer of screening. The purpose of this study was to assess how feasible it 
would be to establish chlamydia screening in non-medical settings and, if successftil, to 
assess how willing young men and women would be to accept the offer of screening in 
these settings by providing a urine sample. 
The main aims of the study were to determine the feasibility of offering testing for 
chlamydia in non-medical contexts; to assess the relative willingness to be tested for 
chlamydia in non-medical settings; and, ascertain the knowledge and understanding of 
chlamydia on the part of young men and women. 
The study examined the following research questions: 
* Is offering chlamydia testing in specific non-medical settings feasible, in 
relation to access to settings and case with which participants can provide a 
sample in non-clinical locations? 
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" What proportion of young men and women, in each study setting, accept the 
offer of a chlarnydia test (by urine sample)? 
" What is the extent of young men and women's knowledge of chlarnydia? 
" What are young people's views towards chlarnydia screening being offered 
in non-medical settings? 
Methodology 
The design of this study was driven by the research questions. As such, the methodology 
and methods employed in this study were arrived at via a pragmatic decision-making 
course. The pragmatic approach considers the research question to be more important than 
either the method or the worldview that is supposed to underlie the method; in other words, 
such an approach uses "what works" (Howe 1988). As Howe (1988) explains: 
'... why should paradignis deternzine the kind of work one inay do with inquby any 
niore than the anzount of ilhanination should deterinine Wiere one inay conduct a 
search? ... Escheiving this kind of "tyranny of inethod" (Bernstein, 1983) - of the 
episteinological over the practical, of the conceptual over the einpirical - is the 
hallinark ofpragnzaticphilosophy. '(p. 13) 
Part of employing this process in this study included considering the use of both 
quantitative and qualitative methodologies as being appropriate for use in this study. Prior 
to the emergence of a pragmatically oriented methodology, two dominant social science 
paradigms or models vied for superior position. The quantitative-qualitative debate, or 
'paradigm wars', in social science research, which came to prominence in the 1960s is 
often described as centring on the different theoretical, ontological, epistemological and 
logical underpinnings of each paradigm (Bryinan, 1988). Each research method is based 
on a particular paradigm, a patterned set of assumptions concerning reality (ontology), 
knowledge of that reality (epistemology), and the particular ways of knowing that reality 
(methodology). Rich and Ginsburg (1999), however, argue that the presentation of 
quantitative and qualitative research being diametrically opposed is artificial. This position 
underlies a general debate in the methodology literature about combining approaches 
(Tashakkori & Teddlie 1998). Essentially, despite the apparent polarised epistemological 
positions of quantitative and qualitative approaches, there is now support for combining 
quantitative and qualitative methods in research (Bryman, 1988). Combining methods can 
capitalise on the strengths of each approach whilst at the same time compensate for the 
weaknesses of each: as Punch (1998: 243) suggests, combining approaches can often 
increase the 'scope, depth andpower of research'. 
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This study used a combined methodology. The aims were to assess the feasibility of 
offering chlamydia screening in various non-medical settings and it was felt important to 
attempt both breadth and depth, as Punch (1998) has argued. In the first instance, it was 
important to gain a broad profile of the individuals in each of the three settings, the 
percentage willing to provide a sample and their general views of the appropriateness or 
otherwise of the settings. Additionally, it was recognised that in public areas individuals 
may not feel comfortable to discuss in any depth their views towards chlamydia screening 
being offered in various non-medical settings, the relevant aspects of their sexual history 
and reasons for being willing or otherwise to provide a urine sample for chlamydia testing. 
Studies of sexual behaviour have often used a mixed method approach because assessing 
sexual behaviour can be challenging due to its sensitive and private nature, as well as the 
complex interplay of factors that produce individual behaviour (Fenton et al. 2001b; Rich 
& Ginsburg 1999). Thus, following examples such as Natsal (Johlison et al. 1994), which 
employed a multi-method approach, it was felt that the, different research questions could 
be answered using the appropriate quantitative and qualitative methodology. 
A quantitative approach was considered useful in this study as the type of data required in 
this study permits the use of predetennined categories of measurement using closed 
questioning. Questions could therefore be collected in a standardised way that would 
permit comparisons both between and within the settings. Some commentary made about 
the relative strengths and weaknesses of the. different settings could be made. Although 
this study was exploratory in essence, due to a lack of existing data on the topic, and was 
therefore bereft of hypotheses, a quantitative approach would nonetheless prove useful in 
this study in a variety of ways. Firstly, obtaining numerical data, or quantifying the data, 
would pen-nit setting comparisons across settings as well as quantifying factors which are 
associated with willingness to be screened for chlamydia, such as sexual lifestyles. In 
essence, using a quantitative approach for the purpose of describing participants could then 
say something about the type of individual such an approach to screening could reach. 
Secondly, data collected using quantitative methods are mostly analysed using statistical 
analysis. The resultant data is used to make deductive generalisations about a phenomena 
(Sarantakos 1998). 
Whilst it was an objective of this study to compare views across and within the settings, 
there was also a concern to gain a deeper understanding of the effect the settings may have 
upon individuals and how beliefs about behaviour, knowledge and screening could affect 
individuals' participation in the offer of screening in these non-medical settings. The study 
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was specifically concerned to gain a deeper understanding of young people's sexual 
lifestyles, attitudes and views towards screening and a qualitative approach would allow 
for such data to be collected. Obtaining this data from respondents is an important route to 
considering the meanings that the young people placed on the request for screening in non- 
medical settings. What information that does exist has involved from GUM attendees, 
women, and men who have sex with men (Duncan et al. 2001b; Lambert et al. 2005; 
Scoular et al. 2001b). By exploring with men and women factors associated with their 
participation (or not), the study would result in important findings that could bolster the 
evidence-base. A key feature of qualitative research is that it seeks to 'study ... the social 
ivoi-ld ... fi-oin the point-of-view of those being studied' (Bryman, 1988: 46). Using a 
qualitative approach in this study would therefore complement the quantitative data. 
Recent studies that have utilised a combined approach include those that are primarily 
concerned with assessing the most appropriate method to understand sexual behaviour 
(Plummer et al. 2004); those exploring the best method to gain reliable and valid data on 
sexual behaviour (see for example, (Coxon 1999; Plummer et al. 2004); (Copas et al. 2002; 
Johnson et al. 2001 a); and, prevalence and attitudinal studies with various populations 
(Bachmann et al. 2003; Burstein et al. 2001; Johnson et al. 2001b). 
The most common approach to mixing methods is the triangulation design, which is 'to 
obtain different but coniplenientmy data on the same topic' (Morse, 1991, p. 122) to best 
understand the research problem. Triangulation design brings together the strengths and 
weaknesses of quantitative and qualitative methods. Combining methods can either enable 
a comparison of findings, such as statistical results with qualitative findings, or expand 
quantitative results with qualitative data. 
According to Creswell (1998), triangulation design has four variants: the convergence 
model, the data transformation model, the validating quantitative data model, and the 
multilevel model (as described by Tashakkori and Teddlie, 1998) (Creswell 1998). The 
differences between each of these variants rest upon firstly, how the data is collected, 
secondly, the reason for the particular process of data collection, and thirdly, how the data 
is then treated. In this study, the convergence method was used. This more traditional 
model of combining methods involves collecting and analysing data on the same 
phenomenon separately then converging the results during the interpretation. The analysis 
of study data collected from both approaches would be conducted separately and then 
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brought together during the interpretation phase. More detail regarding the analysis of data 
will be given later in this chapter. 
Regarding the timing, or sequence, of the data collection in this study, a concurrent rather 
than a sequential approach would be the most pragmatic choice since the study involved 
recruitment from various field settings in which both types of data would be collected. The 
weighting of each method in a mixed method design can vary: either quantitative or 
qualitative data can be accorded relative priority or importance or both can be accorded 
equal status. Both quantitative and qualitative data would be used in this study to draw 
conclusions about the research questions, and both were given equal status in this study. In 
other words, where as in some studies a qualitative approach is used to infonn the 
development of a quantitative approach, or vice versa, this study accorded each approach 
equal status for the purpose of exploring a phenomenon (Tashakkori & Teddlie 1998). 
Gathering the data 
The methods literature acknowledges the difficulties with studies of sexual behaviour and 
this was borne in mind when the study methods were designed. Both the quantitative 
survey and qualitative interview were chosen for use in this study. The decision to employ 
participant observation techniques during data collection in each of the study settings was 
as a consequence of conducting the pilot. This finding as well as the development of these 
instruments will now be outlined in this section of the chapter. 
Choosing and developing the survey 
For reasons of practicality as well as methodology, the SAQ was considered the most 
appropriate method to use in this study. Self administered questionnaires (SAQ) are a 
commonly used method of eliciting information on sexual behaviours. SAQ have been 
used in large-scale probability sample surveys, such Natsal 1990 and 2000 and the USA- 
based National Health and Social Life Survey (Couper & Stinson 1999) and state-wide 
cross-sectional survey (Torkko et al. 2000), as well as in smaller surveys using 
convenience sampling (Shafer et al. 1993; Slonim et al. 2005). The SAQ was used in this 
study as it would allow for the collection of standardised information in a way that would 
enhance privacy for respondents, and also encourage participation in this potentially 
sensitive study. 
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Further reasons for using SAQ in this study include the higher response rate than mailed 
questionnaires (Oppenheim 1992; Robson 1993), in part due to the positive influence 
researchers can have upon respondents' motivation to participate in the survey, by 
conveying the importance of the study, the 'legitimacy', as well as encouraging hesitant 
respondents (Arber 1993). Given the emerging evidence from the literature regarding the 
poor knowledge of chlamydia among young people, the presence of a researcher to 
motivate respondents to participate could be important to successful uptake; therefore 
SAQs were chosen. 
It was decided that the pen and paper (P&P) method of SAQs would be the most 
appropriate for use in this study. Although other, more newer methods, such as internet- 
administered and CASI, also enhance privacy, there were issues specific to this study such 
as time limitations, costs and lack of availability of computer software which precluded 
their use in this study. The study was not designed as a postal study. Instead, respondents 
would be approached in each setting and asked to participate in the study by completing a 
questionnaire and provide a sample for testing (they could choose not to provide a sample 
and remain in the study - more of which shall be detailed later in the chapter). 
The questionnaire was developed to assess a range of aspects including knowledge, beliefs, 
views and experiences (see Appendix 3). When developing the questionnaire, it was bome 
in mind that it would be administered at thesame time as the offer of screening was made 
to respondents. The survey would also collect data from all study participants and so key 
issues pertaining to the feasibility of non-medical chlamydia screening could be collected 
from all people in the study. This was bome in mind when developing the questionnaire. 
In addition, there was also a qualitative component to the study planned. As such, 
important concerns during the design of the questionnaire centred upon the practicality of 
conducting a survey in the non-medical settings, the willingness of respondents to engage 
with both a survey and screening as well as collecting reliable and valid data on the 
phenomenon. 
Reliability concerns in quantitative research refer to the degree to which a measurement, 
given repeatedly, remains the same; or the stability of a measurement over time (Kirk & 
Miller 1986). Reliability then is a measure of consistency. If a test is reliable the results of 
its repeated administration will differentiate members of a group in a consistent manner. 
Usually, reliability in quantitative research is evaluated by calculating the correlation 
coefficient between the two administrations of the test in the same groups of people 
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(Tashakkori & Teddlie 1998). In this study, however, such measures were not planned as 
the quantitative approach was being employed as a means to describing the participants in 
screening. 
The reliability of data collected in this study could potentially be low due to the many 
potential environmental factors that could prohibit the replicability of the study findings, 
such as the interviewer effect and bias in the sample. Nevertheless, the author planned to 
administer the survey in a consistent manner with all respondents in each setting. In other 
words, the study was planned so that the author would approach young people in each non- 
medical setting to invite them to participate in the study by providing the same inforination 
in the same way to all young people approached. Further the author planned to approach 
all persons whom appeared age-eligible and not simply 'fiiendly-looking' persons or those 
who were located the most conveniently in the study space. 
Validity in quantitative research refers to the degree to which the research truly measures 
that which it was intended to measure and actually reflects the concept to which it is 
supposed to be referring; in other words, how truthful the research results are. It is 
imperative in sexual behaviour research, as indeed it is with many other topics, that the use 
of language, the topics of questions and the topic of the study are understood by subjects 
on a level that the researcher intended. What people understand by sexual intercourse may 
differ and if this occurs then the validity of the instrument could be compromised. In this 
study due attention was paid to existing work that has piloted sexual behaviour questions, 
such as the Natsal and ClaSS studies, so that questions put to respondents in this study 
could be used with confidence regarding their validity (Fenton et al. 2001a; The ClaSS 
Study Group 2001). 
Reliability and validity issues were considered alongside the importance of the sensitivity 
of the topic of this study, and how that could affect the design of the study. In this study, 
young people would be asked to provide information about their sexual behaviour but they 
would be asked for this infon-nation in public settings. How far the setting itself would 
affect the sensitivity of this study remains largely unknown as there is little information in 
the data to suggest the impact. That which does exist certainly suggests that with effort and 
information provision young people do participate in screening in less than private 
circumstances, as the literature review chapter outlined (Gunn et al. 1998; Poulin et al. 
2001; Rietmeijer et al. 1997). Fenton et al (2001), for example, found that participants in 
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the second NATSSAL were less likely to provide a urine sample for chlamydia testing if 
there was a person present in the room, other than the researcher. 
Choosing and developing the interview 
A variety of qualitative approaches have been used in sexual behaviour and STI research: 
participant observation techniques, semi-structured interviews and focus groups, to name 
just a few, have been used in research on STIs and have highlighted the importance of 
lifestyle, contextual and social behavioural factors as being crucial determining factors on 
risk behaviour (Power 1998). Qualitative research is particularly appropriate in examining 
sensitive issues as it is considered non-intrusive and subtle (Power 1998). In addition, 
complex issues such as perception of risk, meaning of sexual health to young people, as 
well as factors aff6cting uptake of screening can be explored in depth using qualitative 
methods. Interviewing remains the most common method used in qualitative research. 
The semi-structured interview, in particular, is one of the most frequently used qualitative 
methods as it allows comparability across interviews but also scope to probe responses and 
thus elicit deeper and richer information. An adva ntage of the semi-structured interview 
for sensitive research is that it guarantees the confidentiality of respondents' responses. 
Focus group inter-views were considered inappropriate in this study, as they cannot 
guarantee confidentiality for the individuals in the group, an issue that could be crucial in 
the respondent's decision to participate in a situation where their sexual experiences are 
being discussed. Focus and group interviews are useful methods with which to explore 
'people'S experiences, opinions, ivishes and concerns'(Kitzinger & Barbour 1999), but in 
this study it was important that respondents be offered an environment to discuss 
potentially sensitive topics that was more private than the study setting. In this way, 
assessing why young people participate (or not) in screening could be ascertained. 
Semi-structured interviews are a useful technique to explore lifestyle and contextual issues. 
Whilst semi-structured interviews follow a thematic guide and are flexible enough to allow 
probing beyond the answers, they are less structured than face-to-face survey interviews, 
which ask each person the same question in the same way. Semi-structured interviews are 
said to allow interviewees to answer on their own terms provide a structure for 
comparability that unstructured interviews do not offer (May 1997). Semi-structured 
interviews were also used as they offer confidentiality for interviewees, which may 
facilitate rapport and encourage the interviewee's willingness to report sensitive 
behaviours. Interviews have been used to explore people's experiences of taking pa rt in a 
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chlamydia screening feasibility survey (for an updated Natsal) (Fenton et a]. 2001 a) as well 
as to explore people's attitudes and views towards screening and follow-up in clinical 
settings (Pimenta et a]. 2003b). Each of these approaches has been used to collect data on 
experiences, views, beliefs and meanings. This is the strength of qualitative research: it 
enables an exploration of the 'subjective experiences ofsocial actors'(Power 2002). 
The interview guide developed for use in this study was designed to address the main 
research questions, concerning the extent of young men and women's knowledge of 
chlamydia, young people's views towards chlamydia screening in non-medical settings and 
factors associated with their willingness to provide a sample in these community settings 
(see Appendix 3). In addition, the interviews also addressed the wider factors that may 
have affected respondents' views towards their sexual health, to contextualise their views 
and beliefs. 
The decision to incorporate participant observation 
During the pilot phase, the author gained invaluable information from both participants and 
non-participants in the settings from the numerous verbal interactions. Views towards 
screening and opinions on the utility of this approach were offered by a variety of young 
people in the pilot phase. It was felt by the author that this data could be an invaluable 
source of additional setting-related information, which could be used in an assessment of 
feasibility. As such, although participant observation was not originally incorporated into 
the design of the study, a decision was taken after the pilot phase to use fieldnote diaries as 
an additional data source. 
Despite the advantages of both questionnaires and qualitative interviews, they both rely on 
self-reported data. Observational methods, such as participant observation, whereby 
behaviours or events are observed in their natural setting and recorded, negate the need for 
a reliance on the participant's viewpoints and/or perceptions. Rooted in social 
anthropology, and stoked by the Chicago School of social research in the 1920s and 1930s, 
participant observation is said to lead to 'an empathic understanding of a social scene' 
(May, 1997: 136). The variety of interactions the author would have when conducting the 
field research, as well as the circumstances experienced, could contribute to a deeper 
understanding of actions within the social context of offering screening in non-medical 
settings. 
Karen Lorimer, 2006 Chapter 3,70 
One of the main advantages of participant observation is its flexibility: a myriad of 
questions can be asked by a researcher of a research setting. According to Jorgensen 
(1989) 'the inethodology ofparticipant observation seeks to uncover, make accessible, and 
reveal the meanings (realities) people use to make sense out of their daily lives' (Jorgensen 
1989). Conversations with both age eligible users and those out with the target age range 
could proyide invaluable insight into attitudes towards chlamydia screening and sexual 
health issues. As such, these naturally occurring conversations could be a potential source 
of rich and illuminating data on people's view§, beliefs and knowledge. In each setting 
fieldnotes were taken, focusing primarily on the experience of establishing the screening in 
the settings, the response by young men and women to being approached and other 
comments made to the researcher during her time in the settings. The researcher 
subsequently made a conscious effort to ascertain the views and beliefs of all settings users 
and make use of the time spent in the settings by also observing behaviours. A count was 
also taken of each person with whom the author approached. If this approach did not result 
in study participation (even if the person approached did not even stop to listen to the 
author) then a tally mark was put in the diaries to represent a non-participant. The 
participation in this study, as the next chapter details, was based on the fieldnote tallies 
kept throughout the study. If any reason was offered at this point for the non-participation, 
such as 'I don't have time right now' or 'I have to go to a class' then the reason was also 
recorded in the fieldnotes. Despite the quantification of data in this way, the fieldnotes 
were used primarily to record the author's. experience of establishing screening in three 
non-medical venues. As the 'here and now of everyday life' unfolded within the settings, 
the author began to witness pattems of behaviour associated with the response to the offer 
of screening. These patterns were recorded in the fieldnotes. 
Data analysis 
It is important to note that this is not a prevalence study, but rather one exploring the 
feasibility of offering young people screening in settings where they can be found in large 
numbers. From the outset, the purpose was to make an assessment of feasibility whilst 
exploring young people's willingness to be tested. Prevalence of chlamydia infection in 
this study will be noted; however, given the non-representativeness of the sample 
population, there is no attempt to generalise to the wider population of young people. 
Subsequent chapters will, however, offer a comparison to existing studies of prevalence in 
similar clinical and non-clinical sample populations in order to contextualise the findings. 
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Statistical analyses on the questionnaire data were carried out using the SPSS statistical 
package. Chi-square tests of independence were used with categorical data, and constitute 
the bulk of the analyses performed on the quantitative data in this study. Significance was 
set at p<0.05 and where associations are highly significant the p-value will be reported as 
p<0.001. Tables that present data from chi-square analyses will provide the p-value to 
note the level of significance. Interactions between setting, gender and age were also 
assessed using binary logistic regression. Odds ratio analyses were performed to assess the 
odds of being willing to accept screening, by setting, gender and age. 
Survey respondents were asked to report their knowledge of the clinical features of 
chlamydia, as well as subsequent associated sequelae and testing methods. The self- 
administered questionnaire included five questions about knowledge of chlamydia, 
including: how infection occurs, symptoms associated with chlamydia infection in women 
and men, associated sequelae and testing method (see Appendix 3). In addition, all 
respondents were then asked to answer 'True' or 'False' to a series of eleven statements, 
with a 'Don't know' option provided. The true or false statements referred to the same 
topics as the five questions described above, only in more detail. Responses to the true or 
false questions were allocated a score (one point for a correct answer, and one point for not 
choosing a wrong answer, 0 for an incorrect answer). The maximum score achievable was 
11. 
Respondents' views towards chlamydia screening were assessed in the survey using Likcrt 
scales, with available responses ranging from 'Very acceptable' to 'Not acceptable'. 
Logistic regression was used to compare groups who were willing or unwilling to provide 
a sample, and odds ratios (ORs) were calculated controlling for age, gender and setting. 
Factors associated with willingness were also explored using Chi-square tests of 
independence. Analyses of willingness to provide a sample for testing (Chapter 6) 
excluded respondents who reported they were not sexually active. Analyses of knowledge 
and other factors included all respondents. 
Qualitative analysis 
Interviews were audio taped and transcribed verbatim. Interviews lasted between 25 
minutes and lhour 40 minutes. The men and women who took part in interviews 
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constituted a heterogeneous group, with regards to their sexual experiences: they reported 
a variety of sexual experiences in their questionnaire responses, from number of lifetime 
sexual partners to the type of relationships they have tended to experience, thus far in their 
lives. Interviewees also constituted those who had either provided a sample for testing or 
declined the offer. Thus, although every individual has their own narrative, and therefore 
individual experiences, the accounts of these young people, with their differing sexual 
experiences, views and behaviours, were nevertheless congruous in the ways that 
knowledge and experiences are drawn from socially constructed realities. 
Transcripts were read repeatedly before being coded in Atlas. Ti. Analysis was carried out 
both 'horizontally' to suggest themes or concepts, as well as 'vertically', to indicate 
individual differences in values, rhetoric or explanations. Individual transcripts were 
initially read repeatedly and codes to identify emerging themes. Subsequently, the 
recurring themes were identified across the transcripts. The study supervisors read a 
subsample of transcripts and emerging and recurring themes were discussed. The analysis 
of the interviews was therefore thematic (Aronson 1994). For example, transcripts were 
read to identify reasons for participating or otherwise in the offer of screening in the non- 
medical settings in which they were a user. The emerging patterns were then grouped 
under a heading of willingness to participate. At the same time, other themes that were 
emerging from the data could then be linked with willingness to be screened, such as 
knowledge and understanding of chlamydi. a. This gathering of themes and sub-themes 
continued to obtain a comprehensive view of the infonnation. At this point the author 
referred back to the literature to provide valid arguments for the chosen themes. Once the 
themes were collected and the literature was been studied, the author formulated theme 
statements to develop a story line. 
The participant observation data was part of a continual process of data collection and 
analysis. Jorgensen (1989) refers to the 'analytic cycle' to refer to the lack of a distinct 
stage of data analysis when using participant observation technique. During the early 
stages of this inquiry, the collection of information focused on gaining entr6e, observing 
and gathering information. The analysis at this early stage was tentative and consisted 
largely of uncovering problems associated with the practicalities of establishing the 
screening opportunities as part of a research study. As the issues pertaining to this became 
more defined, the author was able to focus on data collection as a primary activity. With 
this amassing of materials, the need for additional material became less important than the 
need to concentrate on the analysis of these materials. Analysis was then performed on the 
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fieldnotes in the first study setting prior to moving to the second study setting. Common 
themes that were emerging from the data, such as a gendered response to the offer of 
screening, were further explored before leaving the first setting and continued into the 
second setting. Where possible, the author asked questions of respondents (and where 
necessary from setting staff) to clarify emerging issues or steer a line of enquiry that had 
emerged. So the analysis and data collection were cyclical. 
Ethical considerations 
Given the sensitive nature of the study and the fact that young men and women would be 
offered a test for a STI, which could return as positive for chlamydia infection, there were 
various ethical considerations prior to the commencement of pilot work. The 2000 
'Declaration of Helsinki' provides a set of principles for all medical research, within which 
informed consent constitutes a basic principle of the Declaration. Rule 22 states that 
subject should understand the research, anticipated risks and benefits. The principles in the 
Declaration require that the benefits, risks and justifications for any research are both 
scrutinised by external review and evaluated by autonomous, inforined participants who 
have had the opportunity to reflect upon the implications of the research and to request 
clarification of any issue(s) where necessary (Singleton & McLaren 1995). Ethical 
approval for this study was sought and obtained from the University of Glasgow Faculty of 
Medicine ethics committee (see Appendix 1). 
Informed consent 
Informed consent as been defined as a 'voluntary uncoerced decision made by a 
sufficiently conipetent or autononious person, on the basis of adequate inforination and 
deliberation, to accept or to reject soine proposed course of action which ivill affect 
hinilber' (Singleton & McLaren 1995). Subject recruitment was carried out in accordance 
with this definition and the elements of informed consent as outlined by Singleton & 
McLaren (1995). Guidelines for medical professionals regarding informed consent were 
also useful in this study and so they were referred to during the process of designing this 
study. Although the author is not a medical student or health professional, care was taken 
to act in accordance with current guidelines regarding obtaining consent, especially with 
regards to screening. The GMC recommends that medical professionals '1vork oil the 
presuniption that every adult has the capacity to decide whether to consent to, or refuse, 
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proposed medical intervention, unless it is shown that they cannot understand information 
presented in a clear way ' ". This was the approach used in this study. 
Regarding capacity to provide consent, the Age of Legal Capacity (Scotland) Act 1991 
states that young people have full (or 'active') legal capacity at 16 years. Young people 
aged 16 years or older were invited to participate in this study. Chlamydia infection has 
been increasing extensively in those aged under 25 years. This study therefore targeted 
men and women aged 16 - 24, inclusively. All age-eligible subjects were given clear 
, vritten information regarding chlamydia and the study before they were asked to give 
consent to participate in the study. 
The sensitive nature of this research suggested that there was the potential for interviewees 
to either reveal of request information for which the author was not sufficiently trained to 
deal with or provide. For example, an interviewee could reveal they have been sexually 
assaulted and become distressed recounting this experience. As such, a decision was taken 
that in the event that such an occasion should arise the author would have information 
leaflets to hand on appropriate services to pass on to the interviewce. On a different level, 
it was also anticipated that there could be interest from respondents about GUM clinic 
locations, information about other STIs as well as how to obtain condoms ". Information 
sheets were therefore collected from the Sandyford Initiative in Glasgow (a large sexual 
health service in Glasgow city centre) to be made available to respondents who may 
request such information from the author. 
Study protocol 
This section of the chapter details the approach the author made to young people to recruit 
them into the study, as well as the various materials designed and used in the recruitment 
of subjects into the study. The protocol for contacting men and women with their test 
results is also outlined. The planned approach and possible involvement of respondents in 
the study are illuminated in Figure 2. 
" http: //wwNv. gmc-uk. org/guidance/library/consent. asp 
12 At the time this study was being conducted Greater Glasgow Health Board were promoting the C-Card 
scheme, from which young people can obtain condoms from more than 50 venues across the NHS 
Greater Glasgow area, including health centres, clinics, phan-nacies and many more venues throughout 
the community. 
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All young men and women aged between 16 and 24 years whom were using the study 
settings at the time the researcher was present consisted the target study population. The 
researcher planned the study as an opportunity for young people to participate in 
chlamydia screening. In each study setting a desk would be positioned in a main area so as 
to attract attention to the presence of the screening. The researcher would approach all 
age-eligible men and women to invite them to participate in the study by first completing a 
survey and secondly to choose whether or not to provide a urine sample to be screened for 
chlainydia. 
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Various literature were designed to assist the researcher in providing young people with 
infon-nation about the study, chlamydia and of the screening opportunity. These literature 
were to be displayed on the study table and given to potential participants as part of 
gaining consent to participate. 
The author planned the approach as a consistent one in that it would be similar across all 
interactions, regardless of gender, age or setting. For example, all young people who were 
approached by the author were asked to complete the survey at that moment, rather than 
take away with them to return at a later stage. The author was also aware to maintain a 
consistent manner when approaching people so that, as far as is possible with human 
interaction, the approach would be similar for all those approached. In this way, any one 
not wishing to take part would be doing so for a reason beyond the author's demeanour or 
dress. As the next chapter will describe and discuss, the experience of approaching young 
people revealed a particular gendered response that in turn affected the way in which the 
author approached men and women in the study settings. Nevertheless, and despite this, 
the intention was to maintain a consistency of approach throughout the data collection. 
Gaining consent 
The initial study literature consisted of two leaflets: one gave infon-nation about the study 
and the other information about chlamydia (see Appendix 2). These leaflets invited men 
and women to consider carefully the implications of participating in the study, including, if 
they were to agree to testing, how they would feel if they were to receive a positive, test 
result. Respondents were informed in the leaflets, and verbally by the author, that they 
could withdraw their participation at any point in the study. Once agreeing to take part in 
the study men and women were then asked to sign two consent forms (one for the author to 
keep and one for the respondent to keep) to indicate they understood the nature of their 
participation and the implications of taking part (see Appendix 2). Respondents were 
informed that the study was a chlamydia screening study and that they could be screened 
for chlamydia as part of the study, by providing a urine sample. Respondents could take 
the time taken to complete the questionnaire to consider their response to the offer. 
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During the initial approach with respondents, the issue of screening was raised. 
Respondents were informed that this study included the offer of screening; also that they 
could decline the offer of screening and remain in the study. The information leaflets 
given to all persons at this point clearly conveyed the following information: the purpose 
of the screening; the uncertainties and risks attached to the screening process; any 
significant medical, social or financial implications of screening for the particular 
condition or predisposition; follow up plans, including treatment if the test result was 
positive. The emphasis at this stage was placed upon completing the survey and 'think 
about it'. When possible, respondents were shown the 'test kit' at this stage to present the 
'idea of screening' to them visually. This method allowed respondents time to consider 
their response to the offer of screening. Pilot experience had also highlighted the value in 
this approach as often respondents who expressed immediate reluctance to providing a 
sample reconsidered once they had completed the questionnaire and had the opportunity to 
reconsider the offer. In addition, this often offered respondent who were accompanied by a 
ftiend to discuss the issue: many respondents in the pilot setting were overheard asking 
their ftiend: "Are you going to do it [screening]? " 
When returning the questionnaire all respondents were offered chlamydia screening and 
could accept by providing a urine sample.. The author could often immediately see the 
response to this offer as the last question on the back page of the questionnaire asked if 
they were willing to be screened. The author confirmed willingness with respondents who 
ticked 'Yes' and engaged in a dialogue with those who ticked 'No' (for example, asking if 
they had recently been tested) and also with those who responded 'Not sure'. Those who 
were not sure were again shown the 'kit', which was on a study desk and informed about 
the process of providing a sample and receiving the result. The emphasis was placed on 
how quick and easy the process was, that results could be sent however they chose, and 
that a test was often the only way people know they have chlamydia as it is often 
symptomless - the phrase 'you can't tell by looking' was frequently used. 
Respondents were at this point offered the opportunity to ask questions prior to giving their 
consent to screening. The opportunity to clarify the offer of screening, or to answer any 
questions respondents may have at this point in their participation in the study was 
important as it is important that all persons agreeing to undertake screening for a STI are 
able to make a properly informed decision. Screening healthy or asymptornatic people to 
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detect chlamydia infection carries with it uncertainties including the risk of false positive 
or false negative results. Some results may have social consequences, not only for the 
individuals but also for their partners. In some cases the fact of having been screened may 
itself have serious implications. 
Respondents who were willing to be screened were given a test kit, consisting a standard 
20ml container to collect their first void urine (the first part of the stream), a clear plastic 
bag in which to place their sample, and a white 'jiffy' bag in which to place both these 
items (see Appendix 4). The jiffy bag was to protect the sample during storage and 
transport and also concealed the sample from public view (an important finding from the 
pilot study). 
Collected specimens were labelled (study identifier, individual number, date, age and 
gender) and stored in a cool box container. Samples were couriered within 24 hours to a 
testing laboratory for LCR testing. Respondents were given a leaflet containing 
information about local GUM services and a tailored information sheet that informed them 
what would happen in the even of a positive result (see Appendix 5). In addition, each 
respondent was given a card with the author's contact details should they wish to obtain 
any further information or ask a question in the interim period of awaiting their result. 
Respondents were informed that they should expect to receive their result (by the method 
they chose on their consent form) within one week. All respondents were informed that 
they would be contacted with their result even if it were negative; therefore they were 
advised to telephone the author if they did not receive their result within one week. The 
laboratory sent results to the author. An example of the message respondents received by 
text message is shown in Figure 3, below. 
Contacting people with their test results 
Respondents who accepted screening agreed, as part of the consent procedures, to be 
contacted with their test result. In Chapter 2, the literature review found that obtaining 
contact information at the time samples are obtained results in higher numbers receiving 
test results and subsequently treatment for infection. As such, in this study respondents 
were asked on their consent forrn to provide two forms of contact, which could be postal 
address, e-mail address, and mobile or landline telephone number (see Appendix 2). This 
information was checked and verified by the author with respondents who agreed to 
provide a urine sample. 
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Prior to the pilot study the protocol for contacting people with their results was that the 
author would contact people who tested either positive or negative. As the next section of 
the chapter on the pilot results illuminates, there were difficulties for the author with this 
protocol, as well as ethical concerns regarding participants' welfare. As such, the main 
study protocol became that in the event of a positive test result, participants would be 
contacted by a Health Adviser (HA) from a local GUM clinic (with whom the protocol had 
been agreed) and informed via the HA. In this way, the men and women would receive 
6normal' care, in that they would be part of the same system of care as those who are tested 
for chlamydia in GUM clinics. The consent procedures were changed accordingly, to 
ensure that participants were fully aware that their contact details may be passed to a HA in 
the event of a positive test result. With the study designed and ethical approval sought, 
the practical realities of establishing this study was tested in pilot work. 
Figure 3: Example of text message used to inform respondents of a negative test result 
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Invitation to participate in a follow-up interview 
After returning their urine sample, or when returning their survey if they declined 
screening, respondents were asked if they would be willing to take part in an interview. 
Thus, some respondents were asked when they returned their questionnaires, others when 
they returned their samples. The interview was briefly explained to respondents as a 
second part, but continuation, of the study. Respondents were verbally infon-ned of the 
interview topic areas and assured it would take place in a private location and their 
responses would be completely confidential. Where possible, interviews were arranged 
immediately with respondents who gave initial impressions of agreeing to participate in an 
interview. In relation to those respondents who agreed but were unable to arrange a time 
to take part in an interview, their telephone and/or e-mail details were confirmed by the 
author and respondents agreed to be contacted with a view to arranging their participation 
in an interview. 
Pilot study 
Following receipt of ethical approval (see Appendix 1), a letter was sent to a youth internet 
caf6 organisation in Glasgow, which provided a short explanation of the study and 
requesting access to the setting in order to conduct a pilot study. This setting was chosen 
at the suggestion of a 'gatekeeper', who at the time worked as a Men's Sexual Health 
Worker, who was known to the author. The setting Manager was then contacted by the 
author via telephone to further discuss the proposed study and request access. The 
Manager was enthusiastic about the study and access was granted. The pilot study 
commenced I Oth November 2003 for two weeks. 
The pilot, as a small-scale version of the main study, was conducted largely to assess 
whether the research protocol worked, to test the appropriateness of data collection 
methods and to test whether the sampling frame and techniques were effective. A total of 
10 days screening were offered, resulting in around 20 hours' screening. Twenty-six men 
and women aged 16-24 years participated in the pilot study. A number of barriers to 
participation in the study as well as screening in particular emerged. In addition, problems 
regarding how to approach young people and how best to present the 'test kit' and how 
best to inform respondents of their test result emerged. The lessons learrit will now be 
discussed. 
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A key lesson learned from the pilot study was how best to inform respondents of their test 
results. During the pilot phase of the study, the author obtained contact information from 
respondents on the consent form. The author contacted all respondents who provided a 
sample for testing by the method chosen on their consent form, to convey their results. 
Arrangements were made with a GUM clinic located nearest to the pilot setting to treat any 
persons who received a positive result. The protocol in place was that in the event of a 
positive result the author would contact the respondent to inforrn them of their result, 
provide information regarding their nearest GUM clinic and recommend prompt treatment. 
However, the pilot revealed difficulties with this approach. Firstly, this approach proved 
problematic to the respondents in that they were being asked to arrange their own 
appointment at a clinic. Secondly, not only were there problems with this approach for the 
author as this protocol created more work, more importantly, communicating positive test 
results was difficult when no training had been given to undertake such a task. The pilot 
experience therefore raised the issue of both practical and ethical considerations with this 
approach. To illuminate this: on one occasion a female pilot respondent was contacted by 
telephone by the author and informed of her positive test result. Her male partner had 
participated in screening with her, but had requested he be contacted by letter. After 
speaking to the female respondent, the author was immediately telephoned by the male 
partner for his result, which was negative. The male respondent questioned why his 
girlftiend had chlamydia but he did not. This was a difficult situation for the author. 
Thus, after the pilot phase, and prior to commencing the main study, the protocol for 
communicating test results was altered. The new protocol was arranged and agreed with 
Health Advisers at a GUM clinic in Glasgow. In the main study, the author contacted only 
respondents who tested negative for chlamydia; the contact details of those testing positive 
were passed to a Health Adviser at the GUM clinic. Respondents were advised during the 
consent procedures that in the event of receiving a positive result they were consenting to 
their contact details being passed to the GUM clinic. The Health Adviser then contacted 
these respondents and informed them of their positive result and treatment. Respondents 
would then be offered regular care from the GUM clinic, as regarding treatment and 
partner contact processes. The author later obtained information (via telephone) from the 
Health Adviser as to whether the respondents were successftilly treated. 
Further lessons learned from the pilot study concerned the packaging of the 'test kit' (a 
sample container inside a clear plastic bag to prevent. leakage). On a number of occasions, 
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young women were observed hiding their samples from public view, with some placing 
them inside their jackets or popping their head out from behind the toilet door to check 
who was around in the setting. The author noted this behaviour and upon reflection it was 
felt that more discreet packaging might reduce some of the observed anxiety, especially for 
the young women. When asked how they felt about the packaging, these young women 
confirmed the researchers' suspicions regarding the packaging by stating they felt 'pure 
nzortified condn'out ivith that [sainple] in yer hands'. A white 'jiffy' (bubble) envelope 
was subsequently given to respondents, within which was the sample container and clear 
plastic bag, and this was seen to be more acceptable. The pilot also revealed stylistic 
problems with the appearance of the questionnaire. Initially the font Times New Roman 
was used; however after the document was described on a few occasions by setting users 
as looking 'like an exam' this was changed to Comic Sans MS. A less 'exam like' front 
cover was added. 
As the example of the sample packaging and style of questionnaire begins to illuminate, 
there were data from the experience of conducting the pilot, which suggested there was a 
wealth of rich data to be had from the verbal interactions between the researcher and 
setting users. The decision to incorporate the participant observation technique was a 
direct consequence of the pilot work. As was noted earlier in the chapter, this technique 
does not rely on self reports, compared with the SAQ's and interviews. As such, 
observational data could be a potentially rich source of information about setting and social 
group effects to this approach to chlamydia screening, which could add to those data 
collected via the SAQ and interview. 
Main study settings 
Choosing non-medical settings in which to explore the feasibility and acceptability of 
screening for chlamydia has been discussed in detail elsewhere in this thesis. The idea 
behind this study was to take screening to where young people 'already are', as a means of 
exploring the willingness of young people to accept the offer of screening in these settings 
and to assess how feasible it is to establish screening. Three non-medical locations in 
Glasgow were chosen: 'Education' (a large further education college), 'Health and Fitness' 
(three local authority leisure centres), and 'Workplace' (two contact centres). 
These three non-medical settings were chosen, as they are places where large numbers of 
both men and women can be found. College populations attract a younger and more local 
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population than universities, since many students attend college immediately upon leaving 
school. Local authority health and fitness settings were considered, as private gyms 
require the payment of membership fees, which inhibits the use of these settings by young 
people under 20 years. The average age at contact centres in Scotland is 24 years ", but 
this can vary by industry sector, with healthcare and entertainment and leisure industries 
recording the lowest average age of contact centre operators (Department of Trade and 
Industry 2004). Thus, all three settings could offer access to young populations, but in 
settings where they would be in large numbers. Furthermore, the settings are less open 
than shopping malls, supermarkets and parks (as were used in one study by Rietmeijer et al 
(1997)), and would be more secure environments for the author, given that this study 
would be a one-person approach. 
A large further education college in the centre of Glasgow was chosen and contacted with 
a view to gaining access. This was the first setting to be contacted. After the study was 
conducted from the education setting four health and fitness settings around Glasgow were 
contacted. One college setting was involved in this study as there were large numbers of 
age-eligible men and women who frequented the college each day; in contrast, background 
investigation of the health and fitness settings (sitting in a caf6 in the main foyer of one 
setting in Glasgow for a few hours on two occasions observing the age of setting users) 
suggested that recruiting the required number of young people into the study would be 
enhanced if more than one setting were used con-currently. One setting was planned for 
the workplace but once the study was established it became apparent that another setting 
would be required to increase the number of participants for the workplace setting overall. 
The next section describes the process of accessing the settings chosen and the response 
from 'gatekeepers' to the request that a screening study be established in the settings. 
Accessing the setting 
Education 
Access to the education setting was arranged with the assistance of a Welfare Adviser 
(WA) at the setting. The initial contact with the WA occurred at a sexual health event; 
therefore, the origins of the approach made to request access to the further education (FE) 
setting for the purpose of carrying out a study was not a considered approach; rather it 
occurred naturally. The author was requested to forward a detailed outline of the proposed 
13 http: //iv-, vw. manpower. co. uk/about_manpower/main_equality_diversity. asp 
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research to a Management Group at the further education setting, for consideration. 
Access to the FE setting was subsequently granted and arrangements on the precise nature 
of how the study was to be conducted were discussed with the WA. 
One notable feature of the approach was the ease with which the author was granted access 
for the purpose of conducting a study to offer screening for a STI. The author was not 
asked by the FE settings' management to attend any meetings to present or discuss my 
proposed study; rather, my proposal was accepted promptly and feedback of access being 
granted to me was made via the WA. Subsequent discussions with some setting staff 
revealed a high level of support among college management for sexual health matters to be 
discussed and promoted within the FE setting - indeed, this was why the WA was in 
attendance at the sexual health event on behalf of the FE setting. Throughout the duration 
of the study in this setting, the WA offered continued support by informing me of 
conversations she had with students about the study as well as infon-ning me of the views 
of staff, as she encountered them. A memo was also sent round the setting to all staff 
informing them as to the study. This information was recorded in the fieldnote diaries. 
Health & Fitness 
Unlike my inforinal access to the college setting, the author was required to seek 
permission from a senior member of Glasgow City Council (GCC) prior to approaching 
individual local authority funded leisure settings, with a view to gaining access to the 
setting to conduct the study. Despite this, permission was granted from GCC with few 
difficulties (one letter, see Appendix 1, and two telephone calls were required). No 
concerns were raised and no ftirther inforination was requested regarding how 'the 
screening would be conducted. GCC advised that pennission from each facility should be 
sought from the facility manager. 
The facility manager at each health and fitness setting was contacted first by letter (see 
Appendix 1) and permission to use the facility was established during follow-up telephone 
calls. Although there were many 'gatekeepers' with whom to liase, gaining access to each 
health and fitness setting was straightforward. One facility manager expressed his surprise 
that the study had been granted permission to be conducted from GCC and suggested that 
the funding source (Scottish Executive Health Department) may have influenced this 
decision to grant permission because it 'legitimised' this type of research being conducted 
in local authority settings. As he commented: 
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"They [GCC] can hardly decline access if the Scottish Executive have funded this 
type of research " 
(Fieldnotes, Manager, Health & Fitness setting) 
Once access to each facility was granted, all staff, from managers to cleaners, were helpfill, 
curious, friendly and supportive towards the study and author. At each setting, the 
manager informed the staff about the study via internal memos, prior to the study 
commencing. Thus, when the study commenced at each setting, the staff was prepared for 
the presence of the study: 
Ybe staff areftiendly as I come in each day - they say hello ... the younger guys tend 
to smile at me as they go past or make a comment like 'how are things going? ' or 
'Had many people? ' Female staff who ivalk around tend to keep themselves to 
themselves. 
(Fieldnotes, Health and Fitness, 20th May 2004) 
In two of the three settings, during the first days of the study, male staff members joked 
loudly with male colleagues about testing, which drew negative attention to the study. For 
example, in the first health and fitness setting one male employee said in a loud voice: 
"Roll zip, i-oll tip get yow- chlainydia testing here today! " as a young woman was sitting 
nearby completing a study questionnaire. This female respondent later discussed this 
incident during an interview: 
'7 thought that was out of order, I inean I was sittingfilling in a questionnaire and 
they were all standing about treating it as a bigjoke, making conunents ... if I wasn't 
such a confident person I might have just walked away, I can see how that sort of 
behaviour could be really offputtingfor otherpeople ... but that's guysfor you! (Interviewee it 159, Female, Age 22, Health and Fitness) 
In another health and fitness setting, the assistant manager commented, during an informal 
conversation with the author, that she had joked to male staff members that she 'had' to be 
informed if they tested positive for chlamydia - indeed, she was later heard by the author 
joking with staff that she knew one employee had tested positive for chlamydia (even 
though at this point there were no positive results for this setting). Two male employees 
later informed the author that they were initially cautious about participating for fear this 
was true and it was not until both were reassured by the author of confidentiality (and 
requested the assistant manager inform her staff she had been joking with them) that they 
agreed to participate. In the third health and fitness setting the staff were helpful and 
polite but maintained their distance from the author, with the exception of two female staff 
members who regularly stopped to talk about the progress of my study. 
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Workplace 
Compared to the education setting and three leisure facilities, the workplace setting proved 
more difficult to access. A search on the Internet, using the search terms 'contact centre 
Glasgow' found a website (the Call Centre Association) " for contact centres, based in the 
Glasgow area. Contact with contact centre organisations listed on this website was made 
initially via the main information e-mail address for each organisation given on the website 
(-vv-, v-w. cca. org. uk). Only one of four contacted replied. However, once contact was made, 
access was straightfor%vard. A second contact centre was approached after a colleague 
working in Public Health & Health Policy supplied information. An e-mail was then sent 
directly to the manager of this organisation. 
Once initial contact was made to both organisations via e-mail, the author was invited to 
discuss the study with senior management prior to commencing the study. Management at 
both workplace settings did not query why contact centres were being approached as part 
of this study but did express the view that no employee would wish to accept testing in 
their workplace. Despite this, these 'gatekeepers' were supportive and remained curious 
throughout the study about the willingness of staff to accept screening. A memo was sent 
to all staff in both contact centres informing them of the study and making clear the point 
that it was independent research. The management at both contact centres also enquired 
about the dissemination of study results and requested the organisation remain anonymous. 
At both sites, access to conduct the study was granted for two weeks (compared to four 
weeks at the education and each health and fitness setting). Reasons provided by 
management were that a longer period of time might be disruptive to the work in'the 
organisation and a perception that this was not a study but a management led initiative. 
Aside from this, management raised no other concerns about the study-taking place in their 
contact centres. 
Presentation of results 
Large volumes of data were generated during this study and the author recognises that 
these data may be presented in a number of different ways. For example, one way might 
have been to present the findings by setting, given the importance of the setting to this 
14 littp: //Nvývw. cca. org. uk 
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study. A fourth chapter would have been necessary to pull all of the findings together and 
compare across the settings. Four result chapters, with each discussing similar result areas 
would have rendered the presentation of results exceptionally repetitive and therefore 
ineffectual at illuminating the important trends and themes identified from the quantitative 
and qualitative analyses. 
After various initial attempts to write-up the results of this study, the approach which read 
well and facilitated effectively illuminating important findings was the results presented 
according to the three main areas of investigation in this study: feasibility, knowledge and 
willingness. Attention to settings differences is, however, maintained throughout the 
presentation of results. The study results are presented in three chapters: Chapter 4 
presents the results of the feasibility of establishing screening in the three study settings. 
Fieldnote diary data constitutes the primary source of data used to explore feasibility and 
thus much of Chapter 4 involves a descriptive account of gaining access to each study 
setting and the initial response to screening being offered in the settings. Extracts from 
fieldnote diaries kept constitutes the main data source in this chapter. Both questionnaire 
and interview data were used in analyses of knowledge of chlamydia and views towards 
screening and these are presented in Chapter 5. Similarly, in Chapter 6 data from both 
questionnaires and interviews are given in an account of the willingness of young men and 
women to provide a sample for testing. Throughout the data result chapters, extracts from 
fieldnote diaries will be noted as 'Fieldnotes'; interview data will be references after the 
quotations as 'Interviewee' followed by the interviewee's identifier number, for example, 
'Interviewee #128.. '. 
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Chapter 4 
Feasibility of Offering Chlarnydia Screening in 
Non-Medical Settings 
It was an aim of this study to assess the feasibility of offering screening for chlamydia in 
non-medical settings. This chapter describes the process of establishing screening in each 
of the three study settings - Education, Health & Fitness and Workplace - and the response 
to the offer of screening. This chapter, therefore, presents data by setting to discuss these 
issues in relation to each of the three settings. Both men and women were approached in 
each of these settings, thus emphasis is also placed upon gender differences in the response 
to the approach. 
Conducting the study in each setting 
Three non-medical settings were chosen for this study: education, health & fitness and 
workplace. The education setting was a large further education college; the health and 
fitness settings were three local authority facilities; and the workplace setting was two 
contact centre organisations. All settings were in Glasgow. 
Education 
The approach 
The study was conducted at this site over a period of 2-3 hours, Mondays-Fridays for 4 
weeks (22 nd March - 23 April 2004"). For the first 3 weeks, young people were 
approached by the author and invited to participate in the study. In week four, private 
screening was offered from a room next to the Student Advisory Office for duration of 2 
hours per day Monday-Friday. In total, screening was offered over an average of 55 hours 
at this setting. A total of 145 men and women aged under 25 were approached during the 
first 3 weeks. Of them, 76 were male and 69 female. In addition, nine respondents self- 
referred for private testing in week 4. 
The study was conducted from the large canteen (situated on level 2) and also the snack 
bar area (situated on level 5) of the further education setting. A desk was set up, upon 
15 The study was not conducted for one week during this time (12 th -16th April 2004) due to the one week 
Easter break. 
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which the study material was placed, at the entrance in the canteen and snack bar areas. 
The canteen was the main area from which the study was conducted because a large 
number of students used this setting throughout the day, although primarily during their 
lunch hour, which meant that many young people could be approached in the one area at a 
time when they were seated for a duration of time that would permit me to strike up a 
discussion with them. Students in the canteen area were either sitting at tables eating their 
lunch or playing pool or video games (both facilities provided in the canteen). Students 
who frequented the snack bar area of the college were also approached, as in this area, in 
contrast to the canteen, smoking was not prohibited; as such, the snack bar might have 
attracted students who did not use the canteen facilities. 
Students who used the canteen and the snack bar entered and sat in groups (either 
comprising same sex or mixed sex) or in pairs; few who used these areas were alone. 
Since students mostly frequented the canteen for the duration of their lunch hour, there was 
a 'window' of opportunity in which to approach young people in this setting. In the snack 
bar area, this 'window' was limited to 20 minutes - the duration breaks (which occurred 
mid-morning and mid-aftemoon). 
There were two important influences on the approach to education setting users: the 
gender of students and whether they were sitting in groups or in pairs; these factors were 
often interlinked. Chapter 5 describes respondents' knowledge about chlamYdia and their 
views about screening. These factors could have had a bearing on respondents' response 
to the approach and therefore could be an important aspect of the feasibility of offering 
screening in non-medical settings. These factors have been reported separately from the 
feasibility discussion, as an aim of the study was to assess young people's knowledge of 
chlamydia. 
The influence of gender 
Men and women responded in different ways when approached in the education setting. 
Women conveyed a higher level of awareness about chlamydia, they appeared more 
comfortable discussing this topic and interacted more with me, asking questions and 
volunteering infonnation, than the young men. This information was noted in fieldnotes: 
Men approaching young women in the canteen today I was sti-lick by how at ease 
they absoi-bed the topic and did not seem embarrassed when I said the word 
'ch1amydia'orthephrase 'Sextiallytraiisi? iittediizfectioiz'... 
(Field notes, Education setting, 22 March 2004). 
Karen Lorimer, 2006 Chapter 4,91 
Some women asked why the study was being conducted in the college setting, whereas 
others were curious as to the author's status ("Are you a nurse? "); and others volunteered 
information about their prior experience of being tested for chlamydia ("Oh Igot that done 
at my sinear a couple of nionths ago") or awareness of chlamydia as a public health issue 
("I read about that the other day in the paper"; it's really coninion noiv isnt it"). A few 
offered opinions about non-medical screening during the approach, for example one female 
(who subsequently participated in an interview) commented: 
"That's really good that you can test for it on a urine sample. It'S a good idea to 
make it easierforpeople to get testedfor this [chlanzydia] because it's quite common 
isn't it? " 
(Interviewee #88, Female, Age 22, Education). 
In contrast, young men approached often appeared embarrassed when they heard the topic 
of the study, and few maintained eye contact with the author throughout the entire 
approach period, with the exception of the initial few second when they appeared curious 
as to why they were being approached. On some occasions their embarrassment became 
immediately apparent when the author mentioned the words 'sexually transmitted 
infection'. This was noted in field note diaries: 
Ahnost all of the young men whom I approached today seemed uncomfortable with 
my presence ahnost immediately after I mentioned the words 'sexually transmitted 
infection' Some smiled nervousl others looked away; those who had eye contact Y, 
with me when Ifirst approached them averted their gaze and bhtshed; somefidgeted 
in their seats. One male walked awayfi-om the group of malefriends he had been 
standing with saying "F* *k sake man, no way! " 
(Field notes, Education setting, 23 rd March 2004) 
Some young men appeared initially bewildered with being approached and asked to 
engaged in a discussion about a STI: 
Today afewyoung men standing together in a group turned to look at each other and 
smiled and laughed nervously when I introduced the topic of the study. One asked 
me "ff'hy are you doing that in here? " another asked "Are you serious? ". I 
responded, "You seem a little beivildered about this, why? ". One replied, "I dunno, 
it seems a bit strange doing that here. " In subsequent discussions with these Young 
men when they were handing back their questionnaires, they seenzed less taken aback 
with the topic and one said '7 didnt Imow it was that common ". The ensuing 
discussion was very different to the initial conversation I had with them as they now 
seemed open to discussing the topic. 
(Field notes, Education setting, 31" March 2004) 
16 A front-page editorial about chlarnydia had appeared in a Glasgow-based newspaper the week prior to 
conunencing the study in the education setting. 
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The greater level of immediate embarrassment, discomfort with the topic and 
bewilderment at being approached in the college about this topic among men, affected the 
manner with which the author approached young men. Subsequently, men (especially 
when they appeared embarrassed) responded positively to gentle humour ("bet you didnt 
think a woman would approach you in college today and askyou about sex! "). The use of 
humour at particularly tense moments, especially during the initial approach, often 
appeared to relax the young men and many consequently engaged in ffiendly 'banter' with 
the author, as well as with each other ("he cannae dae it, he's never had a bird! "). A more 
'chatty' approach, whereby a more casual conversation, between young men seated in the 
canteen and the author, was undertaken to ask them what they knew about sexually 
transmitted infections. This often appeared to make them more relaxed in the company of 
the author and also with the topic of the study. Unlike the women, who could immediately 
be engaged with the topic of the study, the young men often needed a brief period to 'get 
their heads around' the topic matter, before then being invited to take part in a screening 
study. Some men initially appeared uncertain if they had heard about chlamydia, for 
example: 
KL: Have you heard of chlamydia? 
R: Eli ... I dunno KL: It's a sexually transmitted infection 
R: Oh aye, I've heard of it but that's about it 
(Field notes, Education setting, 23 rd March 2004) 
The use of humour was used in one study with MSM in entertainment venues and, based 
on the feedback with screening staff, the authors concluded that this style of approach had 
encouraged a positive response from the men targeted for the screening promotion 
(Debattista et al. 2002e). 
In contrast, young women could often be approached in the same manner, with the same 
information provided in the same way each time. Women almost consistently responded 
more positively to a factual-oriented approach, and did not respond particularly well to the 
use of humour. Indeed, when humour was used during the approach with women, this 
often caused embarrassment rather than alleviated it. During interviews, respondents were 
asked how they felt when I first approached them; one male interviewee offered a typical 
view: 
'So embarrassed, because I hate talking about sex... I don't like kind of 
confrontational things like that, especially when it comes to talking about stuff like 
sex. 
(Interviewee #77, Male, Age 20, Education) 
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In contrast, this female interviewee offered a typical female view: 
"I didnt inind you coming zip to its ... it's not like you wanted to start asking its to talk 
about our sex lives there " 
(Interviewee #138, Female, Age 18, Education) 
So, whilst young men often reacted with bewilderment and embarrassment when 
approached, young women generally appeared more aware of the subject matter, which 
seemed to place them at case with the topic of the studY. 
The opposite was evident when men and women were offered screening. After survey 
respondents completed their questionnaires, the topic of screening was raised with them 
again - depending on their response to the final questionnaire item. Men and women were 
asked at this stage to confirm their responses given on the final questionnaire item. 
Whereas the females displayed ease with the topic and a willingness to engage in a verbal 
exchange with the author when they were initially approached, they behaved contrary to 
this when their willingness to be screened was raised for discussion. During an interview 
with one young woman, who did not accept screening, she described how she felt being 
asked to provide a sample in the college: 
"I didnt niind doing the questionnaire but I didn't ivant people to hear ine say "Aye, 
I ivant testedfor an STT'. " 
(Interviewee #138, Female, Age 18, Education) 
A male interviewee, recruited from the college, offered a different view: 
"It wasn't really that embarrassing, because... 'cos there was a group of its, and they 
ivere taking it [test], so you ivere like, you felt comfortable being aniong ftiends, 
talking about it. " 
(Interviewee #38, Male, Age 22, Education). 
There was therefore a gender difference in the social desirability of being heard or seen to 
consent to chlamydia screening in the education setting. Moreover, during interviews, 
female respondents from all settings often referred to issues of privacy and the stigma of 
being seen by others in this public location to want a test for a STI. Females, more than 
males, considered issues of privacy in relation to screening being offered in other non- 
medical settings; however, this will be discussed in more detail in chapter 5 in the section 
on respondents' views towards screening. 
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Approaching groups 
The influence of gender upon the response to being approached was often magnified when 
respondents were seated in groups. The type of groups approached in this setting included 
mixed sex groups of varying ages, mixed sex groups of people aged under 25 years and 
same-sex groups. The response of these groups towards the invitation to complete a 
questionnaire and participate in screening was similar, but which was also in contrast to the 
response of individuals. 
When mixed sex groups of all ages were approached, their reaction, upon hearing about the 
nature of the study, tended to be jovial, with older (mostly male) members of the group 
interceding to encourage their age-eligible companions to participate in the study ("aye, 
he'll dae it, he pulled a bb-d at the iveekeiid! '). Men and women older than 25 years often 
joked that they were within the target age range ("I'M 24. I'vejust had a hard life! "). The 
relaxed reaction to my approach among mixed age groups was in contrast to groups of age 
eligible mixed sex groups, who often constituted those who refused to participate in the 
study. One young male, who had declined to participate in screening along with his three 
other companions (one male and two female), was asked by the author why they had all 
declined. This conversation was noted in field notes: 
A gity who declined to complete a questionnaire the other afternoon (along with 
three others) came in to the snack bar this afternoon and sat alone. I spoke to him 
and asked why he and his filends declined to participate the other afternoon. He 
told me that whilst he couldnt speakfor the others, hefelt uncomfortable answering 
questions about his sex life in front of people he had only recently got to know - 
they werent closeftiends, only collegeftiends and as such he didnt want to reveal 
personal information about hhnseý( to them. I asked if he would be willing to 
complete a questionnaire now and he agreed. 
(Field notes, Education, 5 th April 2004). 
Same sex groups reacted in a different manner to mixed-sex groups. When groups of 
women were invited to be screened they tended to operate under a 'consensus approach': 
all women would ascertain their willingness to complete the survey through non-verbal 
communication with each other (such as eye-contact with each other and nod their heads) 
before communicating their willingness verbally to the author. There often appeared not to 
be any one individual decision-maker in the group, from whom the rest took their lead. In 
contrast, groups of young men tended to take their lead from one male, to whom they 
would look to and base their decision to participate on: if the 'alpha male' agreed to 
participate, so too would the others, and vice versa. It was often prudent during the initial 
approach to quickly identify the 'alpha male' and focus the approach towards him. There 
were a number of occasions when the 'alpha male' refused to participate in screening and 
Karen Lorimer, 2006 Chapter 4,95 
neither did the other men in the group ("If he's no dahz'it Im no"). Young women, on the 
other hand, despite the initial consensus approach, did on a small number of occasions 
provide a sample of urine even if their age-eligible group companions declined. The 
presence of others in same-sex groups therefore appeared to affect the reaction to my 
approach and their subsequent response to the offer of screening. 
It is important to note the effect researchers can have upon interactions that, as noted 
above, require significant communication skills and ability to respond appropriately and 
promptly to situations. In the education setting it was easier to approach females, in part 
because of the author's gender, but also due to the consistency of the interactions and 
dialogue with females. It was, in contrast, often a challenge to approach groups of young 
men, as there was a great deal of uncertainty as to how they would react; much of this 
interaction required on-the-spot reactions, especially in situation where the use of huniour 
was received well by young men. Chapter 6 will discuss respondents' willingness to 
provide a sample based on the perception that the offer of screening was in itself 'non- 
medical' because the author was not dressed in a manner that signified she was a medical 
professional. How far an attribute of the author had a negative effect on those who refused 
to participate in the study is uncertain. 
Regarding refusal to participate in the survey part of the study, most men and women in 
the education setting did not decline participation in the survey when first approached but 
left their uncompleted questionnaires on the table and left the canteen. No gender 
differences were detected, with females as likely as males to leave uncompleted 
questionnaires. However, it appeared to be younger aged respondents (around 16 or 17 
years) who declined to participate. An extract from the field notes records the curiosity by 
the author as to why this was: 
I wonder whether these respondents are set(Iselecting theirparticipation d1le to their 
non-sexually active status ... there is very 
little dialogue or eye contact from these 
students. I wonder whether they are simply too embarrassed to take part because of 
the subject as well as theiryoung age? 
(Field notes, Education, 3 Oth March 2004). 
Interviews were conducted with only two education setting respondents who were under 20 
years (both male), during which both discussed feeling very embarrassed to have been 
approached and engaged in a discussion about a STI and then offered screening. Both 
respondents were approached in same sex groups and completed a questionnaire. One did 
agree to give a sample at this time, whilst the other declined until a later date when he 
asked for a 'kit' at the end of his interview. 
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The pilot study highlighted different responses from males and females and this was 
experienced in the education setting. An additional finding in the education setting was the 
effect mixed sex and single sex groups had upon young people's willingness to engage in 
an interaction about this topic and subsequently with providing a sample for testing. 
Developing rapport, especially with young men, was an important factor that affected the 
participation in the survey part of this study, and possibly with the offer of screening also; 
therefore, understanding the appropriate manner with which to approach young people 
proved important to the success of this study. The inter-viewer effect was therefore of 
crucial importance to the success of engaging with young people in this setting. 
Conducting the study: setting-specific issues 
There were a number of practical difficulties in conducting this study in the education 
setting. In the canteen area it was common for students to not consider it appropriate to be 
approach whilst they were eating their lunch. As such, this reduced the 'window' within 
which an approach could be made. Given that the author was operating alone, and the 
approach consisted of an informal brief discussion about the study so that infori-ned 
consent was ensured, this limited the number of students who could be approached over 
one lunchtime. 
Despite this time limitation, students (as well as canteen support staff) became familiar 
with the presence of the study and the author and this had a positive effect on recruitment: 
as rapport was developed with many students some informed their friends about the study 
and encouraged them to come along to the canteen, or snack bar area, to participate. 
Female students constituted the majority of those who encouraged their friends to 
participate. The rapport developed between the author and support staff also facilitated 
recruitment: the canteen support staff knew some student well and were observed chatting 
to students as they cleared their tables. Two women staff in particular often helped 'break 
the ice' for the author by asking students, when they were approached by the author, 'have 
you taken part in this lassie'S study yet? '. 
The emerging findings from fieldnote data suggested some young people did not accept the 
offer of screening because of the public nature of the setting; therefore, in week 3 of the 
four weeks in the education setting, posters were placed around the setting advertising the 
availability of 'private testing' in a private location within the college where young people 
could come and be tested for chlamydia. Prior to this, there were a few occasions where 
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young women asked the author why they had to return their sample to the author in the 
canteen, and stated a preference to pass their sample to the author in private. Some men 
gave this view also. So whilst these young people intimated their desire to be tested, they 
did not to want to hand over their sample in the public area of the canteen. Neither did 
they wish to meet the author in a private area that day, when this was suggested. As such, 
the author explored the possibility that young people were put off providing a sample 
because of the public nature of the screening approach. 
'Private testing' was offered in the final week of the study for five days (Monday to 
Friday) in a private interview room next to the Student Advisory, where students could 
come to self-refer for testing. Nine students attended this area in five days seeking testing 
(5 males and 4 females). Three young men, who attended together, commented that they 
were aware of the study in the college but that they were too embarrassed to take part in 
the public areas. The two other young men reported that they were too embarrassed to 
seek testing in front of their friends. One female was a young staff member who reported 
symptoms and was self-conscious about being seen seeking testing by students. The other 
three females reported not wishing to be seen seeking testing as the reason they came along 
to the 'private testing' session. All nine students, when asked, confinned they would not 
have given a sample except in this private area. This approach had reached nine young 
people but it is a low number and it is possible that more could have been tested if 
screening had been offered in the canteen in week 4. 
Health and fitness 
The health and fitness setting was the second of the three study settings the study was 
conducted from. Accessing the setting, approaching young men and women and offering 
screening for chlamydia by urine sample was experienced differently in this setting than 
the education setting due to setting-related issues. Three health and fitness settings were 
involved in this study. 
The approach 
Screening sessions were conducted at each site over 2/3 hours each time for a total of 4 
weeks for two of the three health and fitness sites (I 7h May -1 Ph June 2004; and 16th 
August - 10'h September 2004). In the other site, screening was offered for 2 weeks (21" 
June -2 nd July 2004); this was primarily due to the sparse numbers of young people under 
25 accessing this setting. In total, screening was offered over an average of 120 hours 
from all three health and fitness settings. A total of 158 men and women aged under 25 
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years were approached and asked to participate in the study by completing a questionnaire 
and offered screening (65 males and 93 females). 
Unlike in the education setting, it was rare to approach groups of setting users in the health 
and fitness setting. Individuals, or people using the setting along with a friend, consisted 
the majority of those who were approached by the author. This was primarily because the 
study desk in these settings was set up in the reception areas of each setting (see Appendix 
4 for an image of the study desk in situ). Young people were therefore approached as they 
entered the reception area, after paying at the main desk, and they predominantly entered in 
pairs or alone. As in the education setting, there were gender-specific behaviours in 
response to the approach and offer of screening. 
The influence of gender 
As in the education setting, the length and manner of my approach differed according to 
whether women or men were approached. Preliminary descriptive analysis of the 
questionnaire data from the education setting revealed men had a poor knowledge of 
chlamydia compared with women. In addition, questionnaire data and fieldnotes from 
education setting also suggested women had more prior experience of being offered 
screening than men. This was also apparent in the health and fitness settings. When 
approaching men and women, more information about chlamydia was oflen required to be 
provided to young men than women. Two separate groups of young men commented that 
they believed chlamydia to be a 'woman's disease. The response of men and women to 
being approached in the health and fitness setting was similar to that described in the 
previous section regarding the education setting. 
As such, and as in the education setting, young men often responded well to gentle humour 
to overcome their embarrassment to be approached and asked to participate in a chlamydia 
study. In contrast, young women were often relaxed when first approached - perhaps due 
to their familiarity with the topic - the rapport being quickly established, but became 
embarrassed when offered screening. 
After respondents took part in the study they often spoke to the author when they were next 
in the setting; the author, when in the education setting, did not experience this. There was 
a general curiosity among in the health and fitness users as to how willing people were to 
take part in the study ("Have you had many takers? "). Employees in the health and fitness 
settings were encouraged to participate in the study -by the author and most did, at some 
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point in the four week duration. On one quiet evening a group of young male employees 
(who had not yet participated) approached the author and initiated a conversation about 
sexual health issues. Sensing that some wanted information but were afraid to appear 
ignorant in front of their male peers, 'a quiz to see ifyou can catch ine out'was suggested 
by the author. This prompted enthusiastic questions, ranging from 'what is the inost 
conzynon STP' to 'what is the worst one to get? '. Such conversations were often 
experienced with young male employees in the health and fitness settings, (and also in the 
workplace setting as will be discussed below). These young men were often more 
enthusiastic to receive information about sexual health than female employees. In addition, 
other male setting users were also more willing to engage in such conversations than 
women. T he reasons behind these behaviours were explored during subsequent interviews 
with men and women, and this data is presented in Chapter 5. 
Many interesting conversations occurred with setting users who were older than 25 years, 
for example parents waiting in the foyer to collect their children from gymnastics class. 
Many offered positive comments in support of the study. An example from field notes is: 
Female parent: I think this is a good idea because it's not like in nzy day when you 
just didnt have sex, not like now anyway. Teenagers todayfilst don't always 
Imow what they're doing or what's out there. 
KL: what do you think about youngpeople being offered information about sexually 
transmitted infections? 
Parent: If it helps them not catch anything then that's good. I think sex education 
could be a lot better, I mean that's where they should be getting infonnation 
but if they're not then it's better to know isn't it. 
(Field notes, Health & Fitness setting, 24 June 2004) " 
Others, like this mother, spoke of concern for their teenage daughters and framed this 
concern as something they believed most parents experience today, given the pressure on 
young people to become sexually active. Although it was mostly women who engaged in 
conversations with the author, fathers and grandfathers who were waiting to collect their 
children/grandchildren also volunteered views. Typically, they expressed similar positive 
comments, with fathers, especially, discussing concern for their teenage sons' sexual 
health. One in particular, asked to take some condoms for his son - he did not ask for an 
information leaflet. In contrast, mothers requested leaflets for their children and tended to 
express a desire for their children to gain as much knowledge as they could about STIs to 
'protect themselves', as one mother commented; despite this, no mother took away 
condoms. So, whereas mothers tended to view raised awareness as protecting their 
17 Conversation was recorded from memory immediately afterwards. 
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children from STIs, fathers generally considered condoms as a method of protection for 
their children. All, however, offered positive comments about the study and supported 
non-medical testing for sexually transmitted infections in general. Gathering the views of 
setting-users older than 25 years was specific to the health and fitness settings as in the 
education and workplace settings; the overwhelming majority of users were aged under 25 
years. 
Conducting the study: setting-specific issues 
Unlike in the education setting, there was rarely a large volume of age-eligible young 
people using the health and fitness settings at any given time. Even immediately prior to 
an exercise class, martial arts class or other timetabled activity there were still only a few 
whom could be approached. In one health and fitness setting, a weekly ladies only evening 
attracted more age-eligible users through the setting at the one time. In addition, young 
men often entered in groups prior to using a football court. However, with both groups, 
there was often not the opportunity to approach all of these young people at the same time 
and as such there were often missed opportunities to approach the others. In addition, as 
was discussed in the previous section, it was predominantly individuals or young people 
who were accompanied with a ftiend who were approached. As such, it took longer to 
recruit young people into the study in the health and fitness settings. This, in part, explains 
why three health and fitness setting were involved in the study rather than one. 
Unlike the other two study settings, the health and fitness settings were used by people of 
all ages. As such, the author was often asked questions by young children ('101at is that 
[chlanlydia]? "), as well as elderly persons. No parent appeared unhappy with my presence 
and many smiled at me when I replied to their child "It'S sonzething that call affect your 
health. " On many occasions, parents holding toddlers approached the table in the foyer to 
ascertain the topic of the study. Not note negative response was noted in the fieldnotes 
when they realised the study concerned a sexually transmitted infection. On two occasions 
in health and fitness settings the author was approached by GPs who commented that this 
was the first time they had seen screening being offered outwith clinic-based settings and 
added that they considered this a good thing that might reduce the prevalence in young 
people as well as raise awareness of the infection. One GP asked if there were any plans to 
'roll-out' this approach throughout Scotland and appeared very keen that this occurred. 
Each facility manager infori-ned me at the end of the study whether any feedback cards, 
which the settings asked users to complete, contained any negative comments regarding 
the study. No cards offered negative commented on the study; two offered positive 
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comments, with one reading 'The STD screening is a really good idea. Will it be here 
regularlyT and the other stated, "I think a lot of different health checks should be offered 
more often here. The chlainydia testing here niade it really convenientfor nie to have got 
tested. " 
Although the process of gaining access to the health and fitness settings was longer than 
the education setting, it was straightforward to establish screening in the settings. The 
layout of each health and fitness setting meant that toilet facilities were in close proximity 
to the study area, which might have encouraged many young people to accept the offer of 
screening. The reaction of staff within each setting in the initial few days of the study was 
interesting, with men, in general, often displaying boisterous behaviour, which impacted 
negatively on young people's willingness to participate in the survey. 
Workplace 
The workplace was the third of the three settings used in the study. Approaching young 
men and women and offering screening for chlamydia by urine sample was experienced 
differently in this setting than the education and health and fitness settings due to setting- 
related issues. Two workplace settings were involved in this study. 
The approach 
Two contact centres were recruited to this study. Screening was conducted at both sites 
over 2/3 hours each session (five days per week) for 2 weeks at each site (11 'h October - 
22 nd October 2004; and I lth April - 22 nd April 2005). In total, screening was offered over 
an average of 55 hours at these settings. A total of 128 men and women aged under 25 
were approached during this time (48 males and 80 females). Screening was offered from 
a 'chill-out' zone in one contact centre (an area of the contact centre where kitchen 
facilities were provided within an eating area), and from a kitchen/eating facility at the 
second contact centre. All staff were given three 20 minute breaks during an eight-hour 
shift at both organisations. This affected the approach and recruitment to the study, which 
will be discussed below. 
Of the three study settings (education, health & fitness and workplace), the least 
differences between men and women regarding their initial response to being approached 
as well as towards the offer of screening, were detected in workplace. The author's 
approach made to women and men was thereford similar, compared with the factual 
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approach versus the use of humour with female and male respondents, used in the other 
two settings. The response of men and women to this approach in the workplace was also 
similar: both men and women appeared to be aware of chlamydia to similar degrees and 
lacked surprise to be approached and invited to take part in a chlamydia study. Later, chi- 
square analyses of the questionnaire data from workplace respondents showed they had the 
highest knowledge of chlamydia of the three settings, and there was no significant 
difference between male and female workplace respondents (although the numbers are 
small and statistical significance must be viewed with caution). This may explain why 
there was no difference by gender in the reaction to my approach in the workplace settings. 
In contrast, the next chapter will describe how knowledge of chlamydia among the other 
two setting respondents differed by gender. 
Unlike in the other study settings, the study was established in smaller, more intimate areas 
of the contact centres ('chill-out zones'). Staff would frequent the study area and leave 
after 20-minutes (the duration of their break). The room would remain empty of people 
until the next set of breaks. However, because of the intimate size of these areas it was 
possible to inform men and women about the study at the same time (in other words, even 
if one small group of men and women were approached, another group in the area would 
overhear the discussion). This reduced the time taken to approach young people when they 
were present in these areas. 
In addition to the smaller study area positively affecting the nature of the approach made to 
young men and women, the pre-existing relationships between these young employees also 
facilitated the process of recruitment. Men and women in the workplace settings were 
relaxed around each other, appeared to be friendly towards each other and knew each other 
well. Some, during subsequent interviews, commented on this. For example, one young 
man said: 
"No, I didn't mindyou coming zip to talk to me at all ... I mean I know everyone there, 
it's like youre with yourfriends and anyway we all know each other so it's not really 
embarrassing or anything and they were all doing it too so no I was fille with it 
[being approached]. " 
(Interviewee #308, Male, Age 22, Workplace) 
The similarities in age between the author and the respondents perhaps facilitated the 
development of rapport. Since the dynamics of the workplace settings resulted in frequent 
close contact with respondents, one male respondent quipped to the author: "You should 
get a couple of shifts and inake yoursey'sonze nzoney while you'M here! ". It was also 
possible to converse with men and women on a less formal level because of the relaxed 
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atmosphere and the continuing familiarity. Indeed, on the final day of the study in one 
workplace setting a group of respondents gave the author chocolates; one commented "It'll 
bestrange coiningin here on Mondayandyoui-e not here! " The familiarity developed 
with these setting users, the relaxed conversations and the frequency with which they saw 
the author might have been a positive factor associated with being able to recruit 104 
participants in twenty days. It was possible to approach most age-eligible users in the two- 
week period at each organisation and therefore any additional time allowed to conduct the 
study would not have been necessary. 
There was also a 'group effect' present in this setting, similar to the experience of 
approaching mixed gender groups in the education setting. It was often the case that when 
one or two men or women agreed to complete a survey then others would also agree. 
Some of these respondents often commented: "Well if he's doing it I might as well do it 
too". Chapter 6 describes this in more detail. 
After men and women participated in the survey and/or screening, there were often lively 
conversations about sexual health. At times, these conversations did not involve the author 
but occurred between setting users themselves. The ease with which many discussed 
sexual matters may in part be explained by the familiarity and trust they had already 
established from working closely together. The smaller, more relaxed area from which the 
study was conducted facilitated a greater number of conversations in this setting. It was 
possible for the author to 'blend in' more so than in the other two study settings. 
Interviewees also mentioned the 'relaxed' nature of the screening being offered: ".. youre 
inore generally relaxed, basically, aye, inore relaxed in your own kinda safe 
environnient.. " Other workplace interviewees commented positively on the screening not 
being 'private' and were motivated to participate because they saw others doing so. This 
was in contrast to the other two study settings, within which some respondents mentioned 
the public nature of the screening as impacting negatively on their willingness to 
participate in the study. 
Of the 16% of workplace respondents who, when approached, did not complete a 
questionnaire, all gave the reason of time constraints and most were smokers who did not 
frequent the 'chill-out zone' but instead went outside the building to smoke a cigarette. 
Chapter 6 illuminates this in more detail. 
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Conducting the study: setting-specific issues 
Since access was granted for two weeks in the contact centres compared with four weeks 
for each of the other study settings, the window of opportunity in which to approach age- 
eligible setting users was reduced in the workplace setting. Furthermore, employees 
received three 20-minute breaks per shift, which limited the time available to approach 
people, engage in a conversation, ensure informed consent and await questionnaires to be 
completed and samples to be given. However, most employees tended not to leave the 
building during this time (except the few who left to smoke a cigarette) and frequented the 
study area to make coffee, use the microwave oven or sit and read or chat with other 
employees. These young men and women frequented this area on each of their breaks and 
so there were opportunities to approach persons 'missed' earlier. This was an advantage in 
this setting as employees were not allowed or able to complete questionnaires at their 
desks. Often young men and women completed a questionnaire on their first break and on 
their second would return a sample of urine. The staggered nature of the interaction with 
these settings users did have its limitations to offering screening but there were advantages, 
which included offering respondents time to consider whether they wanted to be screened 
for chlamydia. Indeed, on a few occasions, respondents who had completed a 
questionnaire had initially declined the offer of screening only to return on their next break 
requesting a 'kit', having reconsidered. Field notes recorded the reason given by one 
young man for this change of mind: 
.. he said he'd thought about who he'd had sex with without a condont and that sonle 
of the other guys ivere discussing who was going to get tested. It seenzed that these 
guys [the other tivo niales came back for a 'kit' too] approached the offer of 
screening as 'Ilzusketeers': allfor one and onefor all. 
(Field notes, Workplace, 13 1h October 2004) 
Employees who smoked did so outside at the rear of the building. They mostly consisted 
young men, and they were often in groups. As a smoker myself (at the time) I was able to 
approach employees who smoked at the rear of the building in an informal manner and 
inform them about the study. Indeed, often when frequenting this area, men would initiate 
conversations ("so what is it Youre doing this [study]for then? "). Some of these young 
men agreed to be given a questionnaire when they returned to the office and return it at a 
later date, since they often did not have time to complete the questionnaire during their 20- 
minute break as well as smoke a cigarette. Not all, however, returned the questionnaire or 
were available for screening. The approach to young men and women in workplace 
settings was therefore tailored to accommodate their break activities, and the changing 
nature of their willingness to accept the offer of screening in order to maximise the number 
of young people it was possible to encourage to participate in screening. 
Karen Lorimer, 2006 Chapter 4,105 
Feasibility of conveying results and arranging treatment 
by referral to GUM 
Offering screening in non-medical settings is worthless, from an infection control point-of- 
view, unless those who receive a positive result are contacted with their result, treated and 
partner notification procedures are performed. In this study all survey respondents were 
asked for two methods of contact. These details were verified if they went on to provide a 
urine sample. In the event of a positive result, respondents' contact details were passed to 
a health adviser at a local GUM clinic in Glasgow who would then infonn the respondent 
of their result and follow the usual clinic protocols for treatment and partner notification. 
Views of contact method 
Obtaining contact information at the time samples were provided was implemented in this 
study based on evidence from previous studies, which indicated that this is the most 
effective way to ensure all persons are notified of their result (Debattista et al. 2002a; Jones 
et al. 2002; Poulin et al. 2001; Powell et al. 2005; Rictmeijer et al. 1997). Ninety-five 
percent of all respondents, when offered the choice between a letter, e-mail, landline 
telephone or mobile telephone as the method of contact, chose mobile telephone. Three (I 
male and 2 females) requested they be contacted by letter and others by e-mail. Although 
respondents were asked to provide two forrns of contact, all who provided a mobile 
telephone number requested this be the first choice for contact, with the majority of those 
asking to receive their results via text message. 
During interviews, respondents who provided a sample of urine for testing were asked for 
their views on being asked to choose their method of contact. All cormnented positively 
on being offered a choice and also preferred to be contacted, rather than asked to telephone 
for their results. One young man said: 
"I thought the mobile thing was really good, I mean no ones going to read it, it's 
private and it's quick, yknow, no waiting aroundfor a letter which might go missing 
in the post and then you're sittin' like left wondering about your result, so aye that 
[text message] was good. " 
(Interviewee #364, Male, Age 23, Workplace) 
No respondent offered a negative comment on being offered a choice of contact methods, 
or for waiting for their results, rather than telephoning for them themselves. This method 
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was acceptable to all respondents in this study. Further, all 113 screening participants, 
whether testing negative or positive, were successfully contacted with their result. 
Views on awaiting results 
In a recent study, women who were diagnosed with chlamydia described feeling anxiety 
over disclosure of the condition to others (Duncan et al. 2001b). The authors of the study 
comment on the paucity of information on the psychosocial implications of a diagnosis of 
chlamydia. Some evidence is emerging regarding men's feelings about being diagnosed 
with chlarnydia (Darroch et al. 2003). However, very little known about men's feelings 
when awaiting results; in other words, among men who participate in screening but who 
test negative for infection. These feelings of anxiety of partner notification may be 
anticipated by young men and affect willingness to participate in screening. As such, it 
could be important to assess these views so that a screening approach can be developed 
with these factors understood. In this study, male interviewees were asked to discuss their 
feelings when awaiting results. 
No female interviewee in this study, who provided a sample to be tested, commented on 
feeling anxious during the period they were awaiting their test result. In contrast, many 
young men, in interviews and also in conversations in the settings, described feeling 
anxious. Although not statistically significant, young men who reported in their 
questionnaire they considered themselves to be at risk of having chlamydia tended to 
report feelings of anxiety when awaiting their results. One young man commented: 
"I was thinking about the lassies Id been way and if I could have caught anything 
from them and I wisjust thinking about all that you know ... I was pure stressed sitting in nzy house thinking about it actually, I wis really stressed until I got the result. 
(Interviewee #190, Male, Age 21, Health & Fitness) 
A few young men described feeling anxious about potentially having to inform partners of 
a positive result: 
"Aye, I was thinking what ifI have it and I need to tell people. Thativasallightmare. 
I'm glad it was negative 'cos that would really have been a nightmare. 
(Interviewee #194, Male, Age 21, Health & Fitness) 
The anxiety among the young men when awaiting their results often stemmed from 
worrying they would test positive and the subsequent implications they perceived 
regarding informing partners of their result. One male commented: 
"If the results were to come back, like positive kinda thing, you 101ow like coming 
back and having to discuss, I don't think I could do that. 
(Interviewee #258, Male, Age 22, Health & Fitness) 
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No male discussed attributing blame to a female sexual partner or lacked self-blame, as 
was found in one recent study with heterosexual men who were diagnosed with chlamydia 
(Darroch et al. 2003). Another, who tested negative, said: "I was happy not to be having a 
conversation ivith anyone! "(Interviewce #308, Male, Age 22, Workplace). Another 
expressed similar concerns: "A lot of people won't ivant to conle back and have a 
discussion with anyone here that'S the thing" (Interviewee # 258, Male, Age 22, Health & 
Fitness). This young man replied to his text message result (which was negative) with the 
message 'Thanx 4 that. Good 2 no hn safe. All the best 4 rest of study [sic]' (Interviewee 
#258, Male, Age 22, Health & Fitness). 
These comments raise the issue of how successful 'in the field' treatment would have been 
in this study, had that been the protocol. However, similar studies, as chapter 2 reviewed, 
were able to successfully treat the large majority of infected persons in community 
settings: 91.7% were successfully treated in one (Jones et al. 2000), and 100% of infected 
persons were successfully treated in another study (Gunn et al. 1998). The views of the 
young men in this study suggest that men experience feelings of anxiety when awaiting 
results as part of screening. Their concerns tended to be focused on the possibility of 
haying to engage with a treatment process and informing partners of their positive result. 
Treatment of positives 
Screening participants in this study who tested positive for chlamydia infection had their 
contact details passed on to a Health Adviser at the local Gum clinic that had agreed to 
manage any persons who may test positive from being screened as part of this study. 
Verbal feedback from the Health Adviser was provided to the author, followed by written 
confirmation, regarding whether contact with respondents who tested positive was 
successfully made and also whether respondents attended the clinic for treatment. Of the 
five respondents who tested positive, four attended the GUM clinic for treatment. The 
Health Adviser commented that obtaining a mobile telephone number for these 
respondents had made contact with these respondents easier (personal communication, 23d 
April 2005). One male, who did not attend for treatment, was successfully contacted on 
three separate occasions, following the clinic's standard protocol. Despite the Health 
Adviser engaging in a conversation with this respondent on each of the three occasions that 
contact was made, the respondent (to date) has not received treatment for chlamydia at this 
clinic. The Health Adviser stressed to the author that it is possible the respondent sought 
treatment from his GP, as he had mentioned this during a telephone call. 
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During interviews, one respondent, who tested positive, was asked for her experience of 
being referred for treatment after testing positive for chlamydia in this study. Her 
comments focused largely on her experience within the clinic. She offered little 
commentary, even when probed, on how she felt being referred to a clinic after having 
been tested in a non-clinical setting. Her account of her experience was thus: 
R: [niy boyfriend] was taken away first and I'm sitting there a bit sort of scared, 
sitting there inyseý(, but I wasn't really nzinding cos I was getting out of 1vork ... the 
staff, most of thein ivere quite pleasant but Ifound the guy that worked on reception 
was a bit sort of sizidey, I didnt like him-he was bitching about soineone and I 
could hear it and I didnt like that, he was talking about soineow as though they 
ivere a f* *king ivain 
KL A bit condescending? 
R: Min inni and then I noticed that I could hear evetything people were saying 
when they got tip to the reception bit and I mean it's no exactly confidential, I inean 
fair enough ive're all infor the same thing ... and 
I got told different things from nzy 
boyfriend, like he was told not to take the tablets on an empty stomach whereas I 
was told to take the tablets now, so the way ive ivere treated, I though it was a bit off 
y'lazoiv being told different things. 
(Interviewee #128, Female, Age 23, Education). 
Interview recruitment 
Although it had been intended to interview 20 individuals per setting, in practice this 
proved difficult. The author was only in each setting for a relatively short time, which 
meant there was a limited opportunity in which to discuss all aspects of the study with 
young people. Given the one-person approach, there was a lot of information to convey to 
respondents and sometimes discussing their willingness to participate in an interview was 
overshadowed by discussions of infonned consent and methods of contacting them with 
their results. Being conscious to ensure that all persons who provided a sample for testing 
received their diagnosis and understood the importance of seeking treatment in the event of 
a positive result therefore often took precedence over a discussion of participating in an 
interview. 
Among those whom it was possible to discuss interview participation with, more 
respondents agreed to the interview than eventually turned up and with the move to another 
setting, following up non-attendees proved difficult. Respondents who agreed to interview 
were offered the choice of the setting or university as the location for the interview. Most 
respondents who agreed to take part in an interview wished to do so in the university, 
rather than in the setting. However, it proved difficult to arrange interviews with these 
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people, and few eventually participated in an interview. Conversely, the majority of those 
who agreed to participate in an interview in the study setting eventually participated. In 
the workplace setting, respondents received three twenty-minute breaks per shift and so 
some interviews in this setting were conducted in t-wo parts. In the health and fitness 
setting some respondents suggested it was difficult to arrange to take part in an interview 
because they received transport home from a ffiend and did not want their friend to wait 
for them. No incentive to take part in an interview was provided and this may have 
affected the uptake of the interviews. 
Table 3 provides information on the 24 respondents from all settings who participated in an 
interview (10 males and 14 females). Of them, 20 had provided a sample for testing, 4 did 
not take part in the offer of screening. Two of five respondents who tested positive for 
chlamydia participated in an interview. 
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Study ID Gender Age Setting 
Provide a 
sample? Result 
38 M 22 Education Y neg 
75 M 17 Education Y neg 
77 M 20 Education Y§ Pos 
128 F 23 Education Y Pos 
138 F 18 Education N 
159 F 22 H&F Y neg 
181 F 23 H&F N 
190 M 21 H&F Y neg 
194 M 21 H&F Y neg 
230 F 24 H&F Y neg 
237 M 24 H&F Y neg 
255 F 22 H&F N 
258 M 22 H&F Y neg 
294 F 24 H&F Y neg 
308 M 22 Work Y neg 
309 F 20 Work N 
310 F 20 Work Y neg 
311 M 20 Work Y neg 
322 F 21 Work Y neg 
352 F 21 Work Y neg 
354 F 23 Work Y neg 
355 F 23 Work Y neg 
364 M 23 Work Y§ neg 
370 F 24 Work Y neg 
'H &P is Health and Fitness setting; 'Work' is workplace setting. 
§ These respondents did not provide a sample when first approached in the setting, but gave one 
at their subsequent interview. 
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Prior to discussing what respondents knowledge of chlamydia was (Chapter 4) and their 
willingness to accept the offer of screening by providing a sample of urine (Chapter 5), this 
chapter concludes by providing an overview of the study respondents: the numbers 
approached, those who completed questionnaires and those who subsequently provided a 
sample for testing are detailed by setting and gender. 
A total of 431 young people aged 16-24 years were approached about the study. When 
approached, young people were informed about the nature of the study and asked if they 
wished to participate by completing a self-administered questionnaire. Of those 
approached, 84% (n=363) agreed to participate by completing a questionnaire (see Table 
4). The choice of being screened for chlamydia was raised at this point in the approach, 
but respondents could choose to use the time taken to complete the questionnaire to 
consider their response to the offer of screening. After completing the questionnaires, 
young people returned them to the author. At this point in their participation respondents 
were offered screening for chlamydia and they could accept by providing a urine sample. 
Of the 363 who completed a questionnaire, 113 (32.6%) provided a sample for testing (see 
Table 5). No respondent provided a sample without completing a questionnaire. 
The study sample consisted 158 males and 205 females (mean age, 20 years; interquartile 
age range 18-22). Approximately half of education respondents were teenagers, compared 
with one quarter of both health and fitness and workplace respondents (see Table 6). The 
mean age of respondents by setting is presented in Table 6. 
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Table 4: Sample size and response rate, by setting and gender 
Study setting Gender 
Numbers 
approached 
Numbers 
completing 
survey (Yo) 
Response rate 
% 
Education All 145 126 86 
Male 76 62 (49) 82 
Female 69 64 (51) 93 
Health & All 158 133 84 
Male 65 56 (42) 86 
Female 93 77 (58) 83 
Workplace All 128 104 84 
Male 48 40 (38) 83 
Female 80 64 (62) 80 
TOTAL 431 363 84 
Table 5: Numbers of respondents accepting screening, by setting and gender. 
Setting Getider 
Number 
I 
of Number accepting 
X2 test 
respondents screening (Yo) 
Education ALL 115 22 (19.1) 0.07 
Male 59 15 (25.4) 
Female 56 7 (12.5) 
Health & Fitness ALL 127 62 (48.8) 0.01 
Male 53 33 (62.3) 
Female 74 29 (39.2) 
Workplace ALL 104 29 (27.8) 0.40 
Male 40 13 (32.5) 
Female 64 16 (25.0) 
TOTAIL ALL 346t 113(32.6) 0.009 
Male 152 61 (40.1) 
Female 194 52 (26.8) 
t 17 of 363 respondents stated they were not yet sexually active and were excluded from analysis; Significant 
relationships between gender and providing a urine sample are indicated by bold p-values. 
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Table 6: Age of respondents, by sefting. 
Age of respondent (years) 
16-19 (%) 20-24 (%) Mean age 
Education 66 (53.7) 57 (46.3) 19.6 
Health & Fitness 39 (29.3) 94 (70.7) 21.1 
Workplace 24 (23.1) 80 (76.9) 21.1 
Summary 
During the study 431 young men and women under 25 years were approached in three 
community settings and asked to participate in the study by completing a questionnaire. A 
total of 363 (84%) of those persons agreed. Of them 113 (32.6%") provided a sample of 
urine to be tested for chlamydia. A time of - 230 hours was taken to recruit these young 
men and women into the study. This results in an average screening rate of one sample 
every 2 hours. This number seems small; however, in each setting there were periods 
when there were no age eligible persons with whom to approach. On the other hand, there 
were also many occasions when more than one sample was collected by the author during 
the one screening session. For example, on the second day of screening in the education 
setting, 31 persons completed a questionnaire, of whom 8 provided a urine sample for 
testing; on day 20 in the first health and fitness setting, 6 persons completed a 
questionnaire, of whom 5 provided a sample for testing. Despite attention given to the 
times and days most appropriate to the age-eligible clientele at each setting, there was, 
nevertheless, variability both in the numbers of age-eligible young people accessing the 
setting, and in the numbers of respondents who were willing to provide a sample for 
testing. 
The opportunistic nature of this screening approach renders it difficult to accurately assess 
the total potential screening population. However, this study was concerned with 
screening in non-medical settings as an approach to exploring the feasibility of doing so 
but also to collect data on the response by young people to the offer. The one-person 
approach affected the size of the sample recruited. For both of these reasons this study has 
placed little emphasis on the coverage of screening using this approach. Both the numbers 
18 17 persons reported they were not yet sexually active therefore 113 of 346 persons accepted the offer of 
screening. 
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who participated when approached and the time taken to recruit samples was recorded in 
this study. In contrast, most screening approaches in non-medical settings describe using 
one of these two methods of reporting participation rates. There were a number of barriers 
to recruitment, which were often setting-specific. This information, which was recorded in 
fieldnote diaries, provides useful data upon which to assess the feasibility of offering 
chlamydia screening to young populations accessing these three non-medical settings. 
Setting-specific barriers included, being restricted to particular areas of the setting from 
which to establish the screening sessions, which limited the number of persons the author 
was able to approach. For example, in the education setting, the author was not pennitted 
to enter classrooms and so the study was set up in the canteen area. When possible, the 
author moved to another venue within the same setting to recruit more individuals (for 
example, moving from the canteen to the snack bar within the education setting) and also 
changed the time of day the study was conducted. In the health and fitness setting, age 
eligible users frequented the settings at various times. Those who did frequent the study 
area tended to remain for a short period and, given the one-person approach, it was often 
difficult to approach all users within this limited time. In the workplace setting, the author 
was only given permission to approach individuals on their own time (during breaks which 
were 20 minutes each); however, approaching groups of employees meant it was often 
possible to recruit people at the same time. 
For these reasons, approaching individuals was often constrained by the number of eligible 
men and women coming through the setting over the time period and time limitations. The 
lower uptake at the education setting, despite a larger potential sample, in particular 
reflects this difficulty. Despite this, the study had a flexible approach inbuilt, which 
enabled the approach to change to suit the way in which the setting users frequented the 
settings. 
Gaining access to the study settings was relatively easy and unproblematic. Access was 
granted with little or no questions or concerns raised by the 'gatekeepers'. Many of the 
staff at the settings, in particular the health and fitness settings, provided support and useful 
information (such as busy times when age-eligible users accessed the setting) and also 
expressed interest in the study during the course of the screening sessions in the settings. 
Whilst a lack of support from staff may not have prevented the study taking place, 
nevertheless, the absence of disruption facilitated the screening sessions. 
Karen Lorimer, 2006 Chapter 4,115 
The National Strategy for Sexual Health and HIV pays little attention to the question of 
how gender may affect the approach and how screening is offered. Practical issues, such 
as how samples are stored as well as treatment and partner notification are commonly 
discussed in the screening literature. Indeed, the proposed screening strategy for England 
focuses on issues of practical implementation. Further, risk factors associated with 
positive results are often analysed in both clinic and non-medical screening studies. Few 
studies assess and/or report the influencing factors upon uptake of screening in non- 
medical settings. When factors affecting participation in screening have been discussed in 
the literature, interesting findings are emerging, such as the effect of the interviewer, 
confidentiality, the perception of risk and who is around at the time people are asked to 
provide a sample (Debattista ct al. 2002d; Fenton et al. 2001a). This study has found that 
there are important differences in the way men and women responded to the offer of 
screening. The use of humour as well as culturally appropriate language and dress did 
much to break down the reluctance of many young men to become involved in this study. 
This has been reported elsewhere in the literature in relation to screening studies with 
MSM who are approached and invited to be screened in entertainment venues (Debattista 
et al. 2002a). 
Regarding the practical issues of establishing screening in these settings, this study 
demonstrates that it was feasible to offer screening. Testing was carried out in these 
settings with little problems and respondents were all successftilly contacted with their 
results. All respondents who tested positive were successfully contacted by the clinic and 
all except one respondent attended the GUM clinic for treatment and were subsequently 
managed according to the clinic's usual procedures. The uptake of screening among young 
men in non-medical settings varies by screening setting in existing studies (Ford et al. 
2004b); however, all have been shown to be feasible. Other studies have identified 
accessibility as well as access to information about chlamydia as two key facilitators 
among young men of willingness to accept the offer of chlarnydia screening in community 
settings. These studies have predominantly occurred in the USA; this is the first study in 
the UK to consider the feasibility of screening and willingness of young men to accept the 
offer of screening in a health and fitness setting. 
The stability offered by non-medical settings within the community may facilitate 
successful patient follow-up evaluation by providing healthcare workers with venues and 
access points to reach persons who may otherwise be inaccessible for notification and 
treatment. Additional benefits may include an incTeased sense of partnership between 
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researchers and GUM healthcare workers. Respondents' views on these, and other, issues 
will be discussed in greater detail in chapters 5 and 6. 
This chapter described the process of gaining access to the study settings and establishing 
screening in them. The next chapter presents data on what the young people who 
participated in the study know about chlamydia as well as their views towards screening 
being offered in these settings. 
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Chapter 5 
Young People's Knowledge of Chlarnyclia and 
Views Towards Screening for Chlarnydia 
This chapter is in two parts: the first part of this chapter details what young people taking 
part in this study know about chlamydia; the second part describes their attitudes towards 
screening for chlamydia in both medical and non-medical settings in general. Their 
attitudes towards being asked to participate in chlainydia screening study will also be 
explored. 
For this study, both the questionnaire and the semi-structured inter-views collected data on 
knowledge of attitudes and attitudes towards screening for chlarnydia. 'Don't know' 
responses were included in analysis of questionnaire data to ascertain the level of 
uncertainty among respondents regarding their knowledge of chlarnydia. Non-sexually 
active participants were included in analysis of knowledge but excluded in analysis of 
willingness to accept the offer of screening (see Chapter 6). 
Respondents' awareness of chlamydia 
Respondents were asked if, prior to taking part in this study, they had ever heard of 
chlamydia and also to identify what chlamydia is. The majority (93%) of respondents had 
heard of chlamydia before taking part in this study, with no significant gender differences. 
Setting was significantly associated with participants having previously heard of 
chlamydia, with education and workplace setting participants more likely to have heard of 
chlamydia than health and fitness participants. All respondents, except one, correctly 
identified chlamydia as being a sexually transmitted infection (99.2%). 
The survey data revealed a large majority of respondents had heard of chlamydia prior to 
taking part in this study. Data from interviews with respondents and also from fieldnotes 
revealed a geater certainty of awareness of chlamydia among women than men. Many 
young men spoke with uncertainty about their awareness of chlamydia than the young 
wom en and were less able to elaborate their knowledge: "Id heard of chlainydia but I 
didn't know what it was, really... " (Interviewee #75, Male, Age 17, Education). Another 
said: "I've heard aw it but ave no, I don't biow aboot it... " (Interviewee #190, Male, Age 
21, Health & Fitness). In contrast, young women, when approached, often responded 
confidently and with certainty when asked if they had heard of chlamydia before, for 
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example, "Oh, yes, A huh, I've heard of it" and "Chlanlydia yes I've heard of it.. " 
(Fieldnotes, Education, 24 th March 2004). It is possible to have heard about an infection 
and yet know nothing more about it; therefore, survey respondents and interviewees were 
also asked for their knowledge of chlarnydia. 
Knowledge about the clinical features of chlarnydia, 
associated sequelae and testing method 
The survey asked men and women to respond to a series of knowledge questions, 
including: how infection occurs; the symptoms of chlamydia in men and women; the long- 
term health consequences for men and women who had chlamydia; and, the asymptornatic 
nature of chlamydia infection. The majority (99.4%) of all study respondents correctly 
identified unprotected sex (no condom) as how chlamydia infection occurs. Chi-square 
analyses found no significant relationships between gender, age or setting and knowledge 
of this item (p>0.05). 
Regarding knowledge of symptoms of chlamydia, respondents were to choose the 'correct' 
symptoms from a list (see Table 7, and also Appendix 3). First, there were a number of 
misconceptions in relation to female symptoms. The greatest number of misconceptions 
among both male and female respondents were observed for the item assessing knowledge 
that women might develop pain in the lower stomach, with 80% of all respondents 
providing an incorrect answer. Of all respondents, 61% believe unusual discharge, 51% 
believe pain or stinging when urinating and 57% believe pain during sex not to be 
associated symptoms of chlamydia in women - all of which are symptoms of chlamydia in 
women. Chi-square analyses found significantly more males than females answered 
incorrectly to the items unusual discharge (female Symptom) (X2=72.030, p<0.001) and 
pain in lower stomach (female symptom) (X2 =20.991, P<0.001). In addition, Chi-square 
analysis found significantly more women (60.0%) than men (24.7%) knew chlamydia 
could be mostly asymptomatic in women (X2 =45.540, p<0.001). 
Second, in relation to symptoms of chlamydia in men, the greatest number of 
misconceptions were observed for the item assessing knowledge that chlamydia might 
cause pain and/or swelling in the testicles of men, with 75% of all respondents providing 
an incorrect answer. Of all survey respondents, 51% believed unusual discharge and 46% 
believed pain/burning when urinating not to be associated with chlamydia infection in men 
- both of which are symptoms of chlamydia in men. Chi-square analysis found 
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significantly more males (40%) than females (20%) answered the item 'unusual discharge' 
(males) -a common symptom among men who develop symptoms of chlarnydia. - 
incorrectly (X2 =6.326, p=0.042). 
Chi-square analyses were perfortned to assess whether there were any significant 
differences in knowledge of symptoms were reported between the three study settings (see 
Table 7). Workplace respondents answered incorrectly less so than either education or 
health and fitness respondents. The highest misconceptions, by setting, were observed for 
the symptom 'Pain in lower stomach' (female symptom) with 70% of workplace, 80% of 
health and fitness and 85% of education respondents failing to identify this as a correct 
symptom. Thus, although the workplace respondents answered least incorrectly, there 
were nevertheless a large percentage of all respondents who could not identify this 
symptom in women. However, many respondent from each setting chose to respond 
'Don't know' to this item (see Table 7) therefore the significant association between 
setting and knowledge of female symptoms should be treated with caution due to the small 
numbers involved. 
Table 7: Percentage of respondents answering questions of symptoms of chlarnydia in 
women and men incorrectly, by setting. 
Symptoms in women § Education 
Health & 
Workplace 
A, 2 test 
fitness p 
Unusual discharge 37.3 49.2 28.8 <0.001 
Pain or stinging when urinating 50.0 55.3 39.4 <0.001 
Dizziness 0 0 5.8 <0.001 
Headache 0.8 0.8 2.9 0.002 
Pain during sex 54.2 59.1 51.0 0.004 
Pain in lower stomach 84.7 80.3 70.2 <0.001 
Itch and/or rash 19.5 10.6 30.8 <0.001 
Don't know 22.0 27.3 21.2 0.003 
Symptoms in men 
Unusual discharge from tip of penis 50.8 58.3 42.3 0.088 
Pain and/or burning when urinating 47.5 50.9 36.5 0.127 
Dizziness 0 0 1.0 0.294 
Headache 0.8 0 1.0 0.514 
Pain/swelling in testicles 71.3 76.5 76.0 0.457 
Itchiness around groin area 13.9 12.9 15.4 0.594 
Rash 13.1 8.3 17.3 0.143 
Don't know 29.5 33.3 30.8 0.577 
Correct symptoms are indicated by bold typeface. Significant relationships between setting and knowledge 
of symptoms are indicated by bold p-values. §9 missing values, 
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Regarding male symptoms, Chi-square analyses found no statistically significant 
associations (p>0.05) between setting and knowledge, with a similarly high percentage of 
survey respondents in each setting answering incorrectly (see Table 7). Again, -one third 
of respondents stated 'Don't know' to this knowledge item which reduces the overall 
number in each setting providing a 'True' or 'False' answer. 
In addition to these setting-rclated differences in knowledge of symptoms, Chi-square 
analysis of the survey responses revealed significant differences in knowledge by age of 
respondent. Respondents aged 20-24 years provided significantly fewer incorrect 
responses than respondents aged 16-19 years (see Table 8). On three of the four true 
symptoms of chlarnydia in women, survey respondents aged 16-19 years answered more 
incorrectly than those aged 20-24 years. On one of the three correct male symptoms, 
survey respondents aged 16-19 years answered more incorrectly than those aged 20-24 
years. However, whilst survey respondents aged 20-24 answered least incorrectly on both 
female and male symptoms, there is nonetheless a large number who appear unable to 
identify the most common symptoms of chlamydia in women and men, with between 
36.6% and 71.0% of those aged 20-24 years answering symptom questions incorrectly. 
Table 8: Percentage of respondents answering questions of symptoms of chlamydia in 
women and men incorrectiv. bv ace crour). 
Age ofsurvey respondents 
Symptoms !n women 16-19years 20-24years V test 
Unusual discharge 44.5 36.6 0.078 
Pain or stinging when urinating 57.0 44.6 0.023 
Dizziness 0 2.7 0.062 
Headache 3.9 0 0.002 
Pain during sex 68.0 48.2 <0.001 
Pain in lower stomach 92.2 71.0 <0.001 
Itch and/or rash 17.2 21.0 0.107 
Don't know 29.7 20.5 0.034 
Symptoms in men 
Unusual discharge from tip of penis 58.6 47.1 0.095 
Pain and/or burning when urinating 53.1 41.9 0.099 
Dizziness 0 0.4 0.452 
Headache 1.6 0 0.127 
Pain/swelling in testicles 82.8 69.6 0.021 
Itchiness around groin area 15.6 13.2 0.626 
Rash 7.8 15.0 0.106 
Don't know 
Significant relationships between age and knowledge of symptoms are indicated by bold 
p-values. 
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Interactions between setting, gender and age were also assessed using logistic regression. 
The effect of gender, setting and age had upon knowledge of symptoms was found to be 
the same; thus, there are no significant interactions in this study population between 
setting, gender and age. Overall, there appears to be a high percentage of respondents who 
have a low knowledge about the clinical features of chlamydia, especially males, health 
and fitness and education respondents and younger respondents. 
All survey respondents were asked to consider whether chlamydia could affect men and 
women's fertility; also whether chlamydia could cause conjunctivitis. Two thirds (66.1%) 
of all survey respondents believed chlamydia could affect men's fertility, although more 
men than women responded 'True' to this item (71.5% of men and 60% of women). The 
majority of survey respondents knew chlamydia could also affect women's fertility 
(82.6%); and in contrast to the previous item response, significantly more women 
considered this to be true than men (84.9% of women, 76.6% of menJ. Few respondents 
knew that chlamydia might cause conjunctivitis (15.2%). In contrast, the majority of 
survey respondents (97.2%) knew chlamydia could be tested on a sample of urine (with 
blood and saliva as the other available options in the questionnaire); Chi-square analysis 
found no significant associations between gender, setting or age with knowledge of this 
item (p>0.05). 
Regarding the asymptomatic nature of chlamydia, survey respondents were asked to 
respond to statements including 'I'd know if I had chlamydia' and 'I'd only think about 
chlarnydia if I had symptoms'. Respondents were asked to choose their response from a 
Likert scale ranging from Strongly Agree to Strongly Disagree. Responses were 
aggregated into agreement and disagreement with the statements. Regarding the first 
statement, around I in 6 (15.1%) respondents (14.7% of men and 15.3% of women) agreed 
that they would know if they had chlamydia. Around half of men and women (48.0%) 
disagreed and believed they might not know if they had chlarnydia (42.9% of men and 
52.0% of women). Thus, around half of the sample either did not know or responded 
incorrectly to this item; therefore half of all survey respondents were not aware that 
chlamydia is often symptomless -a key feature of this infection. 
Regarding the second statement, one in three (36.6%) of all survey respondents believed 
they would only be concerned about chlamydia if they developed symptoms. Again, a 
high number of survey respondents were therefore unaware chlamydia can run a 
symptomless course. Chi-square analysis found. a gender disparity in this. view: 
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significantly (p<0.01) more men than women agreed with this statement (45.6% of men 
compared with 29.8% of women). Furthermore, around I in 10 of all respondents (8.8%) 
believed chlamydia is a 'women's problem', with no significant differences between male 
and female responses to this item (p>0.05). There was therefore a perception among many 
survey respondents that chlamydia infection would present itself with obvious symptoms 
and that it is largely a female concern. 
Study respondents who agreed to participate in an in-depth interview were again asked 
about their knowledge of chlamydia during interviews. A list of common sexually 
transmitted infections was shown to interviewees, with chlamydia at the top of the list. 
Interviewees were asked what they knew about each infection. Regarding chlamydia, there 
was a low perception of knowledge among most interviewees, which concurs with the 
survey findings. A common response from interviewees is illustrated below: 
KL: Tell nze what you know about chlanzydia. 
R: I don 't know a lot about it to be honest [pause] 
KL: Do you Now any syniptonis of chlainydia? 
R: See, I've heard about it, I dont really luiow, obviously, all the ins and outs 
of it, but I lazow what it is, as inuch as I kinda, I think I know kind of thing, but eln ... I don't know a lot about it. 
(Interviewee #309, Female, Age 20, Workplace). 
This female respondent reported a poor knowledge about chlamydia and used a language 
of uncertainty; however, more male interviewees respondent in this manner to this 
question. The following young man's comment was a common response forrn male 
interviewees: 
"I think IW heard of chlainydia before [participating in the study] fronz sonlelvIlere 
but I'M not sure like Ih-now nizich about it, IthiizkIW heard of itfroln sonlewhere" 
(Interviewee #38, Male, Age 22, Education). 
Other interviewees who were able to comment on the asymptomatic nature of chlamydia 
and the associated sequelae among men and women with long-term infection tended to 
report that they had acquired this information from the study literature: 
R: Id heard of chlainydia before I spoke to you but I didn't know that you might 
not know you have it. Id always thought that with things like this you'd know, 
like youd get a discharge or something wouldjust be like fiamy down there 
flaughs/ but em, yeah I know that that's not always the case now and also that 
it can cause like problems, women not getting pregnant and stuff, I didnt 
really know that 
KL: You sayyou biow those thingsfi-om takingpart in this study? 
R: Yeah, like you don't always kwow or as you said ýou cant fell by looking'. I 
remeniberyou saying that to me. 
KL: Really. So me talking to you.. any other parts of the study you.. 
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R: .. yeah those leaflets you gave me ... I 
did actually read them [laughs] and it had 
like the symptoms and what could happen if you didnt get it sorted kinda 
thing. But like I had read the whole no symptom thing on a poster you had zip 
in the toilet ... you kept passing it and reading another 
line each time. 
(Interviewee #364, Male, Age 23, Workplace). 
Two women had a depth of knowledge about chlamydia: one had previously worked in a 
laboratory which tested samples for STIs and the other had experience of working on a 
sexual health advice line. 
Most interviewees offered comments on their perceptions of young people's knowledge 
about chlamydia. A typical view among the majority of all interviewees was that most 
young people are aware of chlamydia but have poor knowledge about it. By 
contextualising their own poor knowledge of chlamydia with knowledge among young 
people in wider society, respondents were attempting to normalise their own poor 
knowledge. One young woman offered the following comment immediately after 
discussing her own perceived low knowledge of chlamydia: 
"... but I don't think inany, like most people I know, I dont think they k-now all about 
this stuff so, I mean they're about my age ... 
I dunno 
... Ijust think it's, there's just hardly any information about this and I think there should be. 
(Interviewee #309, Female, Age 20, Workplace). 
Most interviewees spoke about their own sex education and offered views on the quality of 
sex education more generally. A typical view from both male and female interviewees 
was that their low knowledge about chlamydia was the 'fault' of their perceived poor sex 
education. A few couched their statements in normative terms: 
KL: iviiatdoyozireiýieiizbei-beiizgtaziglitabozitsexitalitifectioiisitisex education? 
R: No much. I remember it was like AIDS and stuff but that's really all, HIV, that's 
all I kind of remember. I think ive really should have been taught about this 
stuff, like see thefirst time really that I've ever ivent into anything ill ally detail 
has been with yoursetf 
(Interviewee #308, Male, Age 22, Workplace). 
The most common STI interviewees remember being discussed during their sex education 
was HIV/AIDS. Almost all interviewees commented that they do not remember being 
taught about chlamydia at school. 
The belief that poor knowledge was linked with high-risk sexual behaviour was expressed 
by some interviewees, although more so from females than males. According to these 
young people, providing more information about STIs, especially within the school 
context, would reduce high-risk behaviours and therefore rates of STIs. During these 
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specific discussions, some of these interviewees went on retrospectively to describe their 
own sexual behaviour as being high-risk; they believed that their lack of awareness of 
chlamydia led to them taking risks with their sexual health. 
VVhilst overall knowledge among this sample population was low, some knew that 
chlamydia might affect a women's fertility: 
"I didn 't know any side effects or anything, apartfroin infertility ... it was the only one I Imeiv, atid I didnt Now ivhat syniptonis there was or anything like that. 
(Interviewee #255, Female, Age 22, Health & Fitness). 
Some respondents knew of the clinical features of chlamydia; however, many discussed 
leaming about these facts from reading the study literature, especially from the posters and 
conversations with the author. As discussed earlier, one in ten respondents (10.6%) 
reported 'This study' as their first source of information about chlamydia and some 
interviewees discussed their knowledge of chlamydia stemming from reading literature 
given them as part of the study. When asked what they now know about chlamydia from 
taking part in the study, interviewees most commonly referred to the largely asymptomatic 
nature of chlamydia infection. Some female interviewees commented that they had heard 
of chlarnydia and knew it could affect women's fertility because they had read about it in 
women's magazines; however, most, as with males, were largely unaware prior to taking 
part in this study that chlamydia could be asymptomatic. Many young men commented on 
being surprised to learn that the majority of people would have no sign of symptoms of 
chlamydia infection. Some men commented that they believed they would know if they 
had caught a STI: 
'7 was quite shocked by that, cos I always thought, wellfor most things like that, 
that you'd know, y`lbiow I always thought I would Now, I'd have some sort of 
syniptom, so yeah, I was really surprised when I read that iýiost people don't always 
blow. " 
(Interviewee #237, Male, Age 24, Health & Fitness) 
Perhaps on the basis of their surprise, some respondents, especially men, discussed that 
they had subsequently infon-ned their fiiends about how common chlamydia is and of the 
largely asymptornatic nature of the infection. One man commented: 
"Surprisingly a couple of thefriends I've got havent actually had experience with a 
woman yet as it ivere so they're not really worried about it. They didnt really 10low 
about it like they didnt Imow it could affect yourfertility and it call really affect a 
woman'sfertility and stuffso I was telling them and they ivere like 'Oh right I though 
it was just-you started leaking stuff (laughs)... I says sometimes you dont know, 
obviouslyfroln reading the poster andfrom the information you had given its, eh, it 
was sayingyou don't always know and ifyouve had unprotected sex it's a good idea 
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to get checked out, especially ifyou dont Imow the person, even ifyou do k7lo1v theill 
but dont lazow theii- histoty. 
(Interviewee #311, Male, Age 20, Workplace). 
Two female respondents described conversations they had with their respective younger 
brothers, mentioning specifically the lack of symptoms, the commonness of chlamydia and 
how simple the test and treatment is, with one requesting a test 'kit' to take home to her 
brother, as the following field note extract illuminates: 
A female respondent who provided a sample the other evening approached me 
tonight to request a test 'kit' to take home to her brother. She said she had told him 
that she had been testedfor chlamydia and he responded, "Miat's that? " Yheir 
ensuing discussion consisted of her informing her brother about chlanlydia, she 
mentioned the asymptonzatic nature of chlanzydia to hinz and how common it was 
among people under 25 years. She decided that he should be tested andassured him 
that she would askfor a test 'kit'the next time she saw me. 
(Field note, Health & Fitness, 2 nd June 2004) 
The opportunity for health promotion was an unintentional but apparently inherent aspect 
of this study. The surprise among many interviewees from learning of the asymptomatic 
nature of chlamydia infection was subsequently communicated to their friends: "I was like 
that "did you know that nzost people don 't Now the even have it! " kinda thing, cos I Y 
couldnae believe that nian! I thought you would know ifyou had soinething. " (Interviewee 
#77, Male, Age 20, Education). Both women and men reported that they had passed on 
information they had gained about chlamydia from their participation in this study to 
family and/or friends. The health promotion aspect to this approach, albeit unintentional, 
has been discussed in the literature concerning non-medical approaches as a possible 
secondary benefit to this type of approach (Arcari et al. 2004; Debattista et al. 2002a). 
Source of respondents' information 
Survey respondents were asked to choose the source from which they first heard about 
chlamydia. The commonest source chosen was 'Teacher/School', followed by 'Friend' 
then 'Magazine' (see Table 9). Whilst 'Teacher/School' was the most common survey 
response, around three quarters of all survey respondents did not report an educational 
source as being where they first heard about chlamydia. This is a young sample with all 
respondents under 25 years. One might expect the numbers reporting school and or 
teacher to have been where they heard about chlamydia to have been much higher. 
Chi-square analyses of survey responses to source of knowledge found significantly more 
females (13.4%) than males (4.5%) first heard about chlamydia from a medical source 
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(p<0.01) - see Table 9. In addition to a medical source, significantly more female 
respondents (21.8%) first heard of chlarnydia from a media source compared with males 
(0.6%). Whilst similar numbers of male and female respondents reported an educational 
source as their first source of information, females reported sources that males tend not to 
use - doctors and magazines. 
Although 93% of survey respondents stated they had heard of chlamydia before 
participating in this study, one in ten (10.6%) respondents later reported 'This study' as 
their first source of infon-nation about chlamydia. This apparent discrepancy is explained 
by confusion among some respondents regarding the survey question. Some interviewees 
commented that they became aware of chlarnydia from having read study posters and 
leaflets, which circulated in the settings one week in advance of the study commencing in 
each setting. This may explain the apparent discrepancy: that they had first heard about 
chlamydia from reading a study poster and consequently responded 'Yes' to the question 
'Had you heard of chlamydia before taking part in this study? '. In addition, the higher 
percentage of young men than women reporting health information leaflets (14.8% of men 
compared with 5.0% of women) may also be explained as confusion as to the survey 
question. 
Table 9: Respondents' first source of information about chlamydia 
Source of information 
Male 
% 
Female 
% 
All 
% 
Teacher/School 23.9 22.8 23.2 
Friend 25.8 16.3 20.4 
Magazine 0.6 21.8 12.6 
Doctor/Nurse 4.5 13.4 9.5 
This study 12.9 8.9 10.6 
Health information leaflet 14.8 5.0 9.2 
Television 13.5 5.4 9 
Other 1.3 3.5 2.5 
Family member 1.9 2.0 2.0 
Internet 0.6 0.5 0.6 
During interviews both women and men were generally unable to state with confidence or 
talk definitively about the source of their knowledge about chlamydia. Their responses, 
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when probed for a source, were vague and assuming; respondents often suggested a source 
they assumed they 'must' have heard about chlamydia from, as one female suggested: 
"EM ... it's nzaybe been, like, in the doctors, or like, reading, like you know how you 
get those kind of paniphlet things when you're waiting. I'll read thein when Iin 
waiting, or ... maybe even school I would iniagine, I don't really know, or inaybe 
magazines... " 
(Interviewee #159, Female, Age 22, Health & Fitness). 
However, two young men were able to state with certainty where they had learned about 
chlamydia: 
"I'd heard of chlamydia before because I remember my girýrriend that always used to 
watch Sex in the City, and in one episode, eh... the ginger one gets it 
(Interviewee #77, Male, Age 20, Education). 
"Yeah em, I didnt lazow anything about it [chlainydia], like I don't even lazow if Id 
heard about it until I got a callfrom my ex-girl(riend saying she had it and I should 
get checked out. I was like that "what? ..... .. 
(Interviewee #237, Male Age 24, Health & Fitness). 
Certain sources are conspicuous by their absence, for example, doctor/nurse and family 
member: 9.5% stated doctor/nurse as their first source of information about chlamydia 
(although significantly more females reported doctor/nurse); only 2% of all survey 
respondents stated family member. 
During interviews men and women were asked about any conversations they recall having 
with family members about sexual infections, and also contraception in general. Both 
women and men who described experiencing discussions with family members, during 
which they learned about contraception and/or sexually transmitted infections, tended to 
also report consistent condom use and exhibit the broadest knowledge about sexual health 
matters. A male interviewee stated: 
R: Aye iny ina druinnied 'use a condoin, use a condoin' intae ine jae a young 
age ... I think she was terrified Id conze honze saying I'd got soine lassie 
pregnant 
KL: A nd have you alivays used one? 
R: Oh God aye ... yknow it isnaefianzy 
hearing your Yna's voice in yer heid whell 
y'know flaughs/ but hey.. 
KL: flaughs] 
(Interviewee #194, Male, Age 21, Health & Fitness) 
All of the interviewees who discussed having conversations with family members reported 
this person to have been their mother; some female interviewees commented that sexual 
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health was not a subject they considered to be an appropriate topic to discuss with their 
fathers. As one commented: 
"I wouldn't talk to Iny dad about it [sex] but I would talk to my inzan and my 
sister... 'cos, I dunizo, it's different with them, they kinda know what's what. 
(Interviewee it 159, Female, Age 22, Health & Fitness) 
All except two of these interviewees described their experience of discussing sexual 
matters with their mother as embarrassing. Two females, however, explained their ease 
with such conversations because they were introduced to these concepts from a young age 
and believed this has enabled them to feel comfortable today discussing sex and related 
matters. After describing the nature of the discussions her mother had with her since a 
young age, I asked one interviewee how she felt having these conversations with her 
mother: 
"Absohitely normal. Totally like anything else, like she would have told nze "bnIsh 
your teeth before you go to bed. "I laiew it was really a serious inatter but I thought 
it wasjust... the kind of serious matters that parents talk about, like how you need to 
use contraception, ein, be careful when you drive... things like that. So I thought it 
wasjust ... not a special thing, just normal. " (Interviewee #370, Female, Age 24, Workplace). 
Whilst the numbers are small, and generalisations are therefore unable to be made to the 
wider population, this ease with discussing sexual matters linked with discussion with 
family members about sex at a young age was an interesting thematic pattern to emerge 
across these interviews with young people. 
Summary of knowledge of chlamyclia 
Whilst awareness of chlamydia was high in this sample survey population, level of 
knowledge declined as questions became increasingly focussed, so that less than half of all 
survey respondents knew that chlamydia might cause an unusual discharge in women and 
men, a common symptom of chlamydia in both sexes. There were significant gender, 
setting and age differences in knowledge about the clinical features of chlamydia infection 
with males, health and fitness and education respondents as well as younger respondents 
responding incorrectly more than females, workplace respondents and those aged 20-24 
years. 
Around half of the survey sample either did not know or responded incorrectly to the item 
regarding the asymptornatic nature of chlarnydia, which shows they were not aware that 
chlarnydia is often symptomless. Half of men believed they would only be concerned 
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about chlamydia if they developed symptoms. During interviews, many men and women 
confirmed their poor knowledge on the symptomless nature of chlamydia; however, as -a 
consequence of the unintentional health promotion aspect to the study, this was a common 
fact about chlarnydia that interviewees believed they had learned from their participation in 
the study. During interviews, there was uncertainty from many men and women as to what 
they knew about chlamydia, which confirmed the poor knowledge reported in survey 
responses. It was a common perception among men and women in the interview, however, 
that most young people have a poor knowledge about chlamydia. Interviewees therefore 
believed they were not unique in any way by having a poor knowledge. 
One in four survey respondents reported 'Teacher/School' as being where they heard about 
chlamydia. Few interviewees referred to their sex education as being the source of their 
knowledge about chlamydia. Indeed, many when probed remembered being taught about 
HIV/AIDS but they often had no recollection of any other STI being taught. Certainly, 
recall difficulties may have affected interviewees responses but consistently all 
interviewees spoke with great uncertainty as to whether they had ever been taught about 
chlamydia at school. For women, there were a greater number of opportunities to receive 
information, as more women spoke of magazines and doctors as a source of information on 
chlamydia. 
Views towards screening for chlamydia 
This section of the chapter considers survey respondents' attitudes towards being asked to 
participate in chlarnydia screening study, as well as their views on screening being offered 
in various settings, with a specific focus on non-medical settings. Fifteen settings were 
given in the questionnaire and men and women were asked to state how acceptable they 
would consider it if chlamydia screening was offered in the settings (see Appendix 3). The 
three study settings were included in the fifteen suggested settings. Chi-square analyses 
were carried out to assess whether there were any gender, setting or age differences in 
attitude towards screening in the various settings suggested in the questionnaire. 
Respondents' views towards the acceptability of chlamydia screening in various settings 
were also explored during interviews. The survey findings on acceptability will be 
reported first. 
Among all survey respondents, there was a high level of acceptability towards screening 
being offered in medical settings, with 99% of all men and women considering general 
practice an acceptable setting. In contrast, 90% of all men and women considered a 
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bookstore an inappropriate setting. The three most acceptable medical and non-medical 
settings for survey respondents were general practice, family planning clinics and 
colleges/universities; conversely, the three least acceptable settings were bookstores, 
Internet cafes and pubs. Just over half (51%) of all survey respondents supported 
screening for chlarnydia in pharmacies. 
Chi-square analyses found gender to be significantly associated with attitudes of 
acceptability of screening being offered in non-medical settings, with males considering 
pubs (X2=4.942, p=0.026) and clubs (XI=4.942, p=0.026), more acceptable than females; 
however, significantly more females considered local pharmacies acceptable settings in 
which to offer chlamydia screening (57% of females compared with 46% of males; X2= 
4.337, p=0.037). 
Chi-square analyses were preforined to examine whether there were significant differences 
in acceptability found by setting. Survey respondents in each study setting considered 
colleges and universities acceptable settings in which to offer chlamydia testing (XI=2.484, 
p=0.289). In contrast, there were significant differences in views of acceptability. in 
relation to the other two settings (health and fitness, and workplace). Significantly 
(XI=33.396, p<0.001) more health and fitness respondents (75.4%) considered a health & 
fitness setting to be an acceptable setting in which to offer chlamydia testing compared 
with either education respondents (39.3%) or workplace respondents (56%). In addition, 
significantly (X2=37.256; p<0.001) more workplace respondents (65.7%) considered a 
workplace setting an acceptable setting in which to offer chlamydia testing compared with 
education (25.4%) and health & fitness (41.2%) - see Figure 4. So, where all three setting 
respondents considered education to be an acceptable setting in which to offer chlamydia 
testing, the health and fitness and workplace respondents tended to favour their own setting 
more so than the other settings did. Therefore, the setting in which men and women took 
part appears to have affected their views on how acceptable they consider testing for 
chlamydia in that setting, with the exception of education. 
During interviews, respondents were asked for their views on chlamydia screening being 
offered in various settings, focusing specifically on non-medical venues. Interviewees were 
also asked for their views towards being approached and asked to participate in chlamydia 
screening. Interviewees offered a range of views. Firstly interviewees believed screening 
in non-medical settings was acceptable if there was a perceived benefit, such as increasing 
awareness and knowledge or improving accessibility to screening. No interviewee 
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discussed the benefit being reducing the prevalence of infection. Secondly, non-medical 
screening was considered appropriate depending on how the screening would be offered: 
if screening targeted those who 'should' be screened, those who 'would' or else was 
offered in health-related non-clinical settings then it was considered acceptable. Thirdly, 
for some, non-medical screening was not acceptable in all 'feasible' settings because of the 
perception of stigma stemming from the public nature of non-medical settings. These 
views towards the acceptability of non-medical screening, including how interviewees felt 
about being approached in non-medical settings will now be discussed in turn. 
Figure 4: Comparison of study setting respondents' attitudes towards testing for chlarnydia 
in education, health & fitness and workplace settings 
a) 
03 
cu 
90 
80 
70 
60 
so 
40 
30 
20 
10 
0 
N Education 
IS Health & 
fitness 
Workplace 
Non-medical screening would raise awareness of chlamydia 
The chapter earlier described survey respondents' and interviewees knowledge of 
chlamydia. During interviews it was common for men and women to discuss the effect 
their participation in this study had upon their awareness or knowledge about chlamydia: 
"I know a bit inore about it now"; "... it hadn 't occurred to ine before you canze along... ". 
When asked for their views towards the non-medical approach to screening used in this 
study, many interviewees spoke of the effect such an approach may have had on people's 
knowledge: "... it nzight have nzade people inore aivare about it... '). Atypical view from 
men and women interviewed was also that many people in the general population have a 
poor knowledge of chlamYdia. Interviewees often linked this perception of wider 
knowledge with the view that "there is a need to inake people inore aware about if'. 
Education Health & fitness Workplace 
Suggested settings in which to offer testing 
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Screening for chlamydia in non-medical settings would, for many of the men and women 
inter-viewed, have the effect of raising people's awareness of chlarnydia. 
Whilst many interviewees perceived their knowledge of chlamydia to be poor they also 
discussed a desire to learn more about it. improving their knowledge was therefore 
something men and women welcomed. One young male, however, stated he harboured no 
desire to learn any more about chlamydia than he had already learned from taking part in 
the study: "... I don't ivant to kvoiv like too inuch about it, Ijust ivant to know like the 
inain syniptonts and how you can get rid of it, that's what inost people ivant to know" 
(Interviewee #75, Male, Age 17, Education). Despite this, there was little apathy among 
the men a nd women interviewed, with almost all acknowledging their own level of 
knowledge "could be better" and expressing a desire to know more. 
Attached to the view that personal knowledge improvement was required, many 
interviewees believed that gaining knowledge was a pre-requisite to behaviour change. 
Many men and women believed that increasing young people's knowledge about 
chlamydia would affect behaviour change among young people, in terms of reducing risk 
behaviours and increasing care-seeking behaviours. More than half of the men and women 
interviewed believed there was an inverse relationship between increased knowledge and 
decreased risk-behaviour. As one respondent commented: "it should be taught in schools 
'cos like ifpeople have the inforniation they ein, ivell inaybe there wouldnt be so Inally 
people getting stuff and like there being a problein y'know. " (Interviewee #309, Female, 
Age 20, Workplace). 
Whilst the view that increasing knowledge would lead to a reduction in risk-behaviour was 
commonly expressed by both men and women, mostly female interviewees believed that 
increasing young people's knowledge of chlamydia would affect an increase in care- 
seeking behaviour. A typical view from women was that if screening for chlamydia in 
non-medical settings was made more widely available then young people might be 
encouraged to seek GUM services. For those interviewees, there was a belief that to raise 
awareness of one STI would encourage a general raised awareness of STIs in general: 
"Coming itito places like here, y1voiv it makes people think about it aizd then they 
might think about how they could get other things, like it you could get this 
[chlainydia] then you can get other things too... 
(Interviewee #138, Female, Age 18, Education) 
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One woman commented that, on the back of her participation in this study, she had been 
encouraged to seek a full sexual health screen at a local GUM clinic, which she had 
leamed about from the study leaflet: 
"I was eh thinking about was going to that place [referring to local sexual health 
clinic]... I didnt know anything until you came in and I thought 'Oh aye, 'I'll def: I'll 
go tip there. Even, or even down at the doctors... ". 
(Interviewee #181, Female, Age 23, Health & Fitness). 
How far one's desire to seek further screening is replaced with the actual occurrence of 
doing so remains unknown. Another interviewee offered a similar comment regarding 
seeking further screening: 
"I've kinda thought about it before but ... I think it's just 
laziness y7azoiv, you never 
get round to it but then you condn'in here it kinda enz, nojust makes you think but, I 
dunno, I would like to be testedfor everything and I think I definitely will cos it's no 
as scary now that I've seen it and talked to you about it and you've kinda told ine 
things I've askedyou about getting'it done... " 
(Interviewee #159, Female, Age 22, Health & Fitness). 
These views from female interviewees were in contrast to those of men. A few men were 
reticent to seek further screening for STIs after accepting chlamydia screening as part of 
this study: "... I don 't ivant to bzoiv any inore... ", one commented. Another, whilst stating 
that he would like to be tested for other STIs - having become more aware about them with 
his participation in the study - would probably not do so in the near future: "J think that'll 
do inefor now... I biow what it's like just to ivaitfor one result, jeez nian I dont lazow ifI 
could do that again.. " (Interviewee #190, Male, Age 21, Health & Fitness). Despite this, 
he expressed a wish that he had been able to be tested for 'evetything, no just 
chlainydia... get it aw done at the saine thne ylaioiv.. ". A few other men and women also 
commented that it might be a 'good idea' to offer full sexual health screening in non- 
medical settings, on the basis that one could 'catch' People at the same time; however, few 
who offered such comments considered the practicalities involved in offering full sexual 
health screening in non-medical settings. 
Non-medical screening would increase access to screening 
Barriers to uptake of screening that have been discussed in the literature include issues of 
accessibility. Taking screening to non-medical settings, which are frequently used by 
young people, could potentially reduce such a barrier. Although interviewees were not 
directly asked if they thought non-medical screening would have an effect on accessibility 
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of screening, many spontaneously spoke about such an approach improving access to 
screening. 
For some, the increased access to screening with non-medical approaches were considered 
to have the effect of increasing the uptake of screening among young people: 
"77ze nzore places this [chlainydia screeningl is offered then the easier it isforpeople 
to seek testing when and where they ivant it.. 
(Interviewee #364, Male, 23, Workplace) 
Others referred to people having 'limited opportunities to be tested' for chlamydia, or 
services being 'out of the way'. One interviewee, raised in the Highlands of Scotland, 
commented on a dearth of services, in which to seek testing, located in her area. Her 
positive attitude towards wider availability was based on her belief that it would result in 
more young people being able to seek testing: 
"... in the niral areas you dont have like a /sexual health] clinic or anything like 
that... the nearest ones about forty, forty-five minittes drive alvay ... maybe if there 
ivere more places to do it, I dunno... - 
(Interviewee #255, Female, Age 22, Health & Fitness). 
Many interviewees offered views on GUM services being inaccessible, either by virtue of 
location or difficulties in making an appointment. To further evidence this, few 
respondents were able to state where the nearest sexual health clinic was, or indeed where 
any sexual health clinic was; others had a vague idea ('... that place up town somewhere'). 
One male who had not been offered screening until he participated in this study 
commented: 
"How easy is it to get to one of those places [GUM clinic]? You hear about long 
waiting tinzes and like where even is thatplace you nientioned [Sandyford Inlitativel? 
I inean, it's not like it easy ... then again it's not that easy to see your doctor either so 
there you go. - 
(Interviewee #258, Male, Age 22, Health & Fitness) 
One male described being contacted by an ex-girlfriend who informed him she had 
chlamydia. The interviewee telephoned a GUM clinic to make an appointment but was 
unable to obtain one suitable. He stated he was also unable to attend the 'drop-in' service 
at the clinic, as recommended by the receptionist when he was told he could not be given 
an appointment for two weeks. This respondent was approached by the author in a health 
and fitness venue a few days after he had contacted the clinic and he participated in the 
study by providing a sample for testing. During his subsequent interview, this young 
man's views towards non-medical screening appeared to be influenced by his previous 
experience with the GUM clinic: 
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".. 3vith this [non-medical screeningl you cut out all that no appointment or wait 
aroundfor hours, when you cant even get there 'cos you have to work, nonsense ... I 
got tested somewhere I didn't need to go out of nzy way to get to ... 
I nzean it was hick I 
suppose that you turned tip when you did but what about those people who think 
about it but dont do it, how do you lazow that doing it /screeningl in this way won't 
be of benefit to people whofind it hard or whatever to get to clinics? 
(Interviewee #237, Male, Age 24, Health & Fitness) 
The perception among many interviewees (whether they had experience of attending a 
clinic or not) was that GUM services were not accessible; therefore, screening for 
chlamydia being made available in various non-medical settings was considered in a 
positive light, as it would enable people to actually seek testing, or at least be presented 
with an opportunity to be tested. The following field note extract is an example of 
comments made by some education respondents: 
"During a discussion with two female students, one commented that she was in 
support of a testing service being available in the college after this study. She 
thought it would be good if there were a service like this in college eveiy day, or even 
once a week that students could go and use. Wien I asked why she thought this 
should be introduced here she replied that it would make it easierfor people to get 
tested, especially those who wouldn't want to go to a clinic. 
(Field note, Education setting, 24 th March 2004). 
Another barrier to accessing GUM clinic settings that a few respondents raised related to 
the stigma of being seen attending the clinic. Four women and two men commented on the 
negative associations with GUM attendance: 
"Mio'd ivant to go soinewhere like that [GUM clinic] y'bzolv like especially ifyou 
didn't have to ... I don't see people going there unless they have to, I nwan who'd sit in the waiting room with people pure staring at you thinking 7 Imow what she's her 
for'or whatever.. " 
(Interviewee #230, Female, Age 24, Health & Fitness) 
When asked if she thought the same issue of stigma applied to non-medical approaches she 
believed: 
"no because like that's not why you're here, ylazow Im here to go to the gym no to 
come in for a test ... aye I did it 
but, it's kinda different as people dont just 
automatically think 'I Ibiow what she's herefor'y'Now. 
(Interviewee #230, Female, Age 24, Health & Fitness) 
Stigma acts as a barrier to uptake of screening in non-medical 
settings 
The stigma of being seen attending a clinical service for a STI test was discussed by some 
male interviewees. In contrast, more women discussed the stigma of being seen to want a 
Karen Lorimer, 2006 Chapter 5,136 
STI test in non-medical, public settings than men. Stigma acted as a barrier to uptake of 
screening in this study, but this will be discussed in more detail in the next chapter, which 
describes the various barriers and supports to willingness to be screened in this study. 
Here, the views of interviewees to non-medical screening in general are detailed. 
Stigma as a barrier to accessing clinical settings for a STI test was a common view among 
women when they spoke of their views towards non-medical screening in general. More 
women than men expressed the view that many young people in general might not be 
tested for chlamydia in public settings because they would not want to be seen having a 
test for a STI. Women, in particular, believed that being seen to accept screening for a 
STI was off putting, as they did not want people to know they were seeking screening. 
The public nature of screening being offered in non-medical settings was not conducive to 
their acceptance in many cases, such as for pubs, clubs and bookstores. In addition 
women also considered the implication of accepting screening in local pharmacies and 
large high street pharmacies (such as Boots or Superdrugs), in relation to the public nature 
of the setting. As one commented when considering whether she would accept screening 
for chlamydia in these settings: 
"... But a chemist or Superdrug, I wouldnt, probably not. It just depends what way 
you are doing it. .. Boots is 
like, it's just so public... Local pharmacies agaill, sanze 
idea, maybe not as bad because it's quieter, em, and so they're probably not going to 
have a big quette of people like there would be in the middle of Glasgow kind of 
thing, you hiow what I mean? So I mean if that way you arejust going in wid you're 
speaking to a consultant orjustpicking zip a thing, not as bad... 
(Interviewee #128, Female, Age 23, Education). 
One women who refused screening as part of this study considered whether she would 
accept chlarnydia screening in local phannacies: 
"I don't think I would do that, ein because it's busy, like, in a phannacy it's not as if 
there's any, they maybe were-like when you were doing it up there it was kinda open 
but you were asking everybody kinda individually if they wanted to do it whereas I 
think it-Im thinking what inyphannacy is like in [place naine], and it's sinall, em, it's 
just a counter so if Pin going tip to the counter and they say 'oh do you 1vant a 
chlainydia test? ' and eveiybody's looking at you thinking "oh yeah ..... .. 
(Interviewee #309, Female, Age 20, Workplace). 
Of the female interviewees who gave a sample for testing in this study there was a general 
belief that they were not like other women, in the sense that most women would not be 
willing to be tested in public non-medical settings. One commented: 
R: Ijust don't think many [women] would do it in those sorts of places [non- 
medicall. 
KL: Wzy is that do you think? 
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R: Well, it says something about you, I inean for a woman, I think its differentfor 
guyy , lazow it's OK to get tested 'cos that means you're a guy and had sex and 
all that but I dont think women would really want to let the world blow 'Hey 
think I might have an STI'. 
KL: [Phy wouldn't they want people to k7iow if it's OKfor guys? 
R: 'Cos women cant do that, it's different. I'M getting a bit feminist now 
flaughs] but it's tnte. It's wrong, but it's true... wonzen have to think about 
what people might say about thein but guys don't have the sayne things to 
worry about like that. 
(Interviewee #322, Female, Age 21, Workplace) 
Men, in comparison, did not hold the same views about non-medical settings such as local 
pharmacies or the large high street stores (Boots or Superdrug); neither were their negative 
views towards screening being offered in pubs, clubs and bookstores based on this 
consideration of others; rather males simply did not wish to consider sexual health matters 
in these settings because they were setting in which they would socialise with ftiends. 
Men therefore did not want to be interrupted when socialising. Thus, men considered the 
response of their peer group rather than persons in the setting who are unknown to them. 
In addition, young men often mentioned the effect being seen to have a STI test in a pub or 
club on their chances with the opposite sex: 
R: Youd neverpull a bird man ifshe sawyou get a chlamydia test! 
KL: Why not, might she not think ivow he's a healthy guy, looking after his health? 
R: No way man! flaughs] Shed think 'he's pure diseased! Dont come near 
me. 
(Interviewee #190, Male, 21, Health & Fitness). 
One male when considering being interrupted when on his leisure time offered the 
following view: 
"IfFin in a pub, even thosef --- ers who come in and try and sell you the roses, I hate 
them, I hate being asked questions about stuff like that in a pub where Im out to 
socialise. IfFm out socialising I dont ivant to talk about bills and evetything else, I 
just ivant to talk aboutfinz stuff. I wouldnt talk about sexual health to sonlebody in a 
club. " 
(Interviewee 9311, Male, Age 20, Workplace). 
Another when asked how he would feel being asked to take part in chlamydia screening in 
a pub or club commented: "No, Fin out to have a good finie. No, don 't want to start 
worrying about things like that". (Interviewee h! 194, Male, Age 2 1, Health & Fitness). 
The views of men and women were contrasting in relation to perception of stigma. 
Women considered non-medical settings to create barriers for women; in contrast, few men 
expressed this view. 
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These views from interviewees may explain why survey responses showed more men 
considered non-medical settings appropriate in which to offer screening than young 
women. Although some men did speak of the stigma of having a test for a STI in a public 
place, often this was because they considered the effects upon their chances with the 
opposite sex. Women, on the other hand, believed that having a test for a STI in a public 
place in view of 'others' showed their active sexuality, which they believed they should 
not show because of the perceived moral connotations. The exception is with pharmacy 
settings: survey responses revealed women considered this setting acceptable in which to 
offer chlamydia screening more so than men (57% of females compared with 46% of 
males); however, inter-view data suggests men were less reticent about screening being 
offered in pharmacy settings than women. 
Conflicting views expressed in the survey and interview data may be explained by the 
inherent differences in the two methods used to collect data on views towards the 
acceptability of chlamydia screening. Whilst the survey asked respondents for quick 
superficial answers - to tick boxes or write numbers - the interview offered the opportunity 
for men and women to consider phenomena or situations in more depth. Neither results are 
necessarily 'wrong', but the contradictory finding does highlight the strength of the 
qualitative method in collecting more in-depth responses to views on acceptability. In 
many of the interviews women began by stating they considered pharmacies acceptable 
settings in which to offer chlamydia screening; however, some went on to discuss their 
reservations. Interviewees were allowed time in inter-views to consider their views towards 
acceptability and often women returned to the topic later in the interview; in other words, 
their views on a topic they might not have previously considered were being refined 
throughout the process of the interview. The following excerpt from an interview 
highlights the fluidity of views: 
KL: Is there any setting you think, um, that it's just not appropriate to offer 
chlanlydia testing? 
R: Mill... I cant think of anywhere that would be inappropriate. Ehm... 
flaughs] (pause) I dont really have a problem with any place, enz, I call't really 
think of aizjnvlzere Id, like that'S inappropriate. Probably in a wee while I'll think of 
something. 
[later in the conversation] 
R: I dont lazow, a big place like Boots and things, I could imagine a lot of kids 
- you kmoiv, like places like Boots and Superdrug have things now, where they, where 
they provide it, free pregnancy kits to under-tiventies and things like that, so places 
like that would probably be quite good because they're big and they're kinda 
already... but I suppose at a local pharmacy, a lot of kids even dont want t0 go in 
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and buy condoms and things fi-oin local pharmacies because they're embarrassed, 
and they know people that work there and things. Actually, IM not sure Id do it 
there 'cos it's a bit em, like infidl view ofpeople, ylazoiv what ifyou were to go ilito 
your local pharmacy and your neighbour ivalks in and sees you asking for a 
chlainydia test, oh my god flaughs/. No, perhaps not pharmacies ... oh and earlier I'm 
pure like'yeah yeah anywhere'flaughs/. 
(Interviewee #354, Female, Age 23, Workplace). 
Non-medical screening is appropriate if it is targeted to key 
groups: 
The views from men and women, who participated in an interview and asked how they felt 
about non-medical screening described above, were often in contrast; however, there were 
strong views expressed by both men and women regarding who best to target non-medical 
screening towards. These common views will now be described. 
Those who 'should' 
During interviews, the majority of men and women referred to the 'type' of person they 
perceived to be 'at risk' of having and/or contracting chlamydia. A number of 
interviewees spoke about these 'type' of persons in relation to the appropriateness of 
screening in non-medical settings. For example: 
"... students do a lot of sleeping around and stuff like that so, if anything 's going to 
happen, it's going to be students, and a college is a great place to do it... 
(Interviewee #77, Male, Age 20, Education) 
Targeting screening to perceived 'at risk' populations, by using non-medical settings in 
which such groups could be found, was a common view associated with a setting being 
seen as an appropriate one in which to offer chlamydia screening. In other words, a setting 
was considered appropriate if it brought screening to populations who 'should' be 
screened. 
High schools were also considered appropriate settings because such settings were also 
where interviewees considered 'at risk' populations of young people could be found: 
'7 think in schools it ftestingl would be good to make people more aware about 
it-there's a lot of young people getting pregnant these days-evell the fact that 
they're gettingpregnant means they dont know what they can be catching. 
(Interviewee #309, Female, Age 20, Workplace). 
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However, whereas colleges and universities were mentioned in relation to students 
perceived promiscuous behaviour, schools were mentioned in relation to both the 
perceived promiscuous behaviour of many young teenagers but also because interviewees 
believed many school pupils lacked knowledge about the consequences of their 
promiscuous behaviour - in other words contracting sexually transmitted infections. For 
example: 
"I lazow a girl who fell pregnant at fourteen so I think a lot more things should be 
made aware ... she obviously didnt know veiy much about this sorta thing andpeople 
should because othenvise how do they k7mv what they're doing, like what danger 
they could be doing to themselves. " 
(Interviewee #237, Male, Age 24, Health & Fitness). 
So whilst offering screening in colleges and universities was considered appropriate 
because it could offer these at risk populations the convenience of screening, in schools it 
was seen as having the dual benefit of offering convenient screening and raising awareness 
of the risk of contracting sexually transmitted infections. (More will be given on these 
views towards raising awareness and convenience in Chapter 6. ) 
Those who 'would' 
A second view from men and women centred upon whether the setting itself would offer 
targeted screening at populations who are health conscious. So whereas schools, colleges 
and universities were perceived as settings where young people 'should' be screened for 
chlamydia, offering chlamydia screening in settings such as gyms and phannacies could 
target young people who 'would' accept screening: 
"It's like giving you kinda like a wee health check, sort of thing, so I think people 
would be nzore kind of .. willing to do it at the gyni, yeah, I think they would. (Interviewee #309, Female, Age 20, Workplace). 
Another commented: "Yeah, I thinkpeople would do it there [gyms] 'cos they're into their 
health I suppose othenvise why are they going there? " (Interviewee #237, Male, Age 24, 
Health& Fitness). Another commented: 
"Healthiness is notiust about going on the step inachine ol- having a six pack, it's 
about taking care ofyour sexual health as well " 
(Interviewee #355, Female. Age 23, Workplace). 
Men and women interviewed considered young people using gyms or sports facilities to be 
health conscious, therefore, they would be more willing to accept chlamydia screening as a 
way of 'trying to keep healthy'. No interviewee who offered this reason for health and 
fitness settings being an appropriate setting in which to offer chlamydia screening 
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mentioned 'at risk' sexual behaviour as a reason why this particular population 'would' or 
C should' be screened. Rather the focus was the perceived health-seeking behaviour of this 
group of young people. 
Screening should 'fit'with the setting 
A third view commonly expressed by men and women concerned whether a setting was 
perceived to be one in which discussing health-related topics would not appear 'out of 
place'. Thus, gyms and chemists were most commonly referred as settings that would be 
appropriate because these settings were ones in which respondents considered discussing 
health (as most respondents referred to rather than sexual health) as already taking place. 
"Places like Boots and Superdnigs I think yeah go for it because they're [people] 
therefor a health related reason anyway, so while they're there... 
(Interviewee #311, Male, Age 20, Workplace). 
Conversely, settings were not considered appropriate if health issues could not reasonably 
be considered to already be discussed, such as in bookstores, pubs and clubs. As one 
noted, 'It should maybe be tied iii with health sort of thbig'. 
Whilst medical settings such as doctors and family planning were considered 'obvious, 
'traditional' and 'where you would expect something like that [chlamydia screening] to 
be', local pharmacies and high street chemists were considered almost logical extensions 
of these medical settings. As one respondent put it '[it's] a public sort of inedical place'. 
Another noted: 
"... a chendst is where you get your prescriptions and stuff-well wouldnt you get 
your tabletsfor chlainydia there anyway so it's all the saine, it's like the doctors ill a 
way, you get your Pill andpregnancy tests and stuff .. and there's a phannacist there 
to speak to so yeah it's kinda the saine ... ivell not 
like totally but in a way... 
(Intervie-wee # 159, Female, Age 22, Health & Fitness). 
Another offered a similar view: 
"I think maybe even Boots 'cos like there's a lot of like weight testing stuff ill there, 
and you call diabetes testing and stuff... cholesterol and all that... 
(Interviewee #237, Male, Age 24, Health & Fitness). 
During interviews respondents were shown a test kit developed and used as part of the 
chlamydia screening component of the Healthy Respect demonstration project. This 
consisted a small purple drawstring bag within which there was a sample container and 
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laboratory forms as well as an envelope for the person to sent their sample to the 
laboratory. This enabled me to show young people what a kit might look like in order to 
strike up a conversation about their views on community screening. Some interviewees 
modified their opinion on community screening once they held and inspected this 'kit', as 
though they could visualise the testing being offered in these settings. One male 
commented: 
R: Well if this [test kit] is all it is then I dont see how it couldnt be made 
available in lots ofp1aces, even schools cos it's quite discrete and I don't think 
people would have a problem with things like this being in the setting. 
KL: Do you thinkpeople would use them to get tested though? 
R: Yeah, uh huh, 'cos as I say it's discrete and especially if people are 
embarrassed by stuff like this it's not going to draw much attention to them is 
it so maybe they'd be more likely to do it if something like this is made 
available. 
(Interviewee #237, Male, Age 24, Health & Fitness) 
Some interviewees, especially men, appeared intrigued with this particular chlamydia test 
kit. Many young men considered is use a 'good idea' and suggested that men might be 
encouraged to be tested if more of these kits were available in various community settings. 
Young women, however, often identified concerns about people seeing them picking up 
one of these kits: 
"I don't think Id pick tip one of these in Boots and then stand ill a quelle to payfor 
nzy inake-up holding this (laughs) ... like, hello, yes I think I might have an STD! "[Sic] (Interviewee #138, Female, Age 18, Education). 
Another female, whilst having reservations about how she might react to these test kits 
becoming more widely available nevertheless believed they were a good idea: 
"Youngerpeoplejust dont really ivant to talk about something like that [chlanzydia] 
so if they could pick zip a test and take it home then maybe a lot more people would 
do it... I think like having to go to a clinic isnt soinething younger people, like 
teenagers would ivant to do unless they had to kinda thing. 
(Interviewee #128, Female, Age 23, Education) 
Only two interviewees (both female) who spoke about schools being appropriate because 
young people there 'should' be screened considered whether it would be feasible to offer 
chlamydia screening in schools: 
R: I think it's a good idea to kind of do it in a school... but I know you need to 
have perinissionfi-oin thein really 
KL: pennissionfroin.. 
R: like the school and probably parents as ivell, yk-nowyou inight, like there inight 
be a lot of parents who wouldnt ivant that sort of thing in their kids school, 
which is, I think it's like, ein, it's, that's not being realistic... 
(Interviewee #309, Female, Age 20, Workplace). 
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The other woman who considered the feasibility of offering chlamydia screening in non- 
medical settings, did not consider any setting inappropriate per se but focused upon how 
willing she considered people would be to accept screening in such settings: 
"But ifpeople ivere ivilling to go in, then I don't see IvIly it would be inappropriate 
to... I kind offeel like that ivith everything. - ifpeople are willing to, I don't see holv 
any of thein are necessarily inappi-opriate; it's just Wiether people would be as 
willing to take part... " 
(Interviewee #354, Female, Age 23, Workplace). 
A few interviewees spoke of the normalising effect community screening could have if it 
were made more widely available: 
"... makingpeoplefanziliar with nzedical issues has to get out of medical settings, has 
to speak to people's everyday life because that is the only way that people are going 
to become aware of the responsibilities they have to take ... if it takes place in your 
everyday life, they'reprobably going to think of it a lot more and it's going to become 
an evetyday conceni. " 
(Interviewee #370, Female, Age 24, Workplace). 
'7 think it's an idea that it shouldn 't be a taboo, you Imow, you should tiy and bring 
it more into the kinda public eye, and ive shouldnt be hugely embarrassed about it, 
or not willing to discuss it. " 
(Interviewee #237, Male, Age 24, Health & Fitness). 
Discussion 
Awareness of chlamydia was high (93% of survey respondents had heard of it and 09% 
successfully identified it to be a sexually transmitted infection); however, this level of 
knowledge may have been influenced by the approach and consent procedures: all study 
participants were provided with information leaflets about chlamydia during the initial 
approach and were introduced to the fact that chlamydia is a sexually transmitted disease 
as part of this initial approach (as detailed in chapters 4 and 5). Although this was a 
necessary and unavoidable aspect of gaining informed consent into the study it may have 
had the unintended effect of influencing the responses to two questionnaire items: 'have 
you heard of chlamydia? ' and 'what is chlamydia? ' 
Level of knowledge declined, however, as survey questions became increasingly focussed: 
many respondents were unaware of how common chlamydia is among people under 25 
years and of the largely asymptomatic nature of chlamydia infection. The awareness of 
chlamydia in this study is disproportionate to the prevalence, as compared with HW/AIDS 
and has been noted in a study with hiýher-risk populations (Kellock et al. 1999). 
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As all study participants were aged under 25 years, I in 4 survey respondents reporting 
school as their source of information about chlamydia is perhaps a surprisingly low 
proportion. There was certainly a high degree of uncertainty among interviewees 
regarding the source of their information about chlamydia; therefore, it is possible that 
more were actually taught about chlamydia at school. The ability for people to recall 
events decreasing with time is discussed in the literature (Fenton et al. 2001b); as such, 
interviewees may have experienced difficulty recalling with accuracy their source of 
information about chlarnydia. 
Young men, especially, commented during interviews that their knowledge about 
chlamydia was limited to having heard about it. They often knew very little else, even 
when prompted. In contrast, young women engaged in detailed discussions about their 
knowledge, including the source of their more detailed knowledge, which were often 
obtained from sources young men did not report having heard about chlamydia from, such 
as magazines and doctors. Young women spoke of reading about STIs in magazines, for 
example in 'real life stories' or on the problem pages; they were able to recall particular 
stories and some described their feelings towards learning about the implications to 
women's fertility once catching a STI. No male interviewee discussed reading about 
chlamydia and none offered an account of how they felt about the threat STIs pose to male 
fertility. 
Women's exposure to and engagement with specific forms of sexual health discourse 
stands in stark contrast to the lived realities of the young men's lives. At each stage of a 
female's life there is an instruction guide in sexuality: from pre-teen and teen magazines, 
through women's glossies to women's general interest publications. The 'true story', 
popular editorials among many of the young women interviewed, often promotes a moral 
discourse, which discourages 'deviant' sexual behaviour (that which end in unplanned 
pregnancy and STIs). Young men do not experience, or have access to, a linear range of 
magazine publications as young women do; neither have they been subjected to the same 
scrutiny of their sexual behaviour, given the disproportionate weight that public, medial 
and moral discourse concerning teenage pregnancy and sexually transmitted diseases place 
upon women's sexuality. Young mep, therefore, perhaps do not experience the same 
medical and moral intrusions in their lives as young women do. As such, gender, in this 
study, often acted to constrain as well as enable screening in community settings. 
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Most interviewees, who knew about the clinical features of chlamydia, spoke of gaining 
this knowledge from reading the study literature. The health promotion aspect of this 
study was unintentional but present nonetheless as a consequence of the study literature 
(including posters and leaflets) as well as conversations the author was often able to have 
with young people, during which the author was able to answer questions. Chapter 4 
described young men in the health and fitness setting enthusiastically embracing the 
opportunity to have their questions regarding sexually transmitted infections answered. 
Studies have shown knowledge of sexually transmitted infections among young people 
increasing after behavioural interventions (Arcaari et al. 2004). How far increased 
awareness and knowledge about chlamydia effects behavioural change varies in the 
literature, as one recent review concluded (Robin et al. 2004). 
A low level of knowledge about chlamydia could have potentially negative consequences 
for chlamydia screening programmes: without knowledge, young people might not 
understand the implications of screening, as has been suggested in the literature (Kellock et 
al. 1999). In addition, without a baseline understanding of the nature of chlamydia 
infection young people have little foundation on which to base their 'choice' of accepting 
screening when it is offered. How far knowledge impacted on willingness to accept 
screening will be discussed in more detail in the next chapter. However, it has been 
argued that improving knowledge may positively affect individuals' participation in 
screening programmes, and improve the effectiveness of such programmes (Devonshire et 
al. 1999). Indeed, it was a common view among both young men and women who 
participated in an interview in this study, that information about the effects of chlamydia 
and the highly asymptomatic nature of infection should be made widely available to 
motivate more young men to seek screening or accept screening. Indeed, some young men 
and women suggested screening for all STIs be made available in the study settings on a 
regular basis. 
Despite young men showing lower knowledge about chlamydia than women they, 
nonetheless, expressed more relaxed attitudes towards screening being offered in non- 
medical settings than women, they exhibited a greater willingness to learn more about 
chlamydia and pass on this newly acquired information to family/friends and, as the next 
chapter will show, were more willing to accept screening when offered to them in this 
study. 
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Respondents who commented on settings themselves being appropriate in which to offer 
chlamydia screening focused their comments around the three areas of whether people 
L should' be screened, whether people 'would' be screened, and whether the setting was 
health-related, such as gyms and pharmacies. Just over half of all survey respondents 
considered local pharmacies acceptable settings in which to offer chlarnydia screening. 
However, offering chlamydia screening in local phannacies was significantly more 
acceptable to female survey respondents than male, although a large minority of men 
considered it acceptable. Interview data then revealed reservations from many women 
about how willing young people might be to accept the offer of screening in pharmacy 
settings. At the same time, many male interviewees suggested that pharmacies might be 
acceptable settings in which to offer chlamydia screening because they were, for these 
men, extensions of 'traditional' health services; these settings were 'health-related' and so 
the idea of offering a test for a STI in pharmacies was acceptable to these men. Neither 
quantitative nor qualitative results are necessarily 'wrong', but the contradictory finding 
does highlight the strength of the qualitative method in collecting more in-depth responses 
to views on acceptability. 
Pharmacy-based chlamydia screening has already been considered in Scotland (the Healthy 
Respect demonstration project made available screening kits in high street branches of 
'Boots' in Edinburgh and this is being further explored in England through the same 
national phan-nacy chain). Early evaluation has suggested this approach to screening was 
more successful at reaching young men, with more young men being tested using the 
postal testing kits than women during Phase I of the Health Respect project (Williamson et 
al. 2006). Certainly in this sample population, half of male and female survey respondents 
and many interviewees had reservations about the feasibility of pharmacy-based screening. 
Although men and women spoke of the stigma of having a test for a STI in a public place, 
nonetheless, many spoke of the potential for screening in non-medical settings to 
cnormalise' screening, to make it increasingly visible so that it is not 'hidden' behind 
clinical walls. There is potential, for many of these men and women, for a 'de- 
stigmatising' of screening if it were made more widely available in non-medical settings. 
Some women, however, retained some reservation about the extent of this for women. 
The next chapter considers how willing young people were to accept the offer of screening 
by providing a urine sample. Factors associated with their willingness will be discussed, 
with their views towards non-medical screening taken into account. 
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Chapter 6 
Willingness of Young People to be Screened for 
Chlarnydia in Non-Medical Seffings 
This chapter discusses how willing young men and women in this study were to accept the 
offer of screening for chlamydia. The chapter begins with an overview of the numbers of 
respondents who agreed to provide a sample for testing, by gender, setting and age. 
Various factors associated with respondents' willingness to accept screening when offered 
are then explored, including: sexual lifestyles, prior experience of being tested for 
chlamydia and perception of risk. Men and owmen's willingness to provide a urine sample 
for chlamydia screening was recorded alongside their survey responses, so that Chi-square 
analyses could assess the factors associated with williness, such as knowledge, sexual 
behaviour and views. Analysis of interview data suggested there were various barriers and 
supports to willingness to accept screening in non-medical settings. As with chapters 4 
and 5, differences, where identified, are highlighted by setting, gender and age. 
Numbers accepting screening by setting, gender and age 
Screening was offered in six settings over an 18 week period, which resulted in - 230 
hours of screening in total. In this time, 431 young people were approached and invited to 
take part in this study by completing a questionnaire and providing a sample for testing. 
Of the sexually active respondents who were willing to participate in the study (n=346), 
113 (32.6%) accepted the offer of screening for chlamydia. in the three study settings and 
provided urine samples to be tested for chlamydia. Table 10 shows the number of 
respondents accepting screening by setting. Of the 113 samples tested, five were positive 
for chlamydia (4.4% prevalence). Disease prevalence was 4.9% in men and 3.8% in 
women. 
The highest uptake of screening was observed in the health and fitness setting, with 48.8% 
of survey respondents agreeing to provide a sample compared with 19.1% of education 
respondents and 27.8% of workplace respondents. Thus, the health and fitness respondents 
were more willing to accept screening by providing a urine sample for testing then either 
education or workplace respondents. 
Of the 113 men and women who gave a urine sample for testing, the majority were male 
(53.9% were male and 46.1% were female). Of all men offered screening 40.1% were 
I 
Karen Lorimer, 2006 - 
Chapter 6,148 
willing to provide a sample compared with 26.8% of women. Thus, of all men approached 
in the settings more were willing to provide a sample for testing then the women 
approached. By setting, men recruited in the health and fitness settings were more willing 
than either men in education or workplace, or women in each setting to provide a sample, 
with around two thirds (62.3%) participating in screening. However, women in the health 
and fitness setting were more willing to provide a sample than women in either of the other 
study settings (see Table 10). Thus, both men in this study and also health and fitness 
respondents were the most willing to participate in non-medical screening. 
Table 10: Numbers of respondents accepting screening, by setting and gender. 
Setting Gender 
Number of Number accepting 
X2 test 
respondents screening (Yo) 
p 
Education ALL 115 
Male 59 
Female 56 
Health & ALL 127 
Fitness Male 53 
Female 74 
22 (19.1) 
15 (25.4) 
7 (12.5) 
62 (48.8) 
33 (62.3) 
29 (39.2) 
0.078 
0.010 
Workplace ALL 104 29 (27.8) 0.407 
Male 40 13 (32.5) 
Female 64 16 (25.0) 
TOTAL ALL 346 § 113(32.6) 0.009 
Male 152 61 (40.1) 
Female 194 52 (26.8) 
§ 17 of 363 respondents stated they were not yet sexually active and were excluded from analysis. 
Significant relationships between age and providing a urine sample are indicated by bold p-values. 
Considering which age of respondent was most willing to participate in the offer of 
screening, respondents were split into two age groups: 16-19 and 20-24 years. All study 
respondents were aged between 16 and 24 years, inclusively. Respondents aged 20-24 
years were more willing than those aged 16-19 to provide a sample for testing: of the 113 
who provided a sample, 80% were aged 20-24 years (see Table 11). This table also shows 
there is a consistent difference in willingness to accept screening between the age groups in 
each setting; however, the only statistically significant difference exists within the health 
and fitness setting. Thus, older respondents in the health and fitness setting as well as men 
in this study were the most willing to participate in the offer of screening in non-medical 
settings. 
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Number of Number accepting X2 test 
respondents screening (Yo) P 
Education§ 0.449 
16-19 66 10 (15.1) 
20-24 57 12 (21.0) 
Health & Fitness 0.004 
16-19 39 9 (23.0) 
20-24 94 53 (56.3) 
Workplace 0.055 
16-19 24 3 (12.5) 
20-24 80 26 (32.5) 
Total§ <0.001 
16-19 129 22 (17.0) 
20-24 231 91 (39.3) 
Significant relationships between age and providing a sample are indicated by bold p-values. 
§3 missing values. 
The age of respondents in each of the three study setting groups differed so that almost half 
of education respondents were aged 16-19 years, whereas around one quarter of both 
health and fitness and workplace respondents were teenagers; three quarters were therefore 
aged 20-24 years. The greater willingness to accept screening among respondents aged 20- 
24 years may be a true age effect but it may be a setting effect. This was explored with 
binary logistic regression analysis to test for the effect of each of setting, gender and age 
afler adjusting for each other. Odds ratios and 95% confidence intervals (Cls) were 
calculated (see Table 12): there were significant differences in willingness to accept 
screening by setting, gender and age: the odds of providing a sample for testing were 
greater for men, health and fitness respondents and those aged 20-24 years. 
Interactions between setting, gender and age were also assessed using binary logistic 
regression. The effect being male or female has upon willingness was not significantly 
different in all three study settings; the effect of age upon willingness to accept screening 
was also not significantly different in each study setting; and the effect of 'gender on 
willingness was not significantly different in both age groups. Thus, there are no 
significant interactions in this study population between setting, gender and age that may 
affect analyses of willingness to provide a sample. 
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Table 12: Odds of being willing to accept screening, by setting, gender and age 
Accepting screening by: Odds ratio 
P 
(95% CI) 
Setting 
Education 0.7 (1.46 - 3.97) 0.399 
Health & fitness 2.6 (1.51 - 4.77) 0.001 
Workplace 1.0 
Gender 
Male 2.4 (1.46 - 3.96) 0.001 
Female 1.0 
Age 
16-19 years 0.3 (0.20 - 0.64) <0.001 
20-24 years 1.0 
Significant relationships between setting, gender and age, and providing a sample are 
indicated by bold p-values. 
Respondents' reported sexual behaviour 
STI screening studies are often concerned to assess how effective various screening 
approaches are in screening at-risk populations. The definition of 'at-risk' varies 
depending on the population, for example, MSM, drug-injectors or heterosexuals under 25 
years. In this study, various sexual behaviour variables were included in the questionnaire, 
based on the ClaSS study questionnaire. Information on total number of lifetime sexual 
partners, number of sexual partners in the past six months, as well as the nature of their 
most recent relationship and age and condom use at first sex, was collected. This part of 
the chapter presents data on survey respondents' reported sexual behaviour. Chi-square 
analyses were performed on the data (except where indicated otherwise) to assess whether 
there were any differences in sexual behaviour of respondents who accepted opportunistic 
screening (n=113) and those who did not (n=233), to deten-nine whether 'at-risk' 
respondents provided a sample or not. 
Sexual lifestyles 
Sexually active respondents 
Among all survey respondents, 95.3% (346/363) reported that they had experienced sexual 
intercourse; 6/158 males (3.8%) and 11/205 females (5.4%) stated they had never 
experienced sexual intercourse; therefore 17/363 respondents (4.7%) were exclude d from 
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analysis of sexual lifestyles" as well as from analyses of willingness to provide a urine 
sample. Of these 17 non-sexually active respondents, II were from the education setting 
(3 male, 8 female), and 6 from health & fitness study setting (3 male, 3 female). All 
workplace respondents reported they had experienced sexual intercourse. 
Age and use of barrier contraception at first sexual intercourse 
Table 13 shows the age and use of barrier contraception of sexually active respondents, by 
gender. The median age for first intercourse for all respondents was 16 years. Just over 
one third (36.0%) of respondents reported their first intercourse to have occurred below the 
legal age of consent (16 years in the UK)". The age by which 50% of respondents 
experienced first sexual intercourse was between 15 and 16 years. Significantly more male 
respondents reported experiencing first intercourse before they were 16 than females 
(43.7% of males v 30.4% of females). The proportion of male and female respondents 
from both age groups (except females 20-24 years) having intercourse before age 16 years 
was higher than those reported by the equivalent age-groups in Natsal 2000 (see Table 15). 
The rising prevalence of first intercourse before age 16 years has been reported elsewhere 
in the literature (Johnson et al. 1994; Wellings et al. 2001 a). 
Of those who reported first sexual intercourse before age 16 years, the highest percentage 
was among female respondents aged 16-19 years. Chi-square analysis found significantly 
(p<0.001) more females aged 16-19 reported they were not sexually active than females 
aged 20-24 years. Contrastingly, 20-24 year old females had the lowest percentage 
reporting first sexual intercourse before age 16. Thus, among female respondents there is 
an increase in the percentage reporting first sex before age 16 with decreasing age (see 
Table 13). This is also a trend highlighted in comparisons made between Natsal 1990 and 
the recent Natsal 2000 survey (Wellings et al. 2001b). In contrast to this trend among 
females, similar percentages of male respondents from both age groups reported having 
sex before they were 16 years old. The proportion of men having intercourse before age 
16 years has also remained fairly constant across all age groups (16-44) in Natsal 2000. 
Thus, the age at first sexual intercourse, by gender, of study respondents shows broadly 
similar trends with a national probability sample (Natsal 2000). 
Chi-square analysis found study setting was not associated with age at first sex (p=0.343), 
with around I in 3 respondents in each study setting reported first sexual intercourse 
19 With the exception of Table 13, where non-sexually active respondents were included. 
20 Except in Northern Ireland where 17 is the legal age of consent. 
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occurring before the age of 16 years: 31.4% of education respondents, 35.7% of health & 
fitness respondents, and 41.2% of workplace respondents reported first sex under the age 
of 16 years. 
Table 13: Age, use of barrier contraception of sexually active respondents at first 
intercourse, by gender. 
Males 
Current age On years) 
16-19 20-24 
Females 
Current aw On vea 
16-19 20-24 All 
No. of respondents 61 95 68 136 363 
in age group 
Sexually active 95.1% 96.8% 85.3% 99.3% 95.3% 
11 58 92 58 135 346§ 
Age at first intercourse 
Median age 16 16 15 17 16 
loth, goth percentile (14-17) (13-18) (14-17) (15-19) (14-19) 
Aged <16 years* 42.9% 44.2% 56.1% 19.5% 36.0% 
(Natsal)j (29.9%) (25.81/o) (25.6%) (28.4%) 
Use of condom Y 
Used a condom 77.2% 60.4% 68.4% 77.4% 71.4% 
No condom used 22.8% 37.4% 31.6% 22.6% 28% 
§ Numbers do not total 346 as 3 respondents did not give their age. 
Percentage of age group reporting first sexual intercourse before the age of 16 years. 
Percentage of respondents reporting first intercourse before age 16 years in Natsal 2000. 
Y1 (0.3%) respondent did not answer this question. 
Table 13 also shows the use of barrier contraception at first sexual intercourse, by gender. 
Whilst the majority of respondents reported using a condom at first sexual intercourse 
(71.41/o), just over a quarter reported unprotected first intercourse. More of the older male 
age group reported not using a condom at first sexual intercourse than the younger male 
age group (37.4% v 22.8%). In contrast, the opposite was true for the female age groups 
where 22.6% of females aged 20-24 reported condom use compared with 31.6% of 16-19 
year old females. Thus a trend towards increasing condom use at first sex with decreasing 
age of respondents was only seen in males. In addition, significantly (p=0.010) more men 
aged 20-24 reported no condom used at first sex than females aged 20-24. 
Number of lifetime sexual partners & in past 6 months 
Table 14 shows there was heterogeneity in reports of numbers of lifetime heterosexual 
partners; 87.6% of men and 78.2% of women reported more than one lifetime partner 
whereas 34.3% of men and 16.2% of women reported at least ten lifetime partners. The 
skewed nature of the distribution of lifetime number of sexual partners is emphasised by 
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the high value of the 90'h percentile (25 for men, 12 for women) compared with the median 
(5 for men, 3 for women). As might be expected, age is significantly associated with 
having 10 or more lifetime sexual partners, with around one third (31.9%) of 20-24 year 
olds compared with around I in 10 (11.9%) respondents aged 16 - 19 years reporting 10 or 
more lifetime sexual partners. However, a significant majority (59.5%) of respondents 
who reported 10 or more lifetime sexual partners were male. There was no significant 
association between setting and respondents reporting ten or more lifetime sexual partners. 
However, of those respondents who reported ten or more lifetime partners, 33.3% were 
workplace respondents, compared with 22.7% from health & fitness and 19.2% from 
education. As detailed above, a larger proportion of workplace respondents were aged 
between 20-24 years compared with education respondents. This further emphasises the 
link between age and a higher number of lifetime sexual partners. 
Table 14: Distribution of number of heterosexual partners over lifetime and in the past 6 
months, by gender 
Men Female All 
No. of respondents 
in age group 
Item response* 
Number of partnerst 
158 
131 
205 
186 
363 
317 
Lifetime 
0 6 (4.4) 11 (5.6) 17 (5.1) 
1 11(8.0) 32(16.2) 43(12.9) 
2 13(9.5) 34(17.3) 47(14.1) 
3-4 30(21.9) 48(24.4) 78(23.4) 
5-9 30(21.9) 40(20.3) 70(21.0) 
10+ 47(34.3) 32(16.2) 79(23.7) 
Mean (SD)* 9.9(10.3) 5.8(8.0) 7.5(9.2) 
Median (90'h 5 (25) 3 (12) 4 (18) 
percentile)* 
Past 6 months$ N N 
0 11 (7.8) 18 (9.6) 29 (8.8) 
1 76 (53.0) 139(74.3) 215(65.5) 
2 23 (16.3) 17 (9.1) 40 (12.1) 
3-4 21 (14.9) 8 (4.3) 29 (8.8) 
5-9 8 (5.6) 3 (1.6) 11 (3.4) 
10+ 2 (1.4) 2 (1.1) 4 (1.2) 
Mean (SD)* 1.4(0.4) 1.1(0.3) 1.2(0.4) 
Median (90'h 1 (2) 1 (2) 1 (2) 
percentile)* 
f Excluding 17 respondents who were not sexually active and 6 did not answer whether they had ever had sex 
(n--340). T 12 respondents did not state the number of sexual partners in the past 6 months (n--328). 
Survey respondents were asked to state the number of sexual partners they had in the past 6 
months (see Table 14). The mean number of new partnerships in the past 6 months for all 
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respondents was 1.2 (1.4 for males, 1.1 for females). The majority (74.3%) of all 
respondents reported fewer than two sexual partners in the past 6 months; thus, around Iý in 
4 (25.7%) reported two or more in the same time period. Chi-square analyses found 
significantly (p<0.001) more female than male respondents reported less than two sexual 
partners in the past 6 months (83.9% of females compared with 60.8% of males). Thus, 
around I in 3 male respondents compared with around I in 6 female reported two or more 
sexual partners in the past 6 months. In addition to age group and gender, setting was also 
significantly (p=0.015) associated with respondents reporting two or more sexual partners 
in the past 6 months. 
Gender, age and setting were included in logistic regression analysis, with two or more 
sexual partners in the past 6 months as the dependent variable. Only gender and age were 
found to be independently associated with having had two or more sexual partners in the 
past 6 months. Males are almost three times more likely than females to report two or 
more sexual partners in the past 6 months (OR 2.6 95% CI 1.52 - 4.56); 16-19 year old 
respondents are more likely to report two or more sexual partners in the past 6 months than 
20-24 year olds (OR 1.2 95% Cl 0.71 - 2.25). Those who reported their most recent 
partner not to be their regular partner were around three times more likely to report two or 
more sexual partners in the past 6 months (OR 3.195% CI 1.77 - 5.69). 
Is sexual behaviour associated with willingness to accept 
screening? 
Chi-square analysis found no significant difference between those who accepted screening 
and those who declined and their reported age at first sexual intercourse (see Table'15). 
Around one third of both groups of respondents reported age at first sex below the age of 
16 years. 
Significant differences were found between those who provided a sample for testing and 
those who did not and reporting either 1-2 or 3-4 sexual partners (see Table 15 and Figure 
5). More respondents who accepted screening reported two or more sexual partners in the 
past six months. In addition, respondents who provided a sample also reported never using 
a condom with their most recent partner significantly more so than those who did not 
provide a sample. Three significantly different risk behaviours were found between both 
groups of respondents, with those who provided a sample reporting more lifetime sexual 
partners, more recent partners as well as non-use of barrier contraception with their recent 
partner. 
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Table 15: Comparison of sexual behaviours between those who accepted screening and 
those who declined 
Willingness to accept screening 
Accepted Declined 
screening screening X' test 
% % P 
Age at first sex § 0.946 
< 16 years 32.5 67.5 
ýt 16 years 32.9 67.1 
Condom used at first sex Y 0.064 
Yes 29.8 70.2 
No 40.2 59.8 
Number of sexual partners: 
Lifetime <0.001 
1-2 21.1 78.9 
34 24.4 75.6 
5-9 44.3 55.7 
10+ 44.3 55.7 
Mean (SD) 9.89 (11.67) 6.36(7.48) 
Median (90"' Percentile) 7(23) 4(16) 
Past 6 months 0.002 
-<1 63.9 36.1 
>9 79.5 20.5 
Mean (SD) 1.96(l. 89) 1.24(1.31) 
Median (90'h Percentile) 1(4) 1(2) 
Relationship with most 
recent/current partner 0.492 
Cohabiting 33.0 67.0 
Non-cohabiting 29.4 70.6 
Always using a condom with 
recent/current partner 0.009 
Always 24.7 75.3 
Inconsistent 31.1 68.9 
Never 45.6 54.4 
Statisticallv siQnificant differences between nep-ative and t)ositive test results are indicated 
by their p-value in bold font; § 13 missing responses; Y7 missing responses. 
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Figure 5: Number of lifetime sexual partners, by willingness to provide a sample 
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Comparison of sexual behaviours between those who tested 
negative and those who tested positive for C. trachomatis 
Although numbers were small, with 5/113 tests returning a positive result, I was interested 
to assess whether there were any differences between the sexual behaviours of the two 
groups of respondents who provided a sample and test result. The variables considered in 
Chi-square analyses included, age at fifst sex, condom use at first sex, number of lifetime 
sexual partners, number of partners in the past six months, relationship with most 
recent/current partner (living together or non-cohabiting) and 'Always' use a condom with 
recent partner. Statistically significant differences (P=0.033) were found in only one of 
these six sexual behaviour variables: respondents who tested positive for chlamydia 
reported significantly less condom use at first sex (10.5% of those who tested positive 
reported no condom use at first sex, compared with 1.4% of those who tested negative). 
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Prior experience of having been tested for chlarnydia 
As a consequence of screening guidelines in Scotland, which recommend that women 
under 25 years be opportunistically offered chlamydia screening when they attend primary 
care, screening is currently offered in a number of NHS settings. This may affect the 
uptake of screening, as part of this study, as some respondents may have already been 
presented with screening opportunities, and if accepting, would then decline screening 
when offered in non-medical settings. Thus, young people were asked in the survey if they 
had ever been tested for chlamydia, and to state how recently they were tested. 
Chi-square analysis of questionnaire responses found one in four (24.9%) of all sexually 
active respondents had previously been tested for chlamydia (see Table 16). Of these 
significantly (p<0.001) more were female than male (34.0% of females compared with 
13.2% of males). Having prior experience of testing was therefore explored as being 
associated with declining the offer of screening. Eighty per cent (64/85) of respondents 
who had been tested for chlamydia before declined the offer of screening. In contrast, a 
minority (35.4%) of respondents who reported they had never been tested for chlarnydia 
before then provided a sample as part of this study. 
The significant association between having been tested before and not providing a sample 
suggests that experience of testing was a significant factor associated with not providing a 
sample when approached in non-medical settings. However, not all respondents who 
reported having never been tested before then gave a sample. Furthermore, there were 
significant gender differences in willingness to give a sample and the experience of prior 
testing. 
Regarding gender differences, one in three females (33.3%) of females compared with less 
than one in ten males (6.6%) who provided a sample had ever been tested for chlamydia. 
In addition, of those respondents who declined screening when it was offered to them, 
around I in 3 females reported they had previously been screened for chlamydia compared 
with fewer than I in 5 males. Therefore, in both groups of respondents, those who 
accepted and those who declined screening, females were more likely than males to have 
been previously screened for chlamydia. Thus, the large majority (93.4%) of men who 
were screened for chlamydia in this study had never been tested before. Women, on the 
other hand, although reporting prior experience of being tested for chlamydia before, were 
willing to provide a sample when approached in these non-medical settings. This perhaps 
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suggests a willingness among some women to be screened for chlamydia in non-medical 
settings even though they may not consider themselves to be at risk of having chlamydia., 
Table 16: Respondents' reported experience of previously being tested for chlarnydia, by 
gender 
Ever been tested for chlamijdia 
before? A2test 
Yes (016) No (? 1q) P 
All study respondents 
(n=342)§ <0.001 
All 85 (24.9) 257 (75.1) 
Male 20(13.2) 131 (86.8) 
Female 65 (34.0) 126 (66.0) 
Respondents accepting 
screening (n--I 12) Y <0.001 
All 21 (19.9) 91 (91.2) 
Male 4 (6.6) 57 (93.4) 
Fernale 17 (33.3) 34 (66.7) 
Respondents declining 
0 006 
screening (n--230) a . 
All 64 (27.5) 166 (72.5) 
Male 16 (17.8) 74 (82.2) 
Feniale 48 (34.3) 92 (65.7) 
Statistically significant differences between genders are indicated by their p-value in 
bold font. §4 missing values; YI missing value; a3 missing values. 
Female interviewees who reported having previously been screened for chlamydia stated 
that this was during routine care (mostly during their first smear tests). In comparison, 
young men reported that they were all tested when they self-referred to a GUM clinic. 
Only one male interviewee reported seeking routine screening at a GUM clinic despite 
being symptom free. Thus, female respondents who reported prior experience of 
chlamydia screening were offered screening through opportunistic approaches in clinic- 
based settings; in comparison all men who reported being tested before had self-referred to 
GUM clinics. Young men screened in these non-medical settings were being offered 
opportunistic screening for chlamydia for the first time more than females. Having never 
been offered screening before was confirmed from responses by young men in the settings, 
with many commenting "I've never been asked that before! ", or replying 'No' when asked 
if they had ever been offered screening. 
Whilst almost all men who provided a sample had never been tested for chlamydia before, 
neither had the majority (82.2%) of men who declined the offer of screening. Similarly, 
the majority of women who declined the offer of screening reported never having been 
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tested before. Thus, questionnaire responses and interview data was analysed to find other 
possible barriers to the uptake of screening in these non-medical settings. 
Willingness to accept screening and perception of risk of 
having chlarnydia 
Men and women's perception of being at risk of having chlamydia was included as a 
survey item. Of all sexually active survey respondents, 45.7% perceived themselves to be 
at risk of having chlamydia or were uncertain as to whether they were at risk. Chi-square 
analyses were performed to assess the associated factors with perception of being at risk; 
these include: include not using a condom at first sexual intercourse (P=0.003), aged under 
16 years at first sex (p=0.002), reporting ten or more lifetime sexual partners (p<0.001), 
reporting two or more sexual partners in the past six months (p<0.001), having never been 
tested for chlamydia (p<0.001) and poor knowledge of female symptoms of chlamydia 
(p=0.005). 
The survey responses of all sexually active respondents were compared with willingness to 
provide a sample. Of the 113 men and women who accepted the offer of chlamydia 
screening and provided a sample to be tested in this study, 62.8% stated in the survey that 
they perceived themselves to be at risk of, or were uncertain about, having chlamydia (see 
Table 17). In contrast the majority (62.7%) of those who declined screening did not 
believe they were at risk of having chlamydia (see Table 17). 
Table 17: Respondents' perception of risk, by willingness to accept screening. 
Respondents' perceptions of 
being at risk (n=113) 
YES NO 
XI test 
or uncertain p 
Respondents who accepted 
screening 71(62.8) 42(37.3) 
Respondents who declined 
<0.001 
screening 87(37.3) 146(62.7) 
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The large number of people who accepted the offer of screening and who considered 
themselves to be at risk of having chlamydia questions the degree to which it was the 
'worried well' participating in screening. Furthermore, as the last section highlighted, the 
majority (81.2%) of respondents who provided a sample had never been tested for 
chlamydia before. The positive test results in this study also questions how far those who 
maintain good sexual health participated. 
It is plausible that men and women who were previously tested for chlamydia may not 
have perceived themselves to be at risk of having chlarnydia. Among those who did not 
believe themselves to be at risk of having chlamydia, 34.6% had previously been tested for 
chlamydia. Thus, two thirds of those who did not believe they were at risk of having 
chlamydia had never been tested. The differences between perception of risk and having 
been tested before were highly significant (p<0.001) in Chi-square analysis. When 
respondents who had been tested before and those who did not believe they were at risk of 
having chlamydia were removed from analysis, there were 158 eligible respondents, of 
whom 71 (44.9%) provided a sample. Thus, among those who had no experience of 
testing and who considered themselves at risk the majority (55.1%) did not provide a 
sample. 
Table 17 shows that two thirds of respondents who declined screening reported they did 
not consider themselves to be at risk of having chlarnydia; however, just over I in 3 
believed they either were at risk or were uncertain about their risk of having chlamydia. 
Thus, respondents who had never been screened before or provided a sample when 
approached as part of this study nevertheless did not believe they were at risk of having 
chlamydia. Factors affecting respondents' perception of being at risk of having chlarnydia 
were explored during interviews. 
Despite not being a direct question, most interviewees spontaneously offered views on who 
they considered to be at risk of having chlamydia (as detailed in Chapter 5): whilst there 
were similar beliefs expressed by men and women, there were also differences in how men 
and women perceived risk. Most of the beliefs expressed by interviewees were in relation 
to risk in 'others'. When discussing risk behaviours and persons they perceived to be at 
risk, both male and female interviewees spoke of school pupils and college or university 
students as being an 'at-risk' group based on their perceived promiscuous sexual lifestyles: 
"I think students are probably the higher risk than anybody else... some of the 
students have slept with threepeople in one night and all different people". 
(Interviewee #311, Male, Age 20, Workplace). 
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Thus, risk of 'others' acquiring chlamydia, or other STIs, was understood by many of these 
interview respondents to be due to unprotected sex having occurred. 
Some interviewees also discussed their own perception of being at risk of having 
chlamydia. Both men and women did not consider their risk solely in relation to whether 
they had unprotected sex. The use of contraception was for women based on the degree to 
which they 'trusted' their partners. One female interviewee, for example, who had never 
been tested for chlamydia before, declined screening in this study because of her low 
perception of risk. She spoke about 'trust' and 'I knew who he was' as reasons for her low 
perceived risk of having chlamydia. In relation to not using condoms she commented: 
I wasn't bothei-ed about thefact that he wasnt using them [condoins] because 
I was on the pill ... and I knew who he'd been with R: He wasn 't a strangei- to you? 
L Uh-huh. Uh-huh. It wasn't an issue, i-eally. 
(Interviewee #309, Female, Age 20, Workplace). 
When then asked whether she did not provide a sample for testing in this study because of 
her low perceived risk she commented: "yeah ivell it's [chlainydia] just not sonzething I 
think I'm at risk of'. Other females offered similar beliefs based on the status of their 
relationships: those who reported monogamous relationship histories spoke of trusting 
their partner as a reason for not using condoms and for their low perceived risk of having 
chlarnydia. 
Men also considered the 'status' of their female partners in their considerations of personal 
risk and the use of contraception. One young man referred to his use of condoms to 
'protect myself', against acquiring STIs; he also spoke of his use of barrier protection, 
especially when he did not know his sexual partners' experiences. When discussing 
having a 'one-night-stand' I asked if he used any contraception: 
", 4ye. Definitely, yes, 'cos I didnt biow her, I didnt lazow anything about her and I 
did definitely use contraception that n ight ". 
(Interviewee #311, Male, Age 20, Workplace). 
Other young men discussed using barrier protection to prevent acquiring a STI, especially 
when they were having sex with a "lassie who has sex way you on the first night - you 
don't know how many others she's been way; how many others she's slept iva. )ý' (#190, 
Male, Age 21, Health & Fitness). So, men often spoke about why they used condoms, 
whereas women discussed why they did not, but both men and women contextualised their 
behaviour in relation to the degree of trust in the 'other' person - their sexual partner. 
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Research has explored young women's negotiation of sexual reputations (Kitzinger 1995). 
Kitzinger (1995) found that sexual reputation for women still matters today, with the use of 
the word 'slag' continuing because of its relevance to women's lives and its meaning as a 
'descriptor of reality' (Kitzinger 1995). Although both men and women referred to 'trust' 
issues, women also tended to offer a consideration of their own sexual behaviour and make 
an assessment of their risk. In contrast men often considered the status of their female 
partner. Thus both women and men were considering female sexuality in their assessment 
of risk: females who did not perceive themselves as being 'sluts' also did not consider 
themselves to be at risk; males who did not consider their female partners as 'sluts' also 
did not consider themselves at risk. 
One female interviewee discussed her sexual lifestyle as one she viewed with regret, based 
on her perceived 'promiscuous' behaviour; she described 'many' sexual partners - some of 
whom she had a vague recollection of having sex with as she recalled being severely 
inebriated - before adding: 
"Ifelt like a freak, Ifelt like a shit, yknow my ftiends weren't doing that ... I ivent 
through a rebellious streak and got drunk a lot ... but I'M in a stable relationship now, 
which is a goodplacefor ine to be (laughs), Pin protected. " [author's emphasis] 
(Interviewee #352, Female, Age 21, Workplace). 
This interviewee continued to describe seeking a full sexual health check prior to having 
sex with her current partner: 
"I decided to get tested before having sex with iny boyfriend 'cos othenvise Inl 
gonna put him at risk" 
(Interviewee #352, Female, Age 21, Workplace). 
This interviewee described assessing her risk status based on her 'promiscuous' behaviour 
rather than upon having had unprotected sex with her sexual partners - she did not mention 
contraception in her recollection of sexual partners. This was common among many 
interviewees: risk-behaviour was not premised upon unprotected sex but upon the 'type' 
of sex, which was perceived to be risky. 
When approaching young people in this study and discussing chlamydia with them, some 
young women who declined screening responded that they were in a monogamous 
relationship therefore they 'could' not be at risk of having chlamydia. Some young men 
commented that they did not have sex with 'dirty girls' therefore they too 'could' not be at 
risk of having chlamydia, and so declined screening. The attributes of ones sexual partners 
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were therefore being discussed by respondents as morally acceptable or not. It was on this 
basis that their perception of risk was often founded. 
In the previous chapter, interviewees' views on whom should be offered screening was 
discussed. University students were often cited as a population who 'should' be offered 
screening because of their perceived promiscuous behaviour being viewed as placing them 
at high risk of acquiring STIs. These views clearly highlight an understanding among men 
and women that 'risky' sexual behaviour places one at risk of acquiring a STI. Despite 
this, when men and women were asked about chlamYdia (in interviews as well as during 
the approach in the settings) there was sometimes confusion about how chlamydia is 
transmitted. On two occasions in health and fitness settings, groups of young men 
questioned why I was offering them screening for chlamydia: "Isnt Mat a Ivoniall's 
disease? " 
Among those who understood the transmission process of STIs, their risk-decision-making 
process was different depending on whether they considered risk in others or themselves. 
There were strong gender differences found, with male and female interviewees providing 
different narrative accounts of their risk negotiations and decisions, although both 
emphasised 'deviant' female sexuality as their source of concern. 
That many study respondents who considered themselves to be at risk of having chlamydia 
were then willing to provide a sample of urine when approached in non-medical settings is 
a positive finding. This suggests convergence between medical advice and lay responses; 
in other words, the advice for young people is to be tested for chlamydia if there are risk 
factors or a perception of risk, and many young people who considered themselves at risk 
adhered to this general view. However, many who considered themselves at risk did not 
accept testing in these non-medical settings. During interviews men and women offered 
narratives of negotiating their risk of having a STI, which for many was predicated on the 
status of their sexual partners. Although survey respondents knew chlamydia was sexually 
transmitted, and the views of interviewees confirmed this knowledge, the response to the 
offer of screening in the non-medical settings in this study suggests there may be ftirther 
barriers to screening that are either in addition to or instead of perception of risk. 
Barriers to screening: the public nature of the settings 
How interviewees felt when they were approached and offered screening in non-medical 
settings was explored during interviews. The effect the public nature of the screening had 
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upon willingness to provide a sample was a key factor to emerge from interviews, 
especially from women. Interviewees spoke of feeling embarrassed to provide a sample in 
these settings because of the non-private nature of the context. The stigma of being seen to 
want a test for a STI, and the perception among respondents about how this behaviour 
would be viewed, was discussed more by women than men. 
Embarrassment and stigma 
As discussed in chapter 5, many survey respondents did not consider screening for 
chlamydia in non-medical settings, such as bookstores, pubs and clubs, acceptable because 
of the public nature of the setting. However, men were more accepting of these settings 
than women. During interviews both men and women discussed the public nature of the 
setting as influencing their decision to accept the offer of screening: both described 
feelings of embarrassment towards being offered screening in public. However, there were 
gender differences in how these beliefs impacted on their subsequent behaviour: many 
women stated a preference to be offered screening in medical settings; in contrast, men 
often downplayed their feelings of embarrassment by emphasising their preference towards 
conu-nunity screening compared with clinic-based screening - non-medical screening is, as 
one commented, "the lesser of two evils". 
For these young men, they preferred to be embarrassed in the company of their friends or 
colleagues than in 'a clinic full of strangers. ' As one commented: 
"For mepersonally I thinksomemedicalplaces can be quite offputting, they'requite 
daunting ... whereas in Your workplace, youre in your own safe environment, you know everyone in here, you kinda tnist everybody a bit I suppose cos youre working 
with then all day. " 
(Interviewee #311, Male, Age 20, Workplace) 
When considering non-medical settings, young men were typically less concerned about 
people knowing they were seeking screening, than the young women. Their fears of 
attending clinics were greater than their embarrassment at being offered screening in non- 
medical settings. These attitudes were contrary to women's', with many discussing issues 
of privacy and concerns that the testing be 'discrete'. Others spoke of preferring the toilet 
in which to provide their sample, to be in close proximity and for few people to be around 
them at the time they were asked to participate in screening: 
R: I would have preferred to phone tip a number and make an appointment to 
come in ... being out there [mainjoyer] I wouldnt 
have come up 
KL: TP7iy is that? 
R: I dont want to stand in front of anybody, and yknow, give my name or be 
asked questions or anything in fi-ont of other people. Idon'tknowthemandI 
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don't ivant thein to hear those sorta things about nze. 77iat sorta thing is better 
done in private. 
(Interviewee #294, Female, Age 24, Health & Fitness). 
This woman waited until the screening was offered in a private location in one health and 
fitness setting (as advertised on study posters) before being tested for chlamydia in this 
study, as she did not want to approach the author in the public reception area of the setting. 
In the questionnaire, all respondents were asked to state how far the following would 
influence their decision to provide a urine sample for chlamydia testing: the location of the 
toilet in which to provide the sample; how many people are around them at the time when 
they are asked to provide a sample; and, how much time they have when asked to provide a 
sample. Chi-square analyses were perfortried on survey responses to assess the difference 
between these items and gender. 
Significantly (p=0.016) more female respondents stated they would be influences by 'the 
location of the toilet' than male respondents (51.3% of females compared with 35.6% of 
mates). One female interviewee commented: 
".. 3vith this location with the toilets being really close as well I think it's okay. 
You're not having to go through... public or anything to actually get to a toilet, so I 
think that's okay" 
(Interviewee #294, Female, Age 24, Health and Fitness) 
Another female suggested an alternative way in which to offer testing for chlamydia: 
"I suppose the best place here would be actually in the toilets. That way you could 
do it there and then. Even ifyoujustpick one zip on your way out. 
(Interviewee #128, Female, Age 23, Education) 
Other female interviewees spoke of their willingness to accept the offer of screening if it 
were offered 'discretely' or if 'no one knew'. Questionnaire data found that I in 3 males 
(39.6%) and just under half of females (47.6%) believed they would be influenced by how 
many people were around them at the time they are asked to provide a sample. There was 
no statistically significant difference between male and female responses to this item 
(p>0.05); nevertheless, there is a high percentage of the total study sample who believed 
their decision to provide a sample would be influenced by people around them at the time 
they were offered screening. More women than men reported they would be influenced. 
In each study setting young females were observed by the author as producing their 
samples from within their jacket pockets, or even from their bags, in an attempt to conceal 
their samples from public view. On one evening in a health and fitness centre, a group of 
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young females (aged 17-19 years) agreed to the offer of screening. The following field 
note extract illuminates their embarrassment at handing over their samples to me: 
A group of yowig women came back to give Yne their samples. Yhey all appeared 
acutely aware of others arowid them mid were vety quiet. One glaizced over her 
shoulder and produced the Wit'fi-om her bag at the same time as her frieiids 
produced theirs from widerneath a cardigan, a jacket pocket andfrom tucked under 
their arm. Iplaced their 'kits' hi the storage co7itabier mul semed immediately that 
they all relaxed; they appeared happy to chat with me once the samples were out of 
view. 
(Field note, Health and fitness setting, 12 th June 2004). 
In contrast, no male respondents who provided a sample for testing attempted to conceal 
their sample from public view. Even though respondents were given a small white jiffy 
bag (in addition to the clear plastic bag) in which to place their sample, some young men 
returned their samples only in the clear plastic bag and raised their sample high in view to 
peer at the colour and comment on it (to either a male companion or to the author). In 
addition, males who spoke to their companions or me about their samples did not always 
use quiet tones; some spoke quite loudly and behaved in a confident manner. One male 
interviewee commented: "it's inore male bravado to talk about their sexual history than it 
isfenzales... " (Interviewee #258, Male, Age 22, Health & Fitness). 
Chapter 5 discussed women and men's views in interviews towards screening being 
offered in various settings, medical and non-medical. Young women discussed a greater 
preference for medical settings. The stigma and embarrassment of attending specialist 
sexual health services is reported in the literature, mostly in relation to women (Dixon- 
Woods et al. 2001c; Fortenberry et al. 2002; Scoular et al. 2001b). Many interviewees, 
especially women, referred to the stigma of sexually transmitted infections. Most 
commented on the stigma of being seen to want a STI test: 
"... see ifyou couldjust pick something tip and take it away without having to speak 
to anyone, or so that no one biows what you're doing 'cause you don't really ivant it 
to be known that you ivant to be testedfor a sexual infection yluiow. 
(Interviewee #309, Female, Age 20, Workplace) 
Some also commented on the implications on ones 'reputation' by being seen. to want a 
STI test: 
"It's the associations that come ivith STI's. I think thei-e's a sort of stignia around 
thenz, like ifyou might have an STI, it ineans that youve slept with a lot ofpeople. 
(Interviewee #352, Female, Age 21, Workplace). 
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One young man referred to stigma in relation to STIs being perceived as a sensitive and 
embarrassing subject: 
"Well you know, sort of, as soon as you mention the word sex, you lazow, not 
necessarily the ivot-d sex, it's much moi-e actually the words, you know, semially 
transmitted disease... say sex and then they go, you bzoiv transmit they go 'oh, okay, 
no, no, no, nah it's filthy business. '... It's just not something that people are 
comfortable with I think generally. " 
(Interviewee #308, Male, Age 22, Workplace). 
Stigma has been raised as an important factor associated with women's willingness to 
access services, as well as their willingness to accept screening for STIs (Dixon-Woods et 
al. 2001a; Fortenberry et al. 2002). Although during interviews young men discussed the 
public nature of the setting, their embarrassment and being observed to accept screening by 
others. These concerns were not as great as their fears of attending a GUM clinic for the 
purpose of screening or testing. 
Confidentiality 
Men and women's perceptions of the confidentiality of the test result were explored in 
interviews and noted in fieldnote diaries. No respondent who accepted screening raised 
confidentiality as a concern at the point of accepting screening and providing a sample. 
During interviews, one male spoke of confidentiality in a positive light: "I 171eall it's 
confidential anyway so what's the harin in doing it [providing a sample for testing]". 
Women, however, expressed more concern than men over confidentiality. Women tended 
to favour medical settings because they perceived them as offering confidentiality more so 
than non-medical settings. Other studies have shown that women tend to be concerned 
about issues of confidentiality (Dixon-Woods et al. 2001b). Certainly, all study 
respondents were assured of confidentiality of their questionnaire responses and test results 
during the initial approach; therefore, perhaps many accepted these assurances of 
confidentiality and did not require any further clarification or reassurance. 
All study respondents were asked for two methods of contact on their consent fonns 
(collected prior to them completing the survey) so that they could be contacted with their 
result (if they provided a sample) and/or contacted with a view to arranging an interview. 
The great majority readily agreed, with only a small minority of respondents, mostly those 
who declined screening, leaving this section of the consent forms blank. As such, the 
majority feared no loss of confidentiality or anonymity. 
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Both the public nature of the setting and how confidential the test result would be were key 
concerns for many female survey respondents and interviewees in this study. These factors 
acted as a barrier to their willingness to accept the offer of screening in non-medical 
settings. In contrast, many young men did not express the same concerns over the public 
nature of the settings. Rather, men often spoke in interviews about their preference to be 
screened in these non-medical settings than attend a clinic-based setting. Thus, in addition 
to setting-related barriers to uptake in this study, there were supports to willingness, which 
are now discussed. 
Supports to non-medical screening 
Raised awareness and knowledge 
Fieldnote data suggests that views towards acceptability of being approached were often 
based on welcoming the opportunity to gain knowledge about chlamydia. In one health 
and fitness setting, the author engaged in a 'quiz' with (and prompted by) a group of male 
staff. Their enthusiasm to gain knowledge about chlamydia, other STIs and related matters 
was evident in this exchange. Thus, Chi-square analyses were carried out on survey 
responses to assess whether there was an association between respondents' perception of 
their knowledge about chlarnydia, as well as their actual knowledge, and their willingness 
to accept screening. Chapter 5 described the allocation of scores to survey respondents' 
knowledge about chlamyclia. 
No significant association was found between survey respondents' perception of 
knowledge and willingness to provide a sample for testing (p>0.05). In addition, no 
significant differences were found between survey respondents who either accepted or 
declined screening and their actual knowledge of chlamydia (P>0.05). Despite there being 
no significant associations between either perception or actual knowledge of chlamydia 
and willingness to provide a sample for testing, interview data suggests there was a health 
promotion aspect inherent in the study, which appears to have positively affected uptake of 
screening, especially among the male respondents. 
During interviews, I was interested in assessing whether men and women had gained any 
knowledge about chlamydia because of their exposure to information about chlamydia by 
taking part in the study. Interviewees were asked to comment on what they knew about 
chlamydia and were subsequently asked whether that knowledge was the same before they 
took part in this study. Most commented on having merely heard about chlamydia before 
this study, but knew more about it having taken part. One male commented: 
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"I've heard of chlainydia, but I didnt know what it was really ... but I Imow now because ofyou-I guess knowing how common it is, jeez! ... that's really why I thought 
about getting tested... 
(Interviewee #77, Male, Age 20, Education). 
Another referred specifically to the study literature being where he gained knowledge 
about chlarnydia and influencing his decision to be tested: 
'7think it was quite goody' bzow the wayyou had all the posters upfirst ... because 
obviously I had a wee read at them before speakbig to you ... if I didnae read the 
posters atid you says tae me "want to get tested? "... l wouldnae have doize 
it ... everywhere you ivew there was a poster ... So I thitik way that, that helped me 
take part.. " 
(Interviewee #194, Male, Age 21, Health & Fitness). 
Whilst many men in interviews admitted to having poor knowledge about chlamydia and 
spoke of having learned something about chlamydia as a consequence of taking part in this 
study, few females offered similar comments. Most female interviewees offered measured 
answers to questions on their knowledge about chlamydia; whereas young men were often 
uncertain about their knowledge, with many immediately stating "I don't know". 
Chapter 5 described how some young men gained knowledge about chlamYdia by virtue of 
their participation in this study. Whilst some learned about the largely asymptornatic 
nature of chlamydia, others spoke of leaming that chlarnydia. could be tested for on a 
sample of urine: "I didnt k-now it could be done through a urine sample"; "I thought it was 
blood saniples". When interviewees were asked whether learning that a urine sample was 
the testing method had any bearing on their decision to accept the offer of testing, most, to 
some degree, believed it had: 
"I thought it was the cotton bud thing ip yer [whistles]! It's great that it'S only a 
urine sample. Much better aye! " 
(Interviewee # 237, Male, Age 24, Health and Fitness) 
"Ijust thought where's the harm, and Ijust though I couldfind out more information 
for myseýfso where can I go wrong really. If anything happens youre gonna get the 
right advice to get it sorted so there's no, there's no risk involvedfor me. 
(Interviewee #311, Male, Age 20, Workplace). 
Thus, becoming more aware about chlamydia appears to have positively impacted on some 
male respondents' willingness to provide a sample for testing. 
Both male and female interviewees commented more generally about the effect raising 
young peoples' knowledge about chlarnydia would have on their uptake of screening. 
Various reasons were offered as to why some settings are considered 'appropriate' in 
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which to offer chlamydia screening. A common thread throughout these inter-view 
discussions was the belief that screening being offered in these settings would raise their 
awareness about chlamydia: "I think it's a good idea to bring it to thenz ... to make thein 
more aware about it-inaybe nzore would do it [testing]" (Interviewee #308, Male, Age 22, 
Workplace). Both male and female interviewees believed that providing information 
about chlamydia would increase young people's knowledge about chlamydia: "... Cos if 
people have the information ... maybe there wouldn't 
be so many people getting stuff 
[STIs]". 
To summarise, although not all interviewees spoke about their knowledge about chlamydia 
being increased by taking part in this study, the majority did. Young men, especially, 
learned about how common chlamydia infection was among young people under 25 years, 
the largely asymptomatic nature of chlamydia infection as well as the testing method. 
Increasing their knowledge about these three aspects of chlamydia infection appears to 
have impacted positively on these young men's willingness to accept screening when 
offered to them. 
Convenience 
A second common reason given by men in interviews for accepting screening when 
offered in non-medical settings in this study was because it was convenient. The following 
field note extract illuminates this: 
A nian approached me as I was setting tip the study desk this evening and said, "Are 
you the lassie doing the testing? ". He said he W seen my poster in the fitness 
suite ... said he W had unprotected sex a jew times so he W considered being tested but 
then when he saw this study advertised on the posters he waitedfor the study to start 
as it was more convenientfor him "saves sittin'in a clinicfor ages " he said. He took 
a questionnaire and 'kit' there and then and returned it later before he left the gym. 
(Field note, Health & Fitness setting, 23d June 2004) 
In one interview with a young man, he appeared to be skirting round the issue of 
convenience. I asked: 
KL: So, was convenience a reason you did the test then ? 
R: Definitely! Because I wouldnt have gone and got myset(tested ... but while it's 
here, it's convenientfor me ... so I might as ivell. (Interviewee #311, Male, Age 20, Workplace). 
In contrast, one man stated he had tried to get tested but the offer at the health and fitness 
setting was more convenient for him: 
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"I had tried to go and get tested, and Ifound that I couldn't do that vely easily, so 
when this opportunity came up, I said, 'Oh, I think I'll go for that' cos it 1vas just 
there, and it was no pressure either. 
(Interviewee #237, Male, Age 24, Health & Fitness). 
Many interviewees, especially men, used the term convenient; others said the test was 
ceasy', or 'while it's here' and 'it's no effort to do it'. The ease of being tested in these 
settings appealed to many of the male respondents: it was straightforward and required 
little effort on their part. In the workplace setting one lunchtime, a group of men and 
women were completing questionnaires when one young man commented (with a mouth 
full of chips): 
Male 1: "This is great! Eat your hinch, have something to do and while Im at it 
get testedfor an STV Bish, bash, bosh! " [Sic] 
Male 2: 1 Ibiow it's dead easy isiz 't it! 
(Male 1: Interviewee #311, Male, Age 20, Workplace; Male 2: Interviewee #308, 
Male, Age 22, Workplace) 
Other young men commented on the convenience in relation to the urine sample: 
"Aye nae bothei-, I'll be needin'to go in a minute anyway [to the toilet] " 
(Field note with regards to Interviewee #257, Male, Age 22, Workplace). 
In contrast, few female interviewees spoke of convenience as being a factor affecting their 
willingness to be screened. Studies with women who were opportunistically screened for 
chlamydia in GUM or family planning clinics, have noted that women's experiences of 
testing and treatment formed an important element of their judgements of the service 
(Dixon-Woods et al. 2001 a). In this study, young men spoke positively about the case of 
providing a sample for testing, and of this encouraging them to accept screening. 
Male interviewees who spoke of convenience often did so in relation to two associated 
factors: first, screening was offered in a setting they used regularly, which made it easy for 
them to be screened; and second, respondents often commented on their disinclination to 
seek screening at medical settings (such as GUM clinics), therefore, screening being 
available in a setting they frequented offered them an opportunity to be screened without 
attending a clinic. 
In relation to the first factor, some men offered views in support of chlamydia screening in 
the non-medical setting in which they participated as it was convenient for them to have a 
test in a setting they used anyway. A health and fitness interviewee who gave a sample 
commented: 
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"I like the fact that I come here [gym] quite a lot, ylazow a couple of times a week 
and ifyou hadnt been here Iprobably wouldn't have done it 'cos where else do you 
go, a clinic? Im not sure Id do that, ivell not unless I thought there was something 
wrong and although I did a test thinking I was OK, I guess I was just checking 'cos 
you said you might not always Now. I wouldn't go to a clillic to do that, y'k7lo1v to 
check kinda thing but because you came zip to me in here ivell that 111ade it easyjllst to 
go actually yeah, y'know. " 
(Interviewee #259, Male, Age 22, Health & Fitness) 
Another interviewee from a workplace setting commented: 
"... ivell obviouslypersonally I think it's a good thing because I haven't, itfilst hadnt 
occurred to nie to have the test done before, and eh, when you ivere in here you b1oly, 
sort of, obviously somewhere I come evetyday and things, it was like 'Oh cool, well, 
why not, '" (Interviewee #308, Male, Age 22, Workplace). 
Being approached in a location and at a time suitable to them appealed to many of the 
young men who referred to the convenience aspect of non-medical screening. Another 
said: 
R: Personally I don't think I would have done it ifyou hadnt been here. If Idjust 
seen a poster in the toilet like saying contact the clinic Id have went 'Na, I wouldnt 
have done it. 
KL: And why woultlyou say that was? 
R: Pretty much I thinkfitst the convenience and a bit of ignorance as well, I mean 
you're coming in here so youre a bit less ignorant to the fact, just, people coming 
wanting to speak to you about it rather than you [himsew wanting to go speak to 
someone about it, ifyou know what I nzean. 
(Interviewee #311, Male, Age 20, Workplace). 
For this man, the presence of someone offering a chlamydia test in a setting convenient for 
him, acted as a motivator for him to provide a sample. Such views were offered mostly by 
male interviewees, both in relation to their own views and also in relation to their 
perceptions of other males' attitudes towards non-medical screening. As one noted, 'I 
think guys are inore likely to get it [tested] because it's conveident, and girls... are litore 
likely to do it in private places, you k7ioiv... '. So where male interviewees often spoke of 
non-medical screening being convenient for them personally, females who referred to 
cconvenience' in interviews often did so in relation to 'others': "I think if it. was inade 
niore available in places like this and schools and stuff then it's inade easier for people 
y'know, it's easierfor thein to get tested' (Interviewee #309, Female, Age 20, Workplace). 
For other interviewees who spoke of either their or others' reluctance to access medical 
services for screening or testing, non-medical screening was considered positive precisely 
because it enabled them to avoid accessing medical services. Thus, the convenience was 
Karen Lorimer, 2006 Chapter 6,173 
linked with screening, which would otherwise be performed in medical settings, being 
made available in settings regularly used by these respondents. 
Perception of screening as non-medical 
Many male interviewees described feelings of apprehension towards seeking screening in 
medical settings - especially in GUM clinics. This in turn resulted in them holding 
positive attitudes towards non-medical screening precisely because it meant they would not 
have to use a GUM clinic. As one man commented: 
KL: [Phat do you think about offering testing out with medical services? 
R: I think it's, I think it's probably a good idea. Cause I think, I think sonze, 
some people wouldjust, as I say, some people wouldjust make, nzake, I think a lot of 
peoplejust making that, you know, initial step into the, the medical location would be 
the big issuefor thenz. You know, a lot, a lot ofpeople don't like going to the doctor 
filll stop... I think it's more men who are afraid ofgoing to the doctor-I wouldnt go 
to a clinic but I did it /screen ingl here 
(Interviewee #308, Male, Age 22, Workplace). 
One man explained why he would not attend a GUM clinic: 
"Because eveiybody sits and looks at you. Eike that what are you here for? ' 
'Nothing, eh sore finger. ' Sore finger, eh, in a sexual health clinic? Has it got 
chlainydia? " 
(Interviewee #311, Male, Age 20, Workplace). 
Whilst male interviewees spoke of their reluctance to access dedicated sexual health 
services, or general practice - for the purpose of seeking testing - female only referred to 
this in relation to their perception of males. No female interviewee discussed being 
reluctant to access a GUM service. Indeed, when asked in interviews what they would do 
should they be concerned they had acquired a sexually transmitted infection, all men, with 
the exception of one, stated they would go to their GP. Whilst many females also stated 
the same, a few believed they would self-refer to a GUM clinic, primarily because they 
held negative views towards their current GPs. The reticence that male interviewees 
commented on, in relation to accessing medical services for the purpose of sexual health 
screening, is noted in the literature in terms of the stigma associated with GUM clinics: 
stigma is a recognised barrier to patient access (Scoular et al. 2001b). 
During interviews any men perceived the screening offered in the study settings to be non- 
medical: "I quite appreciated the fact that it was not really medical. It was really relaxed". 
Another commented: "It's not just a medical issue ... it's more of a cultural issue as well ... I 
can see the point of having it in a medical facility, but it's not just a medical problem is it? " 
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(Interviewee #258, Male, Age 22, Health & Fitness). Few female interviewees expressed 
this particular opinion; however, one female did comment that sexually transmitted 
infections are not solely an issue for the medical profession, but they are socially and 
culturally produced; in other words, STIs are social infections and as such they should be 
dealt with by wider society. 
No interviewee, male or female, spoke of the screening in terms of it being a medical 
service that was being offered in a non-medical setting; in contrast, the screening was 'de- 
medicalised' in many of the interviewees' perceptions. Whilst screening in particular 
settings, such as schools, is labelled within the research community as 'non-medical', 
ccommunity' or 'nonclinic-based', interviewees in this study perceived the study settings 
as non-medical. Factors such as the appearance of the researcher, as well as the fact that 
the screening was offered in 'less formal settings' - foyers, canteens and 'chill-out zones' - 
contributed to many male interviewees' perceptions that the screening was non-medical. 
Whilst the feasibility study by Fenton et al (2001) for the Natsal 2000 found that some 
respondents would have preferred to be asked for a urine sample by a medical professional, 
this was not as strongly emphasised by men and women during interviews in this study, 
especially not from men. For many of these young men the fact that the author was 
perceived as 'an ordinary person' - in other words, I was not perceived as being a medical 
authority figure - was a positive influence on their willingness to accept screening: 
11 ... 
I COSY011frej . ust like its. Youre not trying to be like above its or anything, which 
a lot of, I suppose doctors and whatever, what have you do... " [Respondents' 
emphasis] 
(Interviewee #311, Male, Age 20, Workplace). 
Treatment of those testing positive for chlarnydia 
Five respondents who provided a sample received a positive result. The prevalence of 
infection in this study was 4.4% (4.9% in men; 3.8% in women). Feedback from the GUM 
clinic, with whom the author had arranged for treatment of any positive respondent, 
confin-ned the successful treatment and partner notification for four of the five positive 
respondents. One male respondent had not attended the GUM clinic, although contact was 
made with this individual on three separate occasions during which a Health Adviser 
engaged in conversation with the individual to arrange treatment. The Health Adviser 
informed the author during subsequent communication that standard clinic protocols had 
been followed and therefore suggested that the author need not follow this individual up. 
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Summary 
This study screened 113 (32.3%) young men and women who were approached in non- 
medical settings. Forty per cent of men compared with 25% of women were willing to be 
screened in these settings. Furthermore, men in each setting were more willing to provide 
a sample than women. However, it was apparent that women had been presented with 
screening opportunities more than men prior to this study, as around one third of women 
compared with I in 10 men reported prior experience of being tested. The majority of men 
who gave a sample for testing in this study had never been screened or tested for 
chlamydia. before participating in this study. This non-medical approach to screening was 
therefore successful in reaching young men, especially those in health-related settings of 
whom 60% provided a sample. Furthermore, men reported more high risk behaviours than 
women; therefore, many of the young men who were willing to participate in screening are 
exactly the group of young men the Chief Medical Officer's Expert Advisory Group 
recommended reaching via 'innovative' screening approaches. 
Despite many women reporting prior experience of chlamydia screening before taking part 
in this study, the majority of women had never been tested before but were less willing to 
provide a sample than men. It stands that this non-medical approach to screening was less 
successfid in reaching young women. Barriers for women included beliefs regarding 
stigma which negatively affected their willingness to provide a sample in these public 
settings, which is similar to findings from research with women who were screened in 
clinical settings (Blake et al. 2003b; Darroch et al. 2003; Duncan et al. 2001b). In 
addition, and in keeping with other research, many women also had a low perception of 
risk, which was entwined with emotions about relationship status and the view that their 
sexual history did not put them at risk (Santer et al. 2003). Many women also considered 
medical settings more appropriate in which to offer screening and therefore did not 
consider screening in the non-medical settings appropriate for them. 
For young men, providing a sample in nonclinic settings was easy and convenient for 
them. The non-medical nature of the approach also appealed to many who were reluctant 
to attend clinics. Few raised concerns regarding the confidentiality of the test result and 
fewer men were concerned about the stigma of being tested for a STI than women. Many 
were enthusiastic to learn more about chlamydia and often engaged the author in lively 
conversation to obtain information. Young men's willingness to accept the offer of 
screening in public settings combined with their views in support of non-medical 
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screening, to particular groups, challenges notions that men are difficult to engage in 
sexual health screening or hold avoidant attitudes towards their sexual health (Darroch et 
al. 2003). 
The views of men and women regarding the acceptability of non-medical screening were 
similar in a variety of ways. Both men and women believed screening in non-medical 
settings would be appropriate if targeted at particular groups: those who 'would', those 
who 'should'. Furthermore, health related settings such as gyms and pharmacies were also 
considered appropriate settings in which to offer screening as they were considered logical 
extensions of medical settings. Both men and women recommended that young people be 
provided w ith more information about the symptomless nature of chlamydia as well as 
suggested increasing the availability of screening. Although few men could suggest non- 
medical settings they considered inappropriate in which to offer screening, some believed 
'there are limits'. 
The next chapter draws together the findings from this study to address the research 
questions. The discussion of the results is placed in the context of the current screening 
debates regarding how best to screen, where best to screen and to whom screening should 
be offered. 
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Chapter 7 
Discussion 
The preceding chapters have described the feasibility of establishing chlamydia screening 
in non-medical settings as well as men and women's views towards screening. They have 
also outlined young men and women's knowledge about chlarnydia and their willingness to 
accept the offer of screening as part of this study. This chapter draws together these 
findings by assessing the aims of the study and providing a summary and interpretation of 
the results. The chapter is in four parts: the first three address the three main aims of the 
study, whilst the fourth concludes by considering the limitations of the study, and also 
implications for policy and future research. 
The feasibility of establishing chlarnydia screening in 
three non-medical settings 
This study assessed how feasible it was to establish chlamydia screening in various non- 
medical settings: education, health and fitness and workplace. Gaining access to settings 
in which to establish chlamydia screening is a specific concern to screening approaches 
that involve non-medical settings, since clinic control efforts have not needed to address 
issues of access to sites and instead rely on persons self-referring or being referred from 
primary care. However, there is increasing interest in going 'beyond the clinic' if we are to 
make inroads to combating current levels of chlamydia infection. It is therefore 
encouraging that access to the three non-medical settings in this study was relatively 
straightforward. Access was granted to settings in which there is no tradition of a screening 
service, in which 'gatekeepers' and managers had little knowledge of chlamydia, and also 
to whom limited information about chlamydia was given. The subsequent encouragement 
and continued support from staff at each setting is suggestive of their positive attitudes 
towards screening being offered in their settings. Though it is uncertain how generalisable 
these findings are to other non-medical settings, nevertheless, the support offered from 
seven non-medical settings approached for this study (including the pilot) raises the 
possibility that support exists in the wider community for chlamydia screening initiatives 
to be introduced into their environments. 
Whilst accessing non-medical settings is an important aspect of the feasibility of this 
approach to screening, the review of screening studies in Chapter 2 revealed the 
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importance of setting-specific issues as well as participation rates, the success of notifying 
infected persons their results and them receiving treatment as being key issues affecting the 
feasibility and ultimately the effectiveness of non-medical screening approaches. These 
issues are less commonly cited in studies within clinic-based settings, as there is a different 
infrastructure in place, such as contact information for patients. The ease with which the 
test was administered, results communicated, and respondents who tested positive were 
treated, was assessed in this study. 
The introduction of non-invasive tests for chlamydia has made possible innovative 
strategies for chlamydia screening. The urine test was easy to administer and all 
respondents who gave a sample were successfully contacted with their results. Obtaining 
contact infori-nation at the same time as the sample has been recommended in the literature 
(Debattista et al. 2002c). All respondents in this study who provided a sample for testing 
were asked to provide two forms of contact and make clear which they preferred. When 
offered this choice of contact method, men and women overwhelmingly chose to be 
notified via text message: 95% chose to be informed by text message. The others chose e- 
mail or letter. Obtaining mobile telephone contact information allowed for easy, rapid 
follow-up of infected individuals. No individual raised the issue of confidentiality about 
receiving his or her result, perhaps due to the large number requesting contact via a 
personal mobile telephone, which facilitates privacy. 
The usefulness of offering a choice of contact method, and more specifically, the utility of 
text messaging results to young people, has also been noted in the literature. When a 
sexual health clinic in inner London introduced a text messaging service for 6 months to 
convey results of chlamydia tests, it was discovered that this reduced the median time to 
treatment as well as saving a total of 46 hours of staff time (Menon-Johansson et al. 2006). 
The clinic concluded that the text messaging service saved time and money for staff, 
reduced the risk of "missed" results and reduced waiting times for diagnosis and treatment. 
Some sites, as part of the Department of Health's phased rollout programme for 
opportunistic chlamydia screening in England, have also introduced text message results 
for those with a negative result. In Glasgow, the Sandyford Initiative (a large sexual health 
service) launched a pilot service in November 2004 sending "all clear" results to patients 
via text messages to their mobile phones, thus reducing pressure on frontline staff and 
casing the anxiety of patients who are waiting to hear their outcomes. There is therefore a 
move towards developing services that 'fit' with young people's current lives, and tailor 
the delivery of results in a way that is accessible and convenient as well as confidential. In 
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this study 100% of respondents who provided a sample were successfully contacted and 
notified of their test result. As such, the choice of contact method and obtaining it at the 
time the sample is provided is a crucial part of the screening process and will facilitate the 
prompt treatment of persons testing positive with chlamydia infection. 
Whilst this study has shown that offering screening, communicating results and treatment 
were feasible and undertaken successftilly, another important aspect to feasibility of this 
screening approach lies with its success at reaching young men and women to whom 
clinic-control efforts are not currently reaching. This study was successftil in bringing 
young men into screening - 93% of whom reported in their survey responses that they had 
not been tested before. In contrast, more young women who provided a sample reported 
having previously screened for chlamydia (33%). Furthermore, men in this study reported 
higher-risk sexual behaviour than women; therefore, at-risk young men who had never 
been screened or tested before were reached via this approach. The CMO's Expert 
Advisory Group acknowledged the potential difficulties accessing young men to offer 
screening (Chief Medical Officer's Expert Advisory Group 1998b). It is a strength of this 
approach to screening that many young men who may not have previously been screened 
for chlamydia before were reached. 
Aside from the clinical benefits of case identification, offering screening in non-medical 
settings can serve as a vehicle for health promotion, education and the fostering of 
collaboration between key community stakeholders, such as FE colleges, workplaces and 
GUM clinics. In particular, this approach offered young people the opportunity to become 
aware about chlamydia and the testing method in a familiar and convenient setting. 
What young people know about chlarnydia and their 
views and attitudes towards screening in community 
settings 
This study was designed to elicit men and women's views towards non-medical chlamydia 
screening. Views towards the offer of screening may act as motivators or barriers to the 
effectiveness of any non-medical screening approach. In addition, given the paucity of 
evidence on young men's views about screening, the findings from this study are important 
because the views of young men were explored in comparison to those of young women. 
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Survey responses showed a high level of awareness of chlarnydia in this study population, 
with 93% reporting they had heard of chlamydia. Nevertheless, whilst awareness was 
high, knowledge decreased as survey questions became increasingly focussed, so that 75% 
of men and 40% of women were not aware that there may be no symptoms associated with 
the infection and less than half of all respondents knew that chlamydia might cause an 
unusual discharge in women and men, a common symptom in both sexes. Further, male 
interviewees in this study, more often than females, discussed their surprise at learning of 
the asymptornatic nature of chlamydia infection. There was a common belief among many 
of the young men interviewed that symptoms would manifest in those with a STI. This has 
also been reported elsewhere in the literature (Garside et al. 2001; Mason 2005). The 
qualitative data validated the high awareness yet poor knowledge finding, with many 
interviewees claiming to have heard about chlamydia prior to participating in this study, 
although equally, many were unable to state with certainty much more about it. 
It is possible that the high level of awareness of chlamydia among respondents was due to 
the infon-nation contained within the study literature (leaflets and posters). All 
respondents, when initially approached, were informed about chlarnydia and given an 
infon-nation leaflet to read prior to giving consent to participate in the study. The study 
leaflet provided basic infon-nation about chlarnydia, including that it is a sexually 
transmitted infection. Furthermore, prior to and throughout the study, there were 
information posters around the study venues, which also provided basic information about 
chlarnydia. It is therefore possible that respondents may have affin-ned their awareness of 
chlarnydia prior to participation in the study based on the information they had obtained 
from this literature. As such, both the consent procedures and the advertising of the study 
on venue posters may have biased the response to this questionnaire item in favour of a 
high awareness of chlarnydia. 
The high awareness of chlamydia in this study population is in contrast to the findings of 
previous studies. In one study 51% of men and 60% of women had heard of chlamydia 
(Devonshire et al. 1999); whilst in another 60% of women had heard of chlarnydia 
(Kellock et al. 1999). The participants in these studies were GUM clinic attendees, 
therefore, findings might not be generalisable to the general population. This study 
involved users of public non-medical settings (except the workplace settings) and although 
the sample was a convenience one, which may have resulted in a bias towards those with 
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more awareness participating, nevertheless, the results may be a more useful reflection of 
young men and women who do not attend healthcare settings. 
Low levels of knowledge about the largely asymptomatic nature of chlarnydia have 
implications for clinic-control efforts, which rely on people self-referring to be tested for 
STIs. In the absence of symptoms, combined with a poor knowledge of the fact that 
chlamydia is often symptomless, young at-risk people might not seek health care in 
specialist settings, or might delay in seeking care. Whilst offering screening in non- 
medical settings could be one way of reaching at-risk asymptomatic populations, it could 
also raise awareness of the lack of symptoms associated with chlainydia infection and 
therefore encourage the uptake of testing. This has been found in some recent research 
with college students in the UK (Hay et al. 2004; Low et al. 2003; McClean et al. 2000). 
McClean et al found that uptake of testing sharply declined when 'information-giving' 
ceased in the college. 
The commonest survey response to the item regarding men and women's source of 
knowledge about chlamydia was 'school/teacher'. Women tended to reported sources that 
men infrequently or do not use, such as doctor/nurse and magazines. This may be 
explained by females accessing primary care more than males (for example, for 
contraception and smear tests) and therefore being exposed to health topics and 
information. Indeed, I in 10 survey respondents, most of whom were men, reported that 
they first heard about chlamydia from their exposure to literature as part of this study, or 
else during conversations with the author. Thus, there would appear to be an information 
gap for young men, which is not currently being filled. The poorer knowledge of 
chlainydia among men suggests that ways in which to deliver information to young men 
are required. It is therefore encouraging that many young men in this study welcomed 
receiving information about chlamydia, with many willing to engage in lively 
conversations with the author to obtain sexual health information. This suggests that 
sexual health information can be delivered to young men. However, perhaps the results of 
this study also reflect a desire among men to receive information in culturally appropriate 
ways that 'fits' with the realities of their lives. 
More research on how best to deliver information on STIs to young men could be of 
benefit to control strategies. If knowledge of chlamydia is increased, this may result in an 
increase in care-seeking behaviour. However, it is important to recognise that knowledge 
is only one prerequisite for effective disease prevention. Furthermore, how far information 
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affects behaviour change remains uncertain. Nevertheless, the implications of poor 
knowledge for disease control are significant unless there is an improvement in young 
people's understanding of this infection. Furthermore, poor knowledge works against 
notions of choice, which is so important in the New Labour modernising agenda for health 
care: persons have choice when they also retain knowledge. Condorcet, an eighteenth 
century French philosopher, trusted in people to have the ability to make correct decisions 
about their personal lives and society at large, if they are enabled to do so (Correa & Parker 
2004). Knowledge, therefore, may be an important barrier to the utility of any screening 
approach - medical or non-medical - as it could limit young people's ability to make 
informed choices about their sexual health. 
This study also found barriers to the uptake of screening in non-medical settings in the 
views of young people towards the appropriateness of this screening approach. Whilst 
knowledge is one important prerequisite for effective disease prevention, views towards 
chlamydia screening among the target population is also an important factor that warrants 
investigation because of the implications to the uptake of screening, as well as the delivery 
of services to take account of these attitudes. Whilst respondents from all three settings 
considered the education setting to be acceptable, both the health and fitness respondents 
and workplace respondents favoured their own setting more than others. This suggests that 
once screening in established, it has a positive effect on young people's views towards the 
acceptability of screening. Furthermore, this finding also suggests that it may be 
important to obtain the views of men and women who have experienced screening 
opportunities in non-medical settings, rather than their views towards a hypothetical 
situation, as some telephone surveys have done (Ford et al. 2002; Ford et al. 2004a). Boag 
and Kelly (1998) have argued that knowledge of chlamydia assumes greater importance 
once a screening programme is initiated; perhaps this may also be true for views towards 
the acceptability of screening in non-medical settings. 
When asked about a broad range of screening opportunities, there was a high level of 
acceptability towards screening being offered in medical settings among both women and 
men. However, views towards screening being acceptable in non-medical settings were 
highest among males, with them considering non-medical settings, such as gyms, pubs and 
clubs, more acceptable than females. During interviews, three themes emerged relating to 
the setting and acceptability of chlamydia screening: first, a setting was seen to be 
appropriate if it was one where chlamydia screening could target those 'perceived' to be at 
risk of having chlamydia (i. e. those who 'should' be screened); second, and related, a 
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setting was appropriate if chlamydia screening would target those who are health conscious 
(i. e. those who 'would' do it); and third, if the setting is one where discussing health is 
appropriate to the setting (i. e. pharmacies and gyms). Views towards the acceptability of 
settings in which chlamydia screening could be offered therefore centered almost solely on 
considerations of the characteristics of the target screening population, rather than on 
notions of the practicalities of establishing screening in such settings. 
There is clearly a need to address the myths that persist around STIs, for example, that only 
cpromiscuous' young people are at-risk of acquiring chlamydia. The majority of men and 
women who refused the offer of screening in this study believed they were not at-risk of 
having chlamydia. A significant majority of those persons reported being in a relationship 
as the reason why they did not consider themselves to be at risk. Many of these 'serial 
monogamists', who during interviews reported they ceased condom use after a short-time 
with each sexual partner, failed to understand their risk of acquiring chlamydia as a result 
of their non-use of barrier protection. 
A number of barriers to accessing clinical settings for the purpose of STI screening has 
been identified in the literature, such as how confidentiality is dealt with (Burack 2000), 
being offered a choice of gender of staff (Armitage et al. 2004), stigma associated with 
GUM clinic attendance (Cunningham et al. 2002; Fortenberry et al. 2002; Scoular et al. 
2001b) and poor knowledge of GUM clinic locations (Garside et al. 2001). Such barriers 
to accessing clinical settings could be significant enough to limit the effectiveness of 
clinic-control efforts. Barriers, and also supports, to access may be specific to the 
screening approach; the findings of this study suggest this may be the case. 
More women identified the public nature of the non-medical screening as a barrier to both 
their views towards acceptability but also willingness to be screened. However, even for 
these women, as well as among many men, there was a view that the more widely available 
screening becomes the more young people would have access to services, increase their 
knowledge and change their behaviours. The view that screening should be made more 
available mirrors a view which underpinned the recent White Paper 'Our Health, 0111- 
Care, Our Say', which emphasises the expansion of community health services 
(Department of Health 2006). 
Although women spoke of the stigma of having a test for a STI in a public place, 
nonetheless, many spoke of the potential for screening in non-medical settings to 
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(normalise' screening, to make it increasingly visible so that it is not 'hidden' behind 
clinical walls. Young men's views reflected these. That men's views were more accepting 
of non-medical screening than women's suggests that there is the potential for men to be 
included, and even targeted, for screening in these public environments which may 
challenge notions that chlamydia is a 'woman's disease', as I in 10 respondents believed. 
If men are seen to be targeted for screening, and are willing to engage with the offer, then 
there is potential for the stigma that women spoke about to decline with time. Non- 
medical screening could therefore lead to a 'de-stigmatising' of screening, if it were made 
more widely available. 
These men and women's views were based upon their experience of being approached in 
non-medical settings and offered screening, which is typically conducted in medical 
settings. Thus, new environments were created in canteens, foyers and 'chill-out zones'. 
How young men and women feel about being approached in non-medical settings, for the 
purpose of screening, has been little reported in the literature. As such, this study has 
painted an important portrait of the views towards being offered screening in these 'new 
environments'. 
Willingness of young men and women to be screened for 
chlarnydia in community settings 
One third of all persons approached and whom participated in the study by completing a 
survey were subsequently willing to provide a sample of urine in non-medical settings. 
The success of non-clinical screening is achieved by identifying infections and reaching 
populations that would not otherwise receive screening opportunities. In this study three 
quarters of men and women reported having never been previously screened for 
chlamydia, which suggests that young people who use these non-medical settings consist a 
population to target screening towards. More men than women had never been screened 
before participating in this study. There was also a greater willingness among men than 
women to be screened in non-medical settings. This study was therefore successful in 
reaching people who had no experience of testing or screening and who might not 
otherwise have received the opportunity to be screened. Improving providers' practices 
could significantly increase chlamydia screening for women in clinical settings, under the 
SIGN recommendations for opportunistic screening. Meanwhile, screening in non-medical 
settings could fill the gap in providing these services in populations who do not access 
Karen Lorimer, 2006 Chapter 7,185 
care, and among those who do access care but may require more frequent screening 
because of higher risk. 
Men were consistently more willing than women to provide a sample in each study setting, 
with the highest uptake in the health-related settings. The uptake in health-related settings 
of 60% is comparable with research conducted in a university sports arena, whereby 60% 
of male respondents participated in screening (Powell et al. 2005). Being male, aged 20-24 
years and a user of health and fitness settings were factors (in the quantitative analysis) 
significantly associated with the decision to provide a sample. Older male respondents in 
this study reported more lifetime sexual partners and more partners in the past six months 
than their female peers. It was this group of men who were the most willing to provide a 
sample. Given the reported risk behaviour among these men, it is therefore encouraging 
that the majority who gave a sample also perceived themselves to be at risk of having 
chlamydia. These findings suggests that men did not necessarily hold avoidant attitudes 
towards their sexual health, as has previously been suggested (Darroch et al. 2003). Men 
were willing to engage with screening and perceived themselves to be at risk. It may 
however be that non-medical approaches to screening will be more successful in reaching 
male populations, since fewer women who had not been tested for chlamydia before then 
gave a sample. 
Various barriers and supports to women's willingness to be screened for chlamydia were 
identified in this study. For many women, the public nature of the screening was 
associated with stigma. Women's beliefs negatively affected their willingness to provide a 
sample in non-medical settings. Women often reported a preference for screening to be 
offered in medical settings, predicated upon their belief that this setting offered a more 
confidential and private environment. Clearly, women were uncomfortable being invited 
into these 'new environments', which bridge health and social worlds. For women, 
medical settings are more acceptable in which to offer chlamydia screening as they offer 
anonymity and also confidentiality of seeking testing. There is the potential to reduce 
stigma for women by increasing screening in men, especially in public non-medical 
settings. If more men are seen to be offered and then engaging with screening then it is 
possible for screening to become 'normalised'. The effects of this could be to challenge 
notions that chlamydia is a 'women's disease', as one in ten respondents believed. 
It is clear that offering screening for chlarnydia in public, social settings does not 
necessarily reduce stigma-associated barriers to uptake for many women. A greater 
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availability of screening in non-medical settings could normalise screening and thereby 
reduce stigma for women. Non-medical settings are not traditionally associated with STI 
screening and this study has shown that there are setting-specific barriers to women's 
willingness to be screened in them. Thus, it is important to continue to consider the 
gendered impact of these new screening environments to assess whether they will have an 
effect on reducing stigma for women. 
In contrast to women's views, few men discussed the public nature of screening and being 
embarrassed to accept screening in the study settings. Men's concerns regarding non- 
medical screening were less than those of attending GUM clinics for the purpose of 
screening. Many men perceived the screening in this study as being 'non-medical', in that 
the author was viewed as an 'ordinary person'; in other words, not a medical authority 
figure. This finding is in contrast to that of a chlamydia screening feasibility study for the 
second Natsal study, which found that many respondents preferred to be asked for a urine 
sample by a medical professional (Fenton et al. 2001 a). 
Key differences included the degree of awareness about chlamydia, which enabled or 
inhibited further discussion during the approach, and the interaction with peers suggests 
the social envirom-nent, with its associated gender norms, impacts on the feasibility of a 
non-medical approach. Indeed, as part of the continuing investigation and evaluation of 
non-medical approaches, an evaluation of the 'new environments' that will be created is 
necessary to be able to fully assess the unique barriers and supports to screening in such 
settings as well as the effects these 'new cnvironments' have upon the target groups for 
screening. Establishing screening in social and public areas creates a new environment as 
it combines both health and social worlds. As Engebretson et al (2005) suggest: 
'These new spaces may contribute to a paradoxical experience for the 
participants ... Situated in this manner, the health screening participant in a public 
setting has one foot in the world of the health care arena and another in the social 
world of friends who accompany that person. ' 
(Engebretson et A 2005). 
The context, impact of gender and access to non-medical settings to establish screening 
requires further investigation to strengthen our understanding of how effective nonclinic- 
based screening is as part of control strategies to reduce the prevalence of chlamydia 
infection in the population. 
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Limitations 
Different limitations to this study must be considered in the interpretation of the results. 
The one-person approach used in this study to offer screening meant that there were young 
men and women who used the setting but were not offered screening. In the health and 
fitness settings, for example, there was often a high volume of age-eligible young people 
accessing the setting at particular times (for exercise classes or to play football). The time 
taken to engage with young people and ensure informed consent meant that opportunities 
to invite other young men and women were missed. The degree of effectiveness of this 
approach to reach a variety of young people is therefore uncertain. Whilst the majority 
(63%) of young people who provided samples in this study considered themselves to be at 
risk of having chlarnydia, it is possible that those who were willing to be approached and 
to provide a sample did so by virtue of the fact that they considered themselves to be at risk 
of having chlamydia. As such, it is possible that it is not only clinic-control efforts that 
might miss people. Essentially, there may be some people who do not wish to be screened 
regardless of how or where the offer of screening is made. 
The one-person approach created 'missed opportunities' for engaging with men and 
women. The convenience sampling procedure might have introduced bias into the study. 
For example, it is possible that on some occasions, the author might have unintentionally 
approached 'fhendly' and approachable young people who could have different 
characteristics to an unapproachable population. The author was aware not to introduce 
such bias into the study: there were many occasions when the author was present in 
settings with either no setting users or persons were over 25 years, therefore, attempts were 
made to approach all age-eligible setting users possible in the time available. 
A further limitation stems from the use of the convenience sampling: the participants were 
not chosen randomly and it was impossible to verify their representativeness. Thus, a 
selection bias may have occurred. The reliability of answers to survey questions is also an 
important factor to consider. Recall and social desirability biases may have been involved 
in responses to questionnaire items; however, the latter may have been reduced since the 
questionnaire was self-administered and anonymous. Despite these methodological 
limitations, this study was able to obtain the views and attitudes of young men and women 
towards chlamydia screening in community settings. More research on men's views has 
been advocated by many commentators (Bellis et al. 2000; Fenton 2000; Hart et al. 2002). 
The results of this study will contribute to the evidence base, which is sparse in qualitative 
data from young men. 
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Implications of findings on policy and recommendations 
for future research 
The current study was not commissioned research and therefore not intimately bound up 
with a policy process making recommendations for service provision for young people. It 
was, however, a response to policy urgency: how best to offer 'innovative' approaches to 
chlamydia screening that will reach at-risk young people (Department of Health 2001b). 
The study was too small in scale to base national policy on the findings, yet there are 
important questions to be asked about the way in which the project was established and 
run, and its findings. On the back of the findings of this study there are various 
recommendations for non-medical chlamydia screening, which can be grouped into t-wo 
major themes: staff training and service design. 
The role of the researcher 
Offering screening in non-medical settings was the core of this study and as a result, the 
researcher spent a considerable amount of time in each of the settings, setting up her stall 
and being available for the young men and women to approach her, as well as approaching 
young people who passed through the study area. A time of - 230 hours was taken to 
recruit 363 young men and women into the study. The amount of time it took to attract the 
sample is not replicable in routine health service delivery, and thus the strictly research 
focus of the study needs to be acknowledged. 
This study has highlighted the importance of the role of the individual implementing non- 
medical screening. The approach of the researcher in this study, as described in the 
previous chapters, affected both the uptake of screening and ultimately the feasibility of 
this approach to screening. The ways in which uptake was affected were related to the 
adaptability of the researcher, the way in which she personally encouraged people to take 
part in screening, as well as her style of dress and the manner with which young people 
were addressed. As the study progressed the researcher tried out different fortus of 
approach and became highly successful at encouraging the young people to take part in the 
study. Evidence of the author's success is the high uptake of screening by men in this study 
- the highest in any non-medical (non-postal) approach. The limitation, however, is that 
the response to a particular approach may not be easily replicated if it is rolled out. 
Karen Lorimer, 2006 Chapter 7,189 
If this approach to screening is more widely introduced, there could be problems 
replicating the above findings: others may be less successful in engaging young men and 
women in the process of non-medical screening. The implications are therefore that uptake 
may not be as high in subsequent interventions. One way to combat this may be to place 
an emphasis within staff training on some of the key factors this study found to be 
associated with achieving a high willingness among young people to be screened for 
chlamydia in non-medical settings. Firstly, there has to be an awareness of gendered 
responses; the researcher found that men and women reacted well to different forms of 
encouragement to take part in the study. Young men responded particularly well to the use 
of humour or a more light-hearted initial approach. Many men appeared reluctant when a 
more fact-based approach was used, with the researcher describing the study in a matter of 
fact way and with a neutral manner. In contrast, women responded better to being 
approached in a more serious manner. The use of humour as a general approach to 
encouraging male participation is not a new finding: the Men's Health Forum conducted 
focus group research in Phase I of their research into the feasibility of introducing 
chlamydia postal testing kits in workplaces for testing men (Wilkins 2005); the outcome of 
their research was the use of the tag line 'Put yer tackle to the test' over a close up image 
of a man's crotch area in jeans. As a result, their postal testing approach reached more 
men than women (80% were men) as compared with Healthy Respect (where 17% of 
testers were men) (Wilkins 2005; Williamson et al. 2006). In addition, evidence from non- 
medical screening of the client group men who have sex with men also found the use of 
humour encouraged uptake in screening (Debattista et al. 2002a). 
Secondly, adaptability is key to the success of getting young people involved in screening; 
the need to try out different approaches and see what worked. The researcher developed a 
sensitivity as to how young men and women responded in the different settings and what 
they would find appropriate. Some things did not appear to work (for example, asking 
young people if they were sexually active at the time of the initial approach was not well 
received, especially by young women) and were abandoned early on. Thus, with training 
and careful selection of those involved in offering screening (paying attention to age, 
manner and ability to be adaptable), the successful uptake of this approach perhaps could 
be replicated. 
Service design 
The positive views that young people in this study held towards non-medical screening 
included an appreciation of the convenience of the offer, the non-medical nature *of the 
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approach (including the non-medical dress, the non-clinical language and manner of the 
person offering screening), and being offered information on chlamydia and opportunities 
to receive condoms. These factors encouraged participation in screening and are worth 
bearing in mind in the design of any future non-medical screening approach. At the same 
time more women than men reported disliking the public nature of the setting and the 
perceived stigma of being seen in public settings to want an STI test was too great for 
some women to agree to participate in screening and resulted in fewer women providing a 
sample for testing than men. Women already have other venues in which they attend and 
are more likely to be offered screening (for example, general practice and family planning 
settings), and indeed a greater proportion of the women in the sample had already been 
screened for chlamydia than the men. Thus although the involvement of women in this 
study suggests that some will find non-medical settings acceptable, it may be that men, 
who have fewer other options in the community in which to be screened, may benefit more 
from a non-medical approach to screening. The success of the approach used in this study 
is in keeping with the findings from Healthy Respect, which had greater success in 
reaching young men through the innovative postal testing kits than women (Williamson et 
al. 2006). Thus, there may be elements of this approach which can be generalisable to any 
future innovative screening initiatives or interventions. 
It is important to bear in mind that improving service provision for young people is not just 
about improving individual services for individual users, important as that is, but should 
involve whole communities, as poor sexual health is not just a property of an individual but 
needs to be understood in a systematic manner. For instance, in addition to individual 
factors, social factors such as ethnicity, gender and social deprivation are known to play a 
major role in the risk of acquiring a sexually transmitted infection (Bonell et al. 2003; 
Cohen et al. 2000; Leishman 2004; MacDowall et al. 2002; McCulloch 2001; McLeod 
2001; Scottish Executive 2003c). Whilst this study did not seek to obtain such 
information, there is an increasing evidence-based upon which findings from current work 
should acknowledge. The findings of this study, that men may be better reached through 
'innovative' approaches to screening, that there is a gendered response and that the 
researcher can play a pivotal role in engaging young people in screening, suggests social 
factors are important in the delivery of STI screening services. Young people, especially 
men, are not necessarily as 'hard to reach' as some policy documents suggest (Chief 
Medical Officer's Expert Advisory Group 1998b; SIGN 2000), as 'innovative' approaches 
are reaching many men and women and including them in screening opportunities. 
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Opportunities that reflect the social and cultural backdrop may therefore prove effective in 
the longer-ten-n. 
Further research is required on how best to establish screening in non-med settings. 
Should such an approach involve a health adviser from GUM offer screening, should 
treatment be offered in the settings and how frequently should screening be offered from 
within non-medical settings are some of the questions that require further evidence before 
non-medical approaches can be championed as effective for disease control. Such research 
could also include further investigation of the feasibility of offering screening in other non- 
medical settings, such as schools. School settings have been used in American-based 
studies and have proved feasible as well as advantageous as they have detected high 
positivity rates (Cohen et al. 1999). Detecting infections early so that fertility problems are 
tackled early could be an important approach to controlling both infections and their 
associated complications, which are costly to the NES. Feasibility work on the 
acceptability and uptake of screening in schools is therefore necessary. 
The majority of the studies reported in the literature have used only one approach to 
offering chlamydia screening. There is also a need to consider more integration of services 
and approaches: screening being offered in non-medical settings alongside the availability 
of internet postal approaches, postal testing kits on site and health adviser sessions to offer 
a ftill sexual health check, counseling and treatment. If young people want their service to 
be as convenient as possible then perhaps offering a choice of screening in one setting 
would be a possible direction of future screening approaches. Offering young people a 
choice of receiving results via text message would also be part of offering a convenient and 
culturally appropriate service. As noted earlier, text messaging results has resulted in a 
reduction in staff hours, the interval between notification and treatment and 'missed' 
results. 
Conclusion 
Clinic-control strategies currently miss many infected, at-risk persons. Strategies for 
reaching these groups could include establishing screening in non-medical settings. Such 
an approach could be one way in which to involve young men in screening and women 
who might not otherwise be offered screening opportunistically in healthcare settings. 
This study showed that it is feasible to offer screening from a variety of non-medical 
settings. This approach identified infections and was acceptable to many men and women. 
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The willingness of young people in this study, especially young men, to produce urine 
samples in less than completely private circumstances, is a good example of the potential 
for the development of mutual trust between screening personnel and the target community 
population. The variability in uptake in screening across the study settings suggests there 
exists a complexity of motivators to willingness to accept screening in non-medical 
settings. Self-care orientations, as well as accessibility and social influences were 
important motivators associated with willingness to be screened for chlamydia in this 
study. Thus, improving access to sexual health services may not be the only consideration 
of improving the uptake of screening among young people; an acknowledgement of, and 
further assessment of, the variety of individual and wider social factors associated with 
care-seeking behaviour is warranted. 
Thus, it is important to continue to assess the best method of establishing chlamydia 
screening in non-medical settings. This is one way to involve young men in chlamydia 
screening, who represent a significant reservoir of infection for women. Young men were 
more willing to be screened in non-medical settings than women in this study. Thus, 
despite the complexities of motivation for care seeking, willingness exists among young 
men. Novel settings may be particularly important when targeting young men, for whom 
traditional health care settings themselves are barriers to accessing testing and treatment 
services. Reducing the prevalence of infection in men is a primary prevention strategy for 
women; as such, increasing screening for men may help reduce the current inequalities 
which exist in chlamydia screening as both sexes will be targeted, thereby reducing the 
burden of responsibility for sexual health on women. 
In Scotland no. chlamydia screening programme is planned. This could be an opportunity 
for the Scottish Health Department to continue to gather evidence before deciding on the 
approach to screening for chlamydia in Scotland. Lessons to be learnt from the English 
model, as well as the evidence from the Swedish experience, could be taken on board when 
planning the strategy for Scotland: men need to be included in screening and screening 
should not be restricted to clinic-based settings. In this way, any proposed Scottish 
strategy for controlling chlamydia will be truly evidence-based and effective. As such, the 
feasibility of screening in non-medical settings requires further investigation and 
evaluation. There is an opportunity in Scotland to develop the most rigorous, evidence- 
based strategy for chlamydia screening in Western Europe. Scotland is in a unique 
position to lead the way in chlamydia control and prevention. 
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Ethics consent and letters to organisations requesting 
access 
[Facility Manager] 
26 March 2004 
Dear [Name] 
I am a doctoral researcher based in the Department of Public Health at the University of Glasgow. 
My research concerns screening young people for Chlanzydia trachonzatis, a sexually transmitted 
infection which is most common among young people and which is often symptomless. Chlamydia is 
causally linked to infertility, which combined with increasing rates of infection, makes screening for 
chlamydia an important public health issue. However, given that only around 10% of infections are 
diagnosed, a significant pool of infections remains in the population. As such, the Scottish Executive 
has recognised the need for innovative chlamydia screening strategies, specifically targeting young 
men outside the traditional clinic setting. My research is concerned to find out appropriate settings in 
which to best offer such screening. I am writing to you, as the Manager of a non-medical community 
setting, to see if you would be willing for me to conduct my study from within your setting. 
As I envisage it, the study would involve: 
" Chatting to users aged 16 to 24 years, informing them about the research and what chlamydia 
is before asking them if they wish to participate in the study; 
" Leaflets have been prepared for participants which detail what chlamydia is as well as the 
nature of their involvement within the study. Participants would sign two copies of a consent 
form (one of which they keep); 
" Participants would be asked to complete a short (anonymous) questionnaire on knowledge of 
chlamydia, attitudes towards screening in non-medical locations and sexual lifestyles; 
" Participants would have the opportunity of being tested for chlamydia by providing a urine 
sample (they may choose NOT to provide a sample and remain in the study); 
" Samples will be sent to the West of Scotland Specialist Virology Centre, Gartnavel Hospital, 
for testing and participants will be informed confidentially of their result; 
" Those testing positive for chlarnydial infection will be referred to a Health Adviser for 
treatment, partner notification and further tests (if required). 
Ethical approval for this study has been granted from the University Faculty of Medicine Ethics 
Committee. The proposed research has therefore been methodically considered in relation to key 
issues, including participant confidentiality and management of those testing positive for chlamydia. 
The study has been rigorously piloted in a youth-oriented centre as well as successfully undertaken in 
a large Further Education college; it is feasible with little disruption to normal activities of the setting. 
Should you require any further information or clarification I am contactable by email and telephone, 
as detailed below. I shall telephone you shortly to discuss the possibility. 
Yours sincerely, 
Karen Lorimer (Ms) 
E-Mail: k. lorimerPclinmed. gla. ac. uk 
Telephone: 0141330 3295 (Direct Line) 
[Facility address] 
18 May 2004 
Dear Mr. [name], 
I am a doctoral researcher based in the Department of Public Health at the University of Glasgow. My 
research concerns screening young people for Chlainydia trachoniatis, a sexually transmitted infection 
which is most common among young people and which is mostly symptomless. Chlamydia is causally 
linked to infertility, which combined with increasing rates of infection, makes screening for chlamydia an 
important public health issue. However, given that only around 10% of infections are diagnosed, a 
significant pool of infections remains in the population. As such, the Scottish Executive has recognised the 
need for innovative chlamydia screening strategies, specifically targeting young men outside the traditional 
clinic setting. Funded by the Chief Scientist Office, my research is concerned to find out appropriate 
settings in which to best offer such screening. I am writing to you, as the Manager of a non-medical 
community setting, to see if you would be willing for me to conduct my study from within your setting. 
[Name], Operational Development Manager within Culture & Leisure Services at Glasgow City Council, 
has approved the study in principle (I am awaiting written confirmation of this). 
As I envisage it, the study would involve: 
Chatting to users aged 16 to 24 years, informing them about the research and what chlamydia is 
before asking them if they wish to participate in the study; 
Leaflets have been prepared for participants which detail what chlamydia is as well as the nature of 
their involvement within the study. Participants would sign two copies of a consent form (one of 
which they keep); 
Participants would be asked to complete a short (anonymous) questionnaire on knowledge of 
chlamydia, attitudes towards screening in non-medical locations and sexual lifestyles; 
Participants would have the opportunity of being tested for chlamydia by providing a urine sample 
(they may choose NOT to provide a sample and remain in the study); 
Samples will be sent to the West of Scotland Specialist Virology Centre, Gartnavel Hospital, for 
testing and participants will be informed confidentially of their result; 
Those testing positive for chlamydial infection will be referred to a Health Adviser for treatment, 
partner notification and further tests (if required). 
Ethical approval for this study has been granted from the University Faculty of Medicine Ethics Committee. 
The proposed research has therefore been methodically considered in relation to key issues, including 
participant confidentiality and management of those testing positive for chlamydia. 
The study has been rigorously piloted in a youth-oriented centre and is feasible with little disruption to 
normal activities of the setting. Should you require any further information or clarification I am contactable 
by email and telephone, as detailed below. I shall telephone you shortly to discuss the possibility. 
Yours sincerely, 
Karen Lorimer (Ms) 
E-Mail: 0009673L(@student. gla. ac. uk 
Telephone: 0141330 3295 (Direct Line) 
[Facility manager] 
25 May 2004 
Dear [Name], 
I am a doctoral researcher based in the Department of Public Health at the University of Glasgow. My 
research concerns screening young people for Chlaniydia trachonzatis, a sexually transmitted infection 
which is most common among young people and which is mostly symptomless. Chlamydia is causally 
linked to infertility, which combined with increasing rates of infection, makes screening for chlamydia an 
important public health issue. However, given that only around 10% of infections are diagnosed, a 
significant pool of infections remains in the population. As such, the Scottish Executive has recognised the 
need for innovative chlamydia screening strategies, specifically targeting young men outside the traditional 
clinic setting. Funded by the Chief Scientist Office, my research is concerned to find out appropriate 
settings in which to best offer such screening. I am writing to you, as the Manager of a non-medical 
community setting, to see if you would be willing for me to conduct my study from within your setting. 
[Name], Operational Development Manager within Culture & Leisure Services at Glasgow City Council, 
has approved the study in principle (I am awaiting written confirmation of this). 
As I envisage it, the study would involve: 
" Chatting to users aged 16 to 24 years, informing them about the research and what chlamydia is 
before asking them if they wish to participate in the study; 
" Leaflets have been prepared for participants which detail what cblamydia is as well as the nature of 
their involvement within the study. Participants would sign two copies of a consent form (one of 
which they keep); 
" Participants would be asked to complete a short (anonymous) questionnaire on knowledge of 
chlamydia, attitudes towards screening in non-medical locations and sexual lifestyles; 
0 Participants would have the opportunity of being tested for chlamydia by providing a urine sample 
(they may choose NOT to provide a sample and remain in the study); 
" Samples will be sent to the West of Scotland Specialist Virology Centre, Gartnavel Hospital, for 
testing and participants will be informed confidentially of their result; 
Those testing positive for cblamydial infection will be referred to a Health Adviser for treatment, 
partner notification and further tests (if required). 
Ethical approval for this study has been granted from the University Faculty of Medicine Ethics Committee. 
The proposed research has therefore been methodically considered in relation to key issues, including 
participant confidentiality and management of those testing positive for chlarnydia. 
The study has been rigorously piloted in a youth-oriented centre and is feasible with little disruption to 
normal activities of the setting. Should you require any further information or clarification I am contactable 
by email and telephone, as detailed below. I shall telephone you shortly to discuss the possibility. 
Yours sincerely, 
Karen Lorimer (Ms) 
E-Mail: 0009673L(cDstudent. gla. ac. uk 
Telephone: 0141330 3295 (Direct Line) 
[Organisation Address] 
14 June 2004 
Dear, 
I am a doctoral researcher based in the Department of Public Health at the University of Glasgow. 
My research concerns screening young people for Chlaniydia trachonzatis, a sexually transmitted 
infection which is most common among young people and wbich is often symptomless. Chlamydia is 
causally linked to infertility, which combined with increasing rates of infection, makes screening for 
chlamydia an important public health issue. However, given that only around 10% of infections are 
diagnosed, a significant pool of infections remains in the population. As such, the Scottish Executive 
has recognised the need for innovative chlamydia screening strategies, specifically targeting young 
men outside the traditional clinic setting - indeed, the Chief Scientist Office (CSO) are funding this 
research. Essentially, I am concerned to find out appropriate settings in which to best offer 
chlamydia screening. I am therefore writing to you, as Manager of a non-medical setting, to see if 
you would be willing for me to conduct my study from within your setting. 
As I envisage it, the study would involve: 
" Chatting to students aged 16 to 24 years, informing them about the research and what 
chlamydia is before asking them if they wish to participate in the study; 
" Leaflets have been prepared for participants which detail what chlamydia is as well as the 
nature of their involvement within the study. Participants would sign two copies of a consent 
form (one of which they keep); 
" Participants would be asked to complete a short (anonymous) questionnaire on knowledge of 
chlamydia, attitudes towards screening in non-medical locations and sexual lifestyles; 
Participants would then have the opportunity of being tested for chlamydia by providing a 
urine sample (they may choose NOT to provide a sample and remain in the study); 
" Samples will be sent to the West of Scotland Specialist Virology Centre, Gartnavel Hospital, 
for testing and participants will be inforined confidentially of their result; 
" Those testing positive for chlamydial infection will be referred to a Health Adviser at the 
Sandyford Initiative for treatment, partner notification and further tests (if required). 
Ethical approval for this study has been granted from the University Faculty of Medicine Ethics 
Committee. The proposed research has therefore been methodically considered in relation to key 
issues, including participant confidentiality and management of those testing positive for chlamydia. 
The study has been rigorously piloted in a youth-oriented centre as well as successfully undertaken in 
a large Further Education college; it is feasible with little disruption to normal activities of the setting. 
Should you require any further information or clarification I am contactable by email and telephone, 
as detailed below. I shall telephone you shortly to discuss the possibility. 
Yours sincerely, 
Karen Lorimer (Ms) 
E-Mail: k. lorimer(@, clinmed. gla. ac. uk 
Telephone: 0141330 3295 (Direct Line) 
Appendix 2 
Study literature: posters, leaflets and consent forms 
Chlamydia: 
The most common, curable UNIVERSITY 
Sexually Transmitted Infection. Of GLASGOW 
Could I be at risk? 
Yes, if you had unprotected sexual intercourse. There may be 
approx. 1 in 10 young people under 25 with this infection. 
Would I know if I had this infection? 
Not always. Approx. 50% of young men and 80% of young 
women who have this infection do not have any symptoms. 
If I don't have symptoms, why should I bother 
getting tested? 
If left untreated, chlamydia can cause long-term problems for 
men and women: men can experience painful swelling of the 
testicles, and women can develop Pelvic inflammatory Disease 
(PID), which can result in fertility problems. 
How can I get tested? 
Chlamydia can be tested on a sample of urine. A study is 
being conducted in this gym, as part of PhD research at 
Glasgow University. The aim is to ask you how you feel about 
being tested and to offer you confidential testin . If you would like to have a test orjust fill in a questionnaire come along 
and speak to Karen. Study starts )000( 
What happens if I have chlarnydia? 
You will be referred to a Health Adviser who will arrange for 
you to be treated. A short course of antibiotics will get rid of 
this infection. 
Your test and all information in this study are confidential. 
Only you will be told your result, no one at this health & 
fitness location will know your result. 
Appendix 3 
Chlamydia: 
The most common, curable 
Sexually Transmitted Infection 
Could I be at risk? 
Yes, if you've had unprotected sex. 
Approx. I in 10 young people under 25 
have this infection. 
Would I know if I had this infection? 
Not always. Approx 50% of young men 
and 80% of young women will have no 
symptoms. You can "t tell by looki 
How can I get tested? 
Chlamydia can be tested on a sample of 
urine. A study is being conducted in this 
college to see how willing people are to 
be tested for chlamydia at this college. 
If you would like 
Karen. 
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CONSENT FORM UNIVERSITY 
Of 
GIASGOW 
PLEASE RETURN THIS FORM 
Chlamydia study. 
Please read each statement carefully and tick either 'yes' or 'no'. 
Please tick 
YES NO 
1.1 conf irm that I have read and understood the information 
leaf let on chlamydia. 
1: 1 1: 1 
2.1 understand that my participation is voluntary and that I 
am free to withdraw from the study at any time without 
1-1 F-I 
giving a reason. 
3.1 agree to take part in the research. F-I 171 
You may be contacted at some point during the study. Please CHOOsE your 
preferred method of contact: 
1. Telephone (landline or mobile): 
2. Address: 
Postcode 
E-Mail: 
Name of participant (PLEASE PRINT) Date 
KAREN LORIMER 
Name of researcher 
University of Glasgow 
Public Health & Health policy 
Division of Community Based Sciences 
I Lilybank Gardens 
GLASGOW, G128RZ. 01413303295 
(PRINT) bate 
Si! gnature 
Signature 
a 
CONSENT FORM 
13 
UNIVERSITY 
Of 
GIASGOW 
COPY FOR YOU TO KEEP 
Chlamydia study. 
Please read each statement caref ul ly and tick either 'yes' or 'no'. 
Please tick 
YES NO 
1.1 conf irm that I have read and understood the information El 1: 1 leaf let on chlamyclia. 
2.1 understand that my participation is voluntary and that I F] I am f ree to withdraw f rom the study at any time without 
giving a reason. 
3.1 agree to take part in the research. 
Name of participant (PLEASE PRINT) bate Signature 
KAREN LORIMER 
Name of researcher (PRINT) bate Signature 
University of Glasgow 
Public Health & Health policy 
Division of Community Based Sciences 
I Lilybank Gardens 
GLASGOW, G128RZ. 01413303295 
Appendix 3 
Questionnaire and interview guide 
UNIVIERSrrY 
Of 
GLASGOW 
Chlamydia Screening 
Study 
What do young people aged 
16 to 24 think about 
testing for chlamydia in 
non-medical settings. 
For Office Use Only: 
Study No. 
Location: 
Date: 
III "- II 
Part A: About chlamydia... 
IMPOR TANT. - If you haven't had please attempt questions 1-16 
ýjnd on 21. Thanksl questi, 
I Had you heard of chlamydia before this study? 
Yes 
No 
What is chlamydia? 
3 
Ick'anO. 
A blood disorder 1: 1 
A pregnancy complication IJ 
A vitamin Ij 
A sexual infection Ij 
A form of contraception Ij 
Where did you first hear about '(Tick onO -- 
This study 
Friend 
Family member 
t)octor/nur!; e 
Teacher(school) 
Internet 
Magazine 
Television 
Health information leaflet 
Other (please state) 
4 ý How do you rate your knowledge about the following: 
How you get chlamydia 
Symptoms of chlamydic in women 
Symptoms of chlamydia in men 
Medical problems that having 
chlamyclia long-term can cause 
How to test someone for chlamydic 
5a I How can you get chlamydia? 
Excellent Good Fair Poor 
Ij 1: 1 Ij 
Ij Ij Ij 
Ij u U 
Ij Ij ý-Mk 
Ij 1: 1 U Ij 
iiý -, oniq 
Sharing cups 
Kissing 
Toilet seats 
birty needles 
Unsafe sex (no condom) Ij 
Other (Please state) 
5b For those WOMEN who develop symptoms, what ý(You can tick more than One)", 
might they be? 
Unusual discharge 
Pain or stinging when peeing 
Dizziness 
Headache 
Pain during sex 1: 1 
Pain in lower stornach 
Itch and/or rash 
Don't know 
5c For those MEN who develop symptoms, what Vdu cQn'tick'more than one) 
I 
might they be? 
Unusual discharge from tip of penis Ij 
Pain and/or burning when peeing Ij 
Dizziness Ij 
Headache U 
5d 
Pain/swelling in testicles Ij 
Itchiness around groin 
Ij 
Posh Ij 
Don't know U 
Chlamydia may cause problems in women who have it for a long time. 
Do you know what problems? Please state'. 
bon't know 
5e I Chlamydia may cause problems in men who have it for a long time. 
Do you know what problems? Please state: 
Don't know li 
5f How would you be tested for chlamyclia? TA' 
Saliva sample IJ 
Blood sample Ij 
Urine sample Ij 
6 True or False? 
True False Not sure 
- You can catch chlamyclia from toilet seats 
* Men with chlamydia might not have symptoms 
................ 
u 
ýj u 
ýj Ij u 
" Most women will not develop symptoms of chlamydia IJ 
" Only women get chlamydia .................................................................. Ij 
" Chlamydia can of fect men's fertility ............................................. 
Ij 
Chlomydia can affect women's fertility ........................................ 
Ij 
Chlamydia can cause eye infections (conjunctivitis) ............... Ij 
Once you get chlamydia you can't get rid of it .......................... Ij 
You can get chlamydia more than once .......................................... 
J 
Women's smear tests would detect chlamydia ........................... 
'The Pill' prevents sexual infections ............................................... 
Part B -- Testing 
7a When you were approached and asked to take part in a chlamyclia study, 
did you feel embarrassed? 
Not at all embarrassed 
A little embarrassed 
Yes, very embarrassed 
7b 
8 
If you were embarrassed, WHY? 
I get embarrassed quite easy 
I was with people I don't know well 
People were looking at me 
I didn't know anything about Chlamyclia 
Other (Please state) 
ý-mk 
ý: k 
When you were approached and asked to take part in a chlamydia study, 
how willing were you to take part? 
Very willing 
Ij 
Fairly willing U 
Not very willing Ij 
9 You were asked to take part in this research by a woman. 
Would you have preferredto be asked by a man? 
Yes No No preference 
IJ li u 
Not sure 
li 
loa Are other people taking part in this research with you? 
Yes U 
No, I'm by myself just now Go to ques4ion 11 
10b If YES to the lost question: 
Do, you think you would only consider being tested for chlamydia if they would 
too? 
Yes No Maybe Not sure 
ý-Mk 1: 3 [:: 1 1: 1 
11 Thinking about being asked to provide a urine sample in work : 
How far would the following influence you to give a sample 
Strongly 
Influence 
Influence 
a little 
Not 
Sure 
Not really 
influence 
Strongly 
hot influence 
Location of the toilet (in which to 
give a sample) 
How many people are around you at 
the time you are asked 
Whether you could be bothered to 
give a sample at the time 
How much you feel you know about 
chlamyclia Ij U 1= 
How much time you have when you 
are asked to give a sample 
U U 1: 1 [:: k Ij 
Is there anything else not 
mentioned that would inf luence you? 
BF YOU WERE TESTED FOR CHLAMYDIA, would you be worried that 
your sample would be tested for things other than chlomyclia (eg, 
drugs 
... 
)? 
Yes 
No 
Not sure 
Would you be embarrassed to give a urine sample in work? 
Yes, a lot 
Yes, a little 
Not at all 
Don't know 
12 1 bo you consider yourself at risk of having chlamyclia? 
Yes 1: 1 
No 
Maybe 
Not sure 
13 1 Have you ever been tested for chlamydia infection? 
MTH YEAR 
Yes If yes, when 
No 
Not sure 
NB. Chlamydia is tested by providing a sample of urine. This can be done 
anywhere there is a toilet facility. 
14 How acceptable to you personally would it be to test for 
chlamydia, infection in the following settings? 
Very Not very Not 
Acceptable Acceptable Acceptable Acceptable 
Doctors [j 
Family planning clinic 
Termination of pregnancy clinic 
(abortion) 
Boots (chemist) or 5uperdrugs 
Local pharmacies 
Health & Fitness (e. g. gyms) 
Internet cafes Ij U U U 
High school 
CollegelUniversity 
Pubs 
Clubs 
Workplace 
Prison 
Army barracks 
Bookstores (e. g. Borders ... 
) 
15 How far do you agree/&ýeeýwith the following statements? 
, ('Pleas ,e tick one answer for each statement) 
PERSONAL: 
Strongly Not 
I 
Strongly 
Agree Agree Sure Disagree Disagree 
I'd know if I had chlamydia ................................. 
I would worry about pregnancy more than 
sexual infections ........................ 1: 1 U [:: I 
I'd only think about chlamyclia if I had 
symptoms ..................................................................... 
Ij 
I'd feel embarrassed going to a clinic to be 
tested for asexual infection ............................ 
If I caught a sexual infection it wouldn't 
bother me .................................................................. 
GENERAL: 
0 Men should be tested for chlamyclia ............. 
Ij Ij Ij Ij 
Sexual health is more of a woman's concern 
than a man's ............................................................... 
Only doctors (medically trained persons) 
should test people for sexual infections ...... 
Part C: Sexual Lifestyle 
16 
17a 
The following questions ask about your sexual experience. They are important to 
young people's risk of chlamyclia (e. g. condom use and sexual partners)A# your 
answers are IMPORTANT Please try to be as honest as you Thanksl 
Have you ever had sexual intercourse? Yes 
(n. b. Only include pene tra five vaqinal sex). No 6o'to, question, 21 
Altogether, in: ýour life so fa , 
how many people have you had sex with 
(n. b. Pene fra tive vaqinal seA-don't include anal or oral) 
Write the number in your life (so for) F-I 
17b Are you certain of that number? 
Certain [: 3 
I've estimated it li 
l8a How many people have you had sex with in the last 6 month-8 
-. 7 t-; 1 
Write the number none writ! P,, P-..: 
l8b Thinking about your three most recent sexual partners, please state your condom use with 
each; 
Yes, always 
Most of the timc 
Some of the time 
Parel) 
1. Most recent 
sexual partner 
[:: I 
Never 1: 1 
2. One before 
that 
u 
u 
3. One before 
that 
19a 
19b 
19C 
How old were you when you first had sex? 
Wrife age in years 
Did you use a condom this first time? 
Yes Ij 
No Ij 
The person you had sex with MOST RECENTLY, are you now or were you ever 
Married to each other 
Or, living together as a couple 
Or, regular partners but never lived together 
Or, not regular partners (so far) 
20a Next to each infection, tick the box if a doctor (or other medically trained) person 
has ever told you that you had that infection: 
Genital warts 
Genital herpes 
Gonorrhoea 
Chlamydia 
Hepatitis 
HIV 
Yes, can't remember which 
NO, NONE 
OTHER (please state) 
20b I If YES to any: 
q uesti '21 on 
Where were you tested f or f he inf ecf ion? 
21 How old cire you? 
Write age in years 
22 
NB. Recent statistics: 
Chlamydia infection has increase by 300% in the last 5 years in Scotland; 
Approx. I in 10 sexually active people under 25 have chlamydia; 
Around 80% of women and 50% of men who have chlamyclia do not know they have it; 
It's easy treated with a short course of antibiotics. 
j 
Goto 
As part of this study, you can be tested 
for chlamydia here today. 
All you need to do is: 
Provide a urine sample 
" Give contact details (e. g. mobile phone no. ) 
" Within a week you will be contacted with your 
result (e. g. by text message). 
ONLY YOU will be told your result. 
ALL results are CONFIbENTIAL 
Are you willing to give a sample today to be tested for chlamyclia? 
If NO, it would be really useful to know why not? <: 1-i 
END OF QUES'TIONNAIRE 
THANK YOUP 
Karen Lorimer 
Interview Schedule 
General introduction 
" Ask to say a bit about self 
" Work - how long, how came to work in this job 
" Social isi ng/hob bies - go out with work colleagues/friends 
Going to ask more personal things now but remember you don't have to answer anything 
you don't want to. (Remind them of confidentiality. ) 
Relationship(s) 
" Start with current relationship (or most recent) (or most recent sexual experience? ) 
" Background - how met - how long - how it is going? 
" Sex? 
o When first had sex? - story 
o Contraceptive use in the relationship (or with this sexual experience if casual 
partner) 
" What method currently used? 
" Always this method? Previously used different methods? 
" Use of condoms - 
if not used, why? 
if NOT used, why not? Discussed with partner? 
First sexual intercourse 
0 Story of first sexual intercourse 
0 Contraception used? 
0 Discussion of contraception with partner 
0 Discussed with anyone else - family, friends, school, FP adviser 
0 Condoms - used first time? 
Fill in gap - other sexual relationships in between first and most recent 
o Casual - long-term.. 
o Condom use? 
mear - Have you ever had a smear test? 
" Can you tell me how you felt about the experience (physically AND emotionally) 
" Where did you have it done? How did you feel about having your smear done there? 
" When most recent smear? 
Plan on going for next smear when it's due? Why? 
Karen Lorimer 
Knowledge 
Regarding contraception: 
(Show list of persons) Can you ever remember talking to any of these people about 
contraception 
0 Could you tell me all about that conversation (how you came to talk to that 
person - did you initiate the conversation -, what you spoke about, how long did 
it last, did you enjoy the conversation, were you embarrassed, have you spoken 
to them again since about that topic, would you, did you learn anything during 
that conversation that you didn't know before talking to them, did they learn 
something from you.. ) 
Still looking at the list 
Sexual infections 
Can you ever remember talking to any of these people about sexual infections? 
o Could you tell me all about that conversation (same as above) 
Sum up their answer to the above. Check it is correct. 
" Ask about sex education if not mentioned already - what they remember. 
" In general, have they ever learned anything about contraception or sexual infections from 
speaking to people about it? 
(Show list of media) 
Can you look at this list of various media and think whether you remember hearing or reading 
about chlarnydia from any? 
a Tell me what you remember 
Ok, I'd like to ask you a bit more about chiamydia: 
" When 1 st aware about study 
" Thoughts about it? 
" Discuss study/chlarnydia with anyone? [either before filling in questionnaire or after] 
" Can you remember hearing anyone else talk about the study. 
o What did they say? 
" How did you feel being asked to take part in a study about chlamydia? 
" Some people think asking questions about health should only be done in medical locations. 
What's your view about that? 
" Is there anything you think you wouldnY want to talk about in this setting? 
" How did you feel about being offered a test for chlamydia here in your work? 
o Can you remember what other people said about it at the time? 
" How would you feel about chlamydia tests being offered in other places which aren't medical 
settings, so if chlamydia testing was offered in other non-medical places? 
(Show list of locations) 
x If you look at this list which was in the questionnaire, what places, in your opinion, are 
suitable palces in which to offer chlamydia testing? 
o Why so? 
Karen Lorimer 
Sexual infections 
" Ever worried about sexual infections? (is it something that has concerned them? ) 
" Why? 
" Ever known anyone to have caught a sexual infection? 
o What did you think about it at the time? 
" Ever been tested for anything? 
o IF YES: story of how came to be tested for a STI - 
" How felt when negative 
" how felt when positive, treatment, PN and interaction with medical 
staff (good/bad? )... 
IF NO: why never been tested for any infections? [not asked, asked but said no.. ] 
Appendix 5 
Information leaflet given to respondents who gave a 
sample 
Health Advisers & Chlamyclia 
You have just had a test for a treatable sexually 
transmitted infection called Chlamydia. If the result of 
this test returns as positive, a copy of the result will be 
forwarded to the Health Adviser team for Primary Care at 
the Sandyford Initiative, 2-6 Sandyford Place, Glasgow, 
G3 7NB. 
When the health adviser team receive this result they will 
contact you by the method of contact you chose when you 
accepted to have a test taken within the study. They 
will ensure you get the appropriate care and treatment for 
this inf ection. 
A health adviser will discuss with you what this infection is? 
How might you have got it? Your treatment and how you can 
avoid it in the future. 
The health adviser can also help you explore ways of telling 
your partner(s) you have an infection. They will help you 
get your facts right beforehand and discuss any worries 
you have about doing this. 
If you would like to speak to a health adviser at any time 
please telephone 0141 211 8634. 
NHS 
Greater 
Glasgow 
5 
This leaflet should be given to all patients having a Chlamydia test. 
Appendix 4 
Study images: test 'kit' and main study desk 
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